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Preface
This thesis is submitted as part of the requirements for obtaining the Ph.D.
degree from the Technical University of Denmark (DTU). The work presented
here has been carried out from August 2003 to July 2006 at the Department of
Physics, DTU, under supervision of Prof. Henrik Bohr and Assoc. Prof. Lars
Hemmingsen (now Department of Natural Sciences, The Royal Veterinary and
Agricultural University), as well as Assoc. Prof. Per-Ola Norrby, Department
of Chemistry, DTU. A Ph.D. grant from DTU has sponsored the project. Some
of this work has been published, and these papers are included as appendices,
along with two preliminary manuscripts.
Part of thisworkwas carriedout at theDepartment ofChemistry at Syracuse
University, Syracuse, New York, where I had the opportunity to spend two
semesters (fall of 2004 and spring 2005) in the world’s leading FT-VCD group,
supervised by Professors Laurence A. Nafie and Teresa B. Freedman.
Outline of the Thesis
Chapter 1 introduces the fundamental concept of chirality and some research
areaswhere it is significant. Chapter 2 reviews the theoretical and experimental
methods used in this project. Chapter 3 describes some studies of small or
medium-sized organic molecules, followed by larger metal complexes and
myoglobin in Chapter 4. The appendices include a list of abbreviations and
some Unix scripts written during the project. An English and Danish abstract
is also given. Finally, a number of papers and manuscripts are attached.
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Chapter 1
Introduction
1.1 Chirality
At the beginning of this thesis we need to define a central term which the
project revolves around as it progresses. Chirality means ‘handedness’ and is
a phenomenon of great importance in biology and chemistry. Just like our left
and right hands are non-superimposable mirror images of one another, so can
chiral molecules exist in pairs called enantiomers. The phenomenon of chirality
cannot occur for objects with less than three dimensions. If there are several
chiral features, and some (not all) of them are inverted, one has a diastereomer.
Both diastereomers and enantiomers are stereoisomers. The absolute configuration
of a molecule is a complete specification of its chiral features.
An even mixture of opposite enantiomers is called racemic or a racemate. If
the mixture contains a surplus of one enantiomer, the term enantiomeric excess
(abbreviated ee) is used to quantify the composition. An ee of 100% means a
pure enantiomer, whereas 0% ee is the racemate.
Before defining the different types of chirality, we recommend a review
about the science of chiral molecules in the past century [107].
1.1.1 Forms of Chirality
All the amino acids and sugars occuring in living organisms display a form
of chirality called central chirality, i.e., one or more carbon atoms with four
different groups attached. Histidine is shown as an example in Figure 1.1.
Each such tetrahedral carbon (or other chiral centre) can be characterized by a
letter (R) or (S) based on the so-called Cahn-Ingold-Prelog rules.
Another form of chirality is axial chirality. It arises when four groups sit in
a non-planar arrangement about a chiral axis. One example is aromatic rings
connected via a single bond. Depending on the twist around the axis defined
by that bond, such an arrangement can be classified as (P) or (M). If such a
distinction is to have any value, there must be steric hindrance preventing the
groups from rotating between the two orientations. This willmake them a kind
of stereoisomers called atropisomers from the Greek words for not and turn. See
1
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Figure 1.1: The two enantiomers of histidine, a common amino acid. (S)-histidine is
shown to the left and (R)-histidine to the right.
Figure 3.14 on page 41 for an example structure.
Finally, there is helical chirality. A helix, propeller or screw can be twisted
left (minus, M) or right (plus, P) around its axis. Famous examples are the
double-stranded DNA structure and the α-helical secondary structure element
found in most proteins. Obviously, helical chirality is of a more macroscopic
nature.
1.1.2 Symmetry Breaking
There are several fundamental asymmetries in Nature which one would not
expect on purely statistical grounds. As mentioned above, some of the most
abundant molecules in living organisms (amino acids and sugars) are chiral. If
these molecules were synthesized by random processes from achiral starting
materials, we would find equal amounts of each enantiomer. But in living
organisms there is (almost) perfect enantiomeric purity, such that only left-
handed amino acids1 and right-handed sugars occur.2
Another mystery is the helical structure of DNA, which always has a right-
handed twist. Of course, once we have a functioning living organism, we
would expect it to pass its symmetry breaks on to future generations. But how
these symmetry breaks first came about poses a problem to those who believe
that life originated by chance. Many explanations have been invoked [70],
among them the weak nuclear force, which has turned out to be chiral [71,99].
The example from Nature is a case of parity violation. Within quantum
mechanics, parity is the property of a wave function that it is unchanged or at
most negated by an inversion of all spatial coordinates. It is also called space
inversion symmetry. If a wave function does not obey this rule, it is referred to
as parity violation. Such a fundamental asymmetry occurs at the sub-atomic
level, more specifically it has turned out that theweak nuclear force violates the
parity principle. One way this has been observed is in the β-decay of nuclei.
1One of the 20 common amino acids, glycine, is achiral.
2Somebacteriaproduceproteins that break this rule, such as the antiviral protein gramicidin
which has interchangeably left- and right-handed amino acids [125].
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We will not go into details with this, but mention it here because the weak
nuclear force is expected to break the symmetry of some molecular vibrations,
as we will touch upon later in Section 4.2. Interested readers are referred to a
review [14].
1.2 Outline of VCD Development
It may be appropriate at this point to define the term chiroptical:
A term referring to the optical techniques (using refraction, absorption or
emission of anisotropic radiation) for investigating chiral substances [e.g.
measurements of optical rotation at a fixed wavelength, optical rotatory
dispersion (ORD), circular dichroism (CD), and circular polarization of
luminescence (CPL)].3
The simplest and oldest form of chiroptical spectroscopy is optical rotation,
which simplymeasures the (mole specific) angle of rotation of incident linearly
polarized light on a sample. The information content of such a measurement is
rather limited, though. Bymaking thismeasurement in a range ofwavelengths,
one gets optical rotatory dispersion.
Experimentally, circular dichroism (CD) is defined as the difference in ab-
sorbance of left and right circularly polarized (LCP and RCP) light. As one can
imagine, these two polarization states will be absorbed differently by opposite
chiral features—almost like our left and right hands fit differently into opposite
gloves. ECD or electronic circular dichroism is the original form of CD4, which
probes electronic transitions using visible or ultraviolet light [75]. By using
the term vibrational circular dichroism, one specifies that vibrational transitions
are studied, in which case one gets the advantage of many more bands. These
bands resonate with infrared (IR) radiation. However, VCD signals appear
only as small variations on top of an ordinary (unpolarized) IR absorption
spectrum. The difference is 3–4 orders of magnitude, placing high demands
on the measuring apparatus.
The VCD spectroscopic technique has been gradually refined over the past
three decades since its discovery [55, 80], and there are several recent reviews
on the topic [28,38,63,85,110]. Today, VCD is a well-established technique, but
not very wide-spread, even though spectrometers are commercially available
from several companies: BioTools (Wauconda, IL), Bruker Optics (Billerica,
MA), Jasco (Easton, MD), and Thermo Electron (Madison, WI).
The applicability of VCD has greatly increased with the development of
software capable of calculating VCD spectra from first principles, because that
allows for direct comparison of experimental and calculated VCD signals. This
means that the absolute configuration of a sample molecule can be unambigu-
ously determined. Relevant software packages are Gaussian (Gaussian, Inc.
3IUPAC Compendium of Chemical Terminology, 2nd Edition (1997)
4In the literature, sometimes CD is understood as electronic CD. But in this thesis, CD is
used as a common term for ECD and VCD.
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Wallingford, CT), The Cambridge Analytic Derivatives Package (CADPAC)5,
and Dalton6. Compared to VCD, ECD has the advantage of stronger signals,
but on the other hand calculations are more troublesome.
Another, rather complex technique is Raman optical activity (ROA), which
considers four types of Raman scattering of circularly polarized light [7, 76].
It was discovered about the same time as VCD, but the development of both
instrumentation and ab initio software has been slower, and only recently has
a commercial instrument appeared from BioTools (Wauconda, IL).
In Chapter 2, we introduce the theory and instrumentation of VCD in the
context of optical spectroscopyof chiralmolecules. Additionally, the theoretical
methods used are outlined.
1.3 Applications of VCD in Drug Development
Central to the development of new drugs is their 3-dimensional structure,
since this will determine their interactions with, e.g., membrane-bound recep-
tors in our cells. Therefore, it is important to characterize new candidate drug
molecules in terms of prevalent conformers and absolute configuration. These
compounds are often relatively small and chiral, which makes them very suit-
able for vibrational circular dichroism studies combining the experimental and
theoretical approaches [28, 38, 69]. There are other methods used for absolute
configuration determination—primarily X-ray crystallography, which requires
crystallization of the compound—but VCD is a good alternative, because it can
be used for samples in solution and amorphous states [38,105]. For very simple
molecules, optical rotation can be used.
Another useful application of VCD is the determination of enantiomeric ex-
cess or ee. If one has a reference VCD spectrum of a sample with a known, high
ee, then the ee of an unknown mixture of the enantiomers can be determined
from simple interpolation of the VCD spectra.
A number of small tomedium-sized organicmolecules have been examined
with theoretical and experimental VCD during this project, and these studies
are presented in Chapter 3 as well as in Papers 1–4.
1.4 Bioinorganic Chemistry in Nature
At first glance, the term bioinorganic sounds like an oxymoron: What does
inorganic matter have to do with biology? However, “inorganic” should not
be understood here as though nothing organic is involved. Rather, it means
that there are elements such as transition metal ions embedded in organic com-
pounds. Bioinorganic chemistry is highly relevant to biological processes such
as metabolism and gene regulation [11]. Metal centres enable metalloenzymes
5www-theor.ch.cam.ac.uk/software/cadpac.html
6www.kjemi.uio.no/software/dalton/
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to perform their catalytic processes at such high rates that we are only begin-
ning to pick up the trick. Apparently the combination of the bulk protein and
the electronic properties of metal ions provides ideal active sites that are both
(stereo)specific and fast. The production of the natural products considered
in Chapter 3 very likely involve several such catalytic steps, although little is
known about these processes [112, 115].
As an example, some of the methyl-substituted phenyloxirane samples in
Section 3.2 were actually synthesized using a chiral manganese complex as
enantioselective catalyst, see Figure 1.2 [43, 124].
N
Mn
O
N
O Cl
Figure 1.2: The Mn(salen) catalyst (known as “Jacobsen’s catalyst”) used by Peter
Fristrup for synthesis of methyl-substituted phenyloxiranes. Hydrogens are omitted.
Metalloproteins provide good study cases when trying to elucidate the
functioning of large biomolecules, because various spectroscopic techniques
can probe the metal ion and hence the active site directly. VCD spectroscopy
has entered the league of methods used for resolving the structure of chiral
metal sites, although the sample preparation can be more tricky than for the
smaller molecules considered in Chapter 3.
In order to understand howmetal ions contribute to biological systems, we
need to consider their electron orbitals. But a molecule the size of a protein is
still too large to analyze in detail with quantum mechanical methods. Hence,
we have to turn to more limited systems, which hopefully retain most of
the structural and electronic properties. It would of course be wonderful if
we could synthesize smaller metal complexes capable of competing with real
metalloenzymes in terms of catalytic efficiency. But that may not be possible,
since the apoprotein apparently plays a role too in terms of providing a specific
binding pocket or suitable environment for the specific task of that protein [16].
Chapter 4 contains our studies of bioinorganic systems in the form of transi-
tion metal complexes or metalloproteins. Figure 1.3 indicates which transition
metals are present in the compounds studied. The size of these complexes
border on what can be analyzed theoretically with present computers. Hence,
the protein experiments are only compared to calculations of smaller model
systems.
5
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1 2
H He
3 4 5 6 7 8 9 10
Li Be B C N O F Ne
11 12 13 14 15 16 17 18
Na Mg Al Si P S Cl Ar
19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
K Ca Sc Ti V Cr Mn Fe Co Ni Cu Zn Ga Ge As Se Br Kr
37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54
Rb Sr Y Zr Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb Te I Xe
55 56 57 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86
Cs Ba La Hf Ta W Re Os Ir Pt Au Hg Tl Pb Bi Po At Rn
Figure 1.3: Part of the periodic table of the elements, with the transition metals con-
sidered in this project highlighted.
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Methods
2.1 Theoretical Methods
2.1.1 Molecular Mechanics
This approach to modelling molecules is classical in origin: It considers the
atoms as hard spheres with springs between them [44]. One can then evaluate
the forces between atoms based on the bond lengths, valence angles and tor-
sional angles. Figure 2.1 illustrates these bonding interactions that need to be
parameterized. The force constants for these springs can be determined em-
pirically from vibrational spectra or by a more advanced modelling approach.
The simplest possible description of the springs comes from the well-known
Hooke’s law (or sine functions in the case of dihedral angles). It is also nec-
essary to consider non-bonding interactions like van der Waals or electrostatic
forces, which are often only considered for atoms within an appropriate cutoff-
distance. The entire set of parameters is called a force field, which can include
some or all atoms to different levels of sophistication. Some force fields are
targeting metal complexes, which are more tricky than purely organic com-
pounds [87].
Figure 2.1: The classical picture of molecular mechanics, showing an interatomic bond
stretch (left), valence angle bending (middle) and torsional bending (right).
Among the force fields applied during this project is the Merck molecular
force field (MMFF) [46], which gives reliable results compatible with higher-
level calculations [47].
Two different computer programs have been used for our molecular me-
chanics (MM) investigations: MacroModel (Schrödinger, Portland, OR) [73]
and HyperChem (Hypercube, Inc., Gainesville, FL). The latter was used to
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generate the images of molecular structures in this thesis, but unfortunately it
does not indicate bond orders.
MM allows for a simple and fast determination of molecular structure.
Since electrons are not treated explicitly, MM cannot be used to calculate the
spectroscopic properties of interest here. We have only used the technique as a
starting point in optimizing the geometry of theoretical molecular structures,
and therefore we will not discuss it in further detail. Instead, we will turn to
the more advanced methods.
2.1.2 Quantum Mechanics
Here, we briefly introduce some fundamental concepts, which are described
more thoroughly in various textbooks [35, 65]. In principle, quantum mechan-
ics (QM) allows for an exact solution to the problem of how electrons and
nuclei behave in the electrostatic potential created by their spatial arrange-
ment. In terms of the Hamiltonian or energy operator Hˆ, the time-independent
Schrödinger equation below gives the wave functionΨ and energy E of a sys-
tem of n electrons and N nuclei as a function of their coordinates ~ri and ~RI,
respectively, as
HˆΨ(~r1,~r2, . . . ,~rn, ~R1, ~R2, . . . , ~RN) = EΨ(~r1,~r2, . . . ,~rn, ~R1, ~R2, . . . , ~RN), (2.1)
Hˆ = −1
2
∑
i
∇2i −
1
2
∑
I
∇2I −
∑
i
∑
I
ZI
riI
+
∑
i
∑
j>i
1
ri j
+
∑
I
∑
J>I
ZIZJ
rIJ
(2.2)
The terms in the Hamiltonian are the electronic and nuclear kinetic energy
operators followedby three potential termsdescribing theCoulomb interaction
between electrons i, j and nuclei I, J with atomic numbers ZI. Atomic units are
being used.
The Born-Oppenheimer Approximation
Often, the Born-Oppenheimer approximation is invoked. It takes advantage
of the fact that the electron mass is almost 2000 times smaller than that of
the nucleons. This allows us to regard the nuclei as fixed in space and only
consider the electronic wave function ψ with the Schrödinger equation and
Hamiltonian simplified to
Hˆeψ(~r1,~r2, . . . ,~rn) = Eeψ(~r1,~r2, . . . ,~rn), (2.3)
Hˆe = −12
∑
i
∇2i −
∑
i
∑
I
ZI
riI
+
∑
i
∑
j>i
1
ri j
= Tˆe +V (2.4)
where the kinetic energy operator Tˆ and potential V have been introduced.
From this equation, information such as the electron probability distribution
|ψ|2 can be derived—at least in principle.
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The Variational Principle
The Schrödinger equation can only be solved analytically for a two-particle
hydrogen-like system (with a nucleus and an electron), in which case one
gets the stationary states (orbitals) and their energies. Introducing more nuclei
wouldmake the potentialVmore complex, and each additional electronwould
add 3 independent variables to ψ. Therefore, to treat even a single molecule,
one has to resort to numerical methods—which can be done quite efficiently
on computers.
In practice, one approaches the solution to the Schrödinger equation (2.3)
by making use of the variational principle, according to which any guess at a
solutionψdifferent from the true ground stateψ0 will have an energy Ee greater
than the ground state energy E0. Using the shorthand Dirac notation for the
integrals, one has: 〈
ψ
∣∣∣Hˆe∣∣∣ψ〉 = Ee ≥ E0 = 〈ψ0 ∣∣∣Hˆe∣∣∣ψ0〉 (2.5)
This equation introduces the concept of a functional, which is a “function of
a function”, i.e. it takes a function (ψ) as argument and returns a number (Ee).
The trick, then, is to make intelligent guesses among a properly chosen set of
wave functions.
One (conceptually) simple way of guessing at a many-electron wave func-
tion is the Hartree-Fock approximation, which combines molecular orbitals into
a normalized, antisymmetric product called a Slater determinant Φ:
ψ(~r1,~r2, . . . ,~rn) ≈ Φ = 1√
n!
∣∣∣∣∣∣∣∣∣∣∣
φ1(~r1)σ(1) φ2(~r1)σ(1) . . . φn(~r1)σ(1)
φ1(~r2)σ(2) φ2(~r2)σ(2) . . . φn(~r2)σ(2)
...
...
. . .
...
φ1(~rn)σ(n) φ2(~rn)σ(n) . . . φn(~rn)σ(n)
∣∣∣∣∣∣∣∣∣∣∣
(2.6)
which consists of one-electron orbitals φ(~r) and spin functions σ(i), where the
latter indicates the spin of electron i, which is either α(i) (spin up) or β(i) (spin
down). The elements of the Slater determinant are called spin orbitals. Having
chosen this form of thewave function, one applies the variational principle and
tries to find the set of one-electron orbitals which minimizes the total potential
and kinetic energy
〈
Φ
∣∣∣Hˆe∣∣∣Φ〉 of the electrons. This is done iteratively in a
computer by a procedure called the self-consistent field (SCF) method, because
the solution is only implicitly given: The Hamiltonian depends on the wave
function.
2.1.3 Density Functional Theory
The variational principle reveals that the ground state energy can be deter-
mined in principle from knowledge of just the potentialV (given by the nuclei)
and number of electrons n for the system of interest. But there’s more good
news: There exists a shortcut around thewave functionψ. One can consider the
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electron density ρ(~r) instead of the wave function, which in principle simplifies
the job because ρ(~r) is a function of position in space rather than the coordi-
nates of every electron. Thus, in principle one can introducemore electrons at a
much lower computational cost. Besides, the electron density is much easier to
comprehend than some many-dimensional wave function. It has been shown
that the electron density fully characterizes a system in the ground state—just
as the wave function. In other words, there is a one-to-one correspondence
between these two characterizations. Indeed, this is a surprising and substan-
tial contribution to the field of computational chemistry, which earned Walter
Kohn the 1998 Nobel Prize in Chemistry, along with John A. Pople [66, 98].1
In the present work, we have used DFT as implemented in the Gaussian 03
software (Gaussian, Inc., Wallingford, CT) [41]. Different computers have been
used, predominantly the 16-CPU Linux cluster at QuP and the IBM cluster at
Centre for Scientific Computing, Aarhus, Denmark.
2.1.4 Functionals
The major drawback of DFT is that the functional which gives the energy in
equation (2.5) is not explicitly known. More specifically, it is the exchange-
correlation part of the functional which is unknown. Several terms have been
swept under this carpet, including electron-electron interaction contributions
beyond the classical electrostatics and kinetic energy of non-interacting elec-
trons [65, 66]. Much effort goes into developing better explicit approximations
to this functional, which increase the accuracy while minimizing the computa-
tional cost.
One example of a functional is the very successful three-parameter hybrid
functional B3LYPproposedbyBecke, whichmixesHartree-Fock exchangewith
DFT exchange-correlation (Lee, Yang and Parr) [9]. Another hybrid functional
is B3PW91 [96], which uses the Perdew/Wang 91 correlation functional instead.
These two functionals have proven successful for calculating vibrational spec-
tra [110].
2.1.5 Basis Sets
In QM calculations, the wave function is typically represented by a linear com-
bination of basis functions that are relatively easy to manipulate in a computer.
Almost like a three-dimensional analogue of Taylor series, they approximate
the orbitals of real molecules, which cannot be expressed analytically. This
concept of basis sets are introduced in any decent textbook on DFT [35, 65].
Usually, linear combinations of gaussian functions are used as approxima-
tions of atomic orbitals. Each such basis function or contraction can consist of
one or more so-called gaussian primitives. A minimal basis set has one basis
function for each occupied orbital. We have only used split valence basis sets,
1See http://nobelprize.org/chemistry/laureates/1998/press.html for the entire press release
by the Nobel Committee.
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which include extra basis functions for each valence orbital in order to vary
its size. In double zeta basis sets there are two basis function per orbital, while
triple zeta basis sets have three, etc.
In addition to changing the orbital size, one can allow for changes in shape
by including some orbital character of the higher angular momentum, i.e.,
p-orbital contributions to s-orbitals, d-orbital contribution to p-orbitals, etc.
These contributions are called polarization functions and are important when
modelling atomic bonds.
Sometimes, a further increase of orbital size can be necessary, e.g., to treat
systems with negative charges. To that end, diffuse functions are added, which
have the form of s- or p-orbitals.
Finally, to treat atoms heavier than Ar in an efficient way, one often uses
basis sets which do not handle the inner core electrons explicitly, but rather
put them into an effective core potential (ECP). The rationale for this is that
primarily the valence orbitals are needed to describe bonding. At the same
time, relativistic effects can be included more efficiently.
Name Description Reference
6-31G Valence double-zeta basis set of Pople et al. [26]
6-31G(d,p) 6-31G with d- and p-polarization functions [48]
6-31++G(d,p) 6-31G(d,p) with two diffuse functions [40, 53]
D95V Dunning/Huzinaga valence double-zeta [30]
SDD D95V (H–Ar) and Stuttgart/Dresden ECPs [30]
LanL2DZ D95V (H–Ne), Los Alamos ECP + DZ (Na–Bi) [30, 121]
cc-pVDZ Dunning’s correlation consistent basis set [29]
aug-cc-pVDZ double-zeta cc-pVDZ with diffuse functions [64]
aug-cc-pVTZ triple-zeta cc-pVTZ with diffuse functions [64]
Table 2.1: Standard basis sets in Gaussian 03 used in this study.
Name Primitives→ Contractions Reference
Stuttgart RSC 1997 ECP (8s,7p,6d,1f)→ [6s,5p,3d,1f] [27]
Hay-Wadt VDZ (n+1) ECP (5s,5p,5d)→ [3s,3p,2d] [50, 121]
Ahlrichs TZV (17s,10p,6d)→ [6s,3p,3d] [102]
Ahlrichs VTZ (14s,9p,5d)→ [8s,5p,3d] [101]
Bauschlicher ANO (20s,15p,10d,6f,4g)→ [7s,6p,4d,3f,2g] [8]
CRENBL ECP (7s,6p,6d) [57]
Table 2.2: Basis sets used for the first-row transitionmetals Fe, Co, andNi in this study.
A range of such gaussian basis sets has been applied throughout this study.
Some of them are standard basis sets implemented in Gaussian—these are
briefly listed in Table 2.1.
Of the basis sets in Table 2.1, 6-31G(d), LanL2DZ and SDD have also been
used for transitionmetals. Additional basis sets for transitionmetals have been
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Name Primitives→ Contractions Reference
Stuttgart RSC 1997 ECP (8s,7p,6d)→ [6s,5p,3d] [2]
Hay-Wadt VDZ (n+1) ECP (5s,6p,5d)→ [3s,3p,2d] [50, 121]
Table 2.3: Basis sets used for Re in Section 4.2, in addition to SDD and LanL2DZ.
downloaded from the Extensible Computational Chemistry Environment Basis
Set Database [1]. These are listed in Tables 2.2–2.3.
2.2 Optical Spectroscopy
Classical physics is insufficient to explain the phenomena observed when light
(or electromagnetic radiation in general) interacts with molecules. We need to
understand the discrete nature of molecular energy levels, the electron spin,
and the orbital shapes.
About a century ago, Max Planck introduced the idea that the interaction
between matter and electromagnetic radiation is quantized. Accordingly, the
frequencies of radiation absorbed or emitted would have to correspond to a
specific transition between two states with energies E1 and E2:
∆E = E2 − E1 = h f (2.7)
where f is the frequency and h is (not surprisingly) Planck’s constant. This is
the key to modern molecular spectroscopy.
Molecules are not static entities, as they contain numerous charged parti-
cles that are orbiting, vibrating and rotating mainly due to electrostatic forces.
These particles can generate both electronic andmagnetic dipole moments. Elec-
tronic dipole moments result from displaced charges upon atomic binding,
whereas magnetic moments are due to rotating charges. Hence, interactions
with electromagnetic radiation can take place, which cause transitions in the
molecule between different states. During a transition, charge is redistributed,
leading to electric transition dipole moments (for linear displacements) and
magnetic transition dipole moments (for circular displacements). If the electric
(magnetic) transition dipole moment is zero, one refers to the transition as elec-
tric (magnetic) dipole forbidden [100].2 Information about the molecule can
be obtained by probing those transitions, and this gives rise to three families
of electromagnetic spectra with different energy ranges, as discussed in the
sections below (except for the rotational spectra).
When measuring a spectrum, a number of lines will appear at the frequen-
cies which obey equation (2.7). These lines are broadened due to ensemble
averaging of molecules that are present in many slightly different states at fi-
nite temperatures. To avoid this, one would have to look at an isolated single
2“Forbidden” does not mean that such transitions never occur: Not all electrons obey the
laws we put up.
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molecule, in which case only the inevitable broadening due to the Heisenberg
uncertainty principle will remain.
It seems intuitive to some extent, that chiral molecules will scatter or absorb
the two opposite circular polarizations differently, much like a hand fits better
into one glove than the other. We should expect that oppositely spiraling
electromagnetic waves will interact differently with the chiral arrangements of
oscillating and rotating charges it encounters. Linearly polarized light is also
affected, because it can be seen as a superposition of LCP and RCP light.
A simple way of distinguishing samples of opposite enantiomers is to mea-
sure their optical rotation, i.e., the angular shift of incident linearly polarized
light (usually the orange sodium D line), which is due to different velocities of
left and right circularly polarized light. If the angle is positive, the sample is
designatedwith a (+) or d for dextrorotatory, otherwise with (−) or l for levoro-
tatory. Unfortunately, there is no known correlation between optical rotation
and absolute configuration. Besides, there is very little information content
in the angle of optical rotation, although it can be measured as a function of
wavelength, which is what ORD is about. For our purposes, though, we need
to turn to more advanced techniques.
One chiroptical technique very recently made commercially available is
Raman optical activity (ROA), which considers different kinds of scattering
of circularly polarized light during vibrational transitions and so is the chiral
counterpart of ordinary Raman spectroscopy. We have not used these scatter-
ing techniques in this project, but refer interested readers to a review [76].
2.2.1 Electronic Spectra
Electronic transitions in atoms and molecules usually take place in the visible
or ultraviolet range of the electromagnetic spectrum, and these give rise tomost
of the colours that we perceive (and our very ability to perceive them). Figure
2.2 shows the familiar colours of light in the visible part of the electromagnetic
spectrum.
360 380 400 420 440 460 480 500 520 540 560 580 600 620 640 660 680 700 720 740 760 780 nm
Figure 2.2: The visible range of the electromagnetic spectrum.
The absorption of electromagnetic radiation by electronic transitions gives
rise to ultraviolet/visible (UV-Vis) absorption spectroscopy, which usually goes
down to around 200 nm, depending on the available UV sources. We have only
used this spectroscopic technique once (Section 3.3) and so will not introduce
it in more detail.
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2.2.2 Vibrational Spectra
The vast majority of vibrational transitions in molecules resonate with infrared
radiation, which is sometimes called heat radiation, because we perceive it as
heat. On the molecular level, heat manifests itself as random vibrations and
constant exchange of infrared radiation.
For a molecule with n atoms, the number of independent vibrational pat-
terns (normal modes) is 3n − 6 (3n − 5 for a linear molecule), since we have 3
degrees of freedom for each atomminus the displacements and rotations of the
whole molecule.
Unlike UV-Vis spectroscopy, the abscissa unit of vibrational spectra is usu-
ally wavenumbers ν¯ (in cm-1), i.e., reciprocal wavelength 1/λ, which may be
called frequency by some in the heat of battle, although the correct relation
between them is the familiar c = fλ = f/ν¯, where c is the speed of light and f is
the frequency (Hz). Part of the confusion may arise from the letter ν being used
by some to denote frequency. At least there is a one-to-one correspondence,
so ambiguity can be avoided. Not all spectroscopists are used to thinking in
terms of wavenumbers, but there is a simple relation between λ (in nm) and ν¯
(in cm-1), namely λν¯ = 107.
Interatomic vibrations are often modelled by the harmonic oscillator (the
harmonic approximation), which in the classical case is just Hooke’s law with
energy E in terms of the force constant k and deviation from equilibrium r− req:
E =
1
2
k(r − req)2 (2.8)
From quantum mechanics, we know that such an oscillator has the allowed
energy states [5]
El =
(
l +
1
2
)
h
2pi
√
k
µ
(2.9)
where k is the force constant, µ the reduced mass, and l = 0, 1, 2, . . . is the
vibrational quantum number. We recall that there is a zero-point energy for l = 0
and an identical energy spacing ∆E between subsequent levels. Furthermore,
the selection rules only allow transitions, for which ∆l = ±1.
Real interatomic potentials have an anharmonic shape close to the empirical
Morse potential
E = Ediss(1 − ea(req−r))2 (2.10)
where Ediss is the dissociation energy, req is the equilibrium distance, and a
defines the steepness of the potential well. Contrary to the harmonic oscillator,
the Morse potential has a decreasing ∆E with increasing l. Furthermore, the
selection rules allow for overtones, since ∆l = ±1,±2, . . ., but the intensity of
the overtones (∆l > 1) is rapidly diminished as l grows. Additionally, there
is a possibility for combination bands, i.e. weak absorbances at the sum of
two or more wavenumbers. If two bands (either fundamentals, overtones or
combination bands) are closely spaced, they may easily exchange energy. This
is known as Fermi resonance [5].
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Figure 2.3: TheMorse potential (—) and harmonic approximation (····) to the energy of
an interatomic bond, with some vibrational levels included to illustrate the different
energy spacing and some absorption processes to show the selection rules.
AMorse potential is compared to an approximating harmonic oscillator in
Figure 2.3. Some allowed vibrational levels and transitions for each of them
are included to illustrate the zero-point energies, energy spacing and selection
rules. From the asymmetric shape of the Morse potential, one can infer that
vibrating atoms spend more time on the far side of equilibrium separation,
because the restoring force is lower there.
Around room temperature, the population of the electronic and vibrational
ground state dominates, according to the Boltzmann distribution. Hence, we
can allow ourselves to disregard absorptions starting from the l = 1 level or
higher (called hot bands).
Infrared Spectroscopy
Infrared (IR) spectroscopy gives information about the vibrational modes of
molecules. It is also known as vibrational absorption (VA) spectroscopy, since
the molecular energy levels probed are predominantly vibrational. The ab-
sorbanceA(ν¯) or transmittance T(ν¯) quantifies the amount of radiation absorbed
by a sample as a function of wavenumber:
A(ν¯) = − log I(ν¯)
I0(ν¯)
= − logT(ν¯) (2.11)
where I(ν¯) and I0(ν¯) are the intensities measured with and without the sample
present, respectively, and T(ν¯) is simply the fraction of light transmitted by
the sample. The single-beam signal I0(ν¯) is the IR source output dampened
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by optical components along the light path—including the sample cell with
solvent, if such are being used. In that case, one should subtract a spectrum of
the solvent from that of the sample solution in order to obtain the pure sample
spectrum.
Many available texts are useful when trying to assign observed normal
modes to specific chemical groups [21, 95]. In recent years, software has also
become available, which allows one to animate calculated normal modes of
molecules on the computer screen. Examples are GaussView (Gaussian, Inc.,
Wallingford, CT), Molden3, Molekel4, and Jmol5.
2.2.3 Circular Dichroism Spectroscopy
The definition of CD is simply the difference in absorbance of left and right
circularly polarized light:
∆A = AL − AR (2.12)
Vibrational CD can be understood both as an extension to electronic circular
dichroism (ECD) and as a specialization of IR spectroscopy. Just as ECD
probes the effect of chirality on electronic transitions, VCD probes the chirality
of vibrational transitions. In other words, VCD is to IR spectroscopy what
ECD is to UV-Vis spectroscopy. Since the mid-infrared (MIR) vibrational levels
outnumber UV-Vis electronic levels, VCD provides more information than
ECD. One further advantage of VCD over ECD is that high quality vibrational
spectra can be obtained without treating excited electronic states.
Unfortunately, VCD has the disadvantage compared to ECD, that the CD
signals relative to the parent absorption spectrum are smaller. VCD is usually
around 4 orders of magnitude smaller than the parent IR absorption, this factor
is known as the anisotropy ratio g [80]:
g =
∆A
A
(2.13)
An alternative definition of g will appear below, which is more suited for
theoretical results. Needless to say, VCD requires careful optimization of in-
struments. The starting point for obtaining a VCD spectrum is to have a good
IR spectrum, otherwise the small absorbance difference∆Awill not bedetected.
If a sample molecule is replaced with its enantiomer, it corresponds to
interchanging AL and AR in (2.12), so obviously the VCD will change sign. A
racemate has zero VCD signal, at least in theory. In practice there will be small
artifacts, which one can eliminate from a VCD spectrum of a chiral sample
by subtracting its racemate spectrum or even better—if one has the opposite
enantiomer—by subtracting the average spectrum of the two enantiomers,
which is equivalent to taking half their difference.
Since our project has focused on VCD rather than ECD, only the theory of
the former will be reviewed in the following section.
3www.cmbi.ru.nl/molden/molden.html
4www.cscs.ch/molekel/
5http://jmol.sourceforge.net/
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2.3 Theory of IR and VCD
Calculations of IR and VCD spectra usually employ the harmonic approxima-
tion, where the potential energy around each equilibrium atomic bond length
is approximated by a parabola. This information is derived from the Hessian
matrix, which contains the second derivatives of the energy with respect to
position, i.e., the force constants. In reality, the shape of the potential along
interatomic bonds is rather like the Morse potential we saw in Section 2.2.2.
The anisotropy ratio g introduced in (2.13) can also be given as
g =
4R
D
(2.14)
since the rotational strength R and dipole strength D for a given transition is
proportional to the integrated VCD and IR intensity, respectively. The dipole
and rotational strengths are defined below in terms of the electric and mag-
netic dipole transition moments. The electric dipole transition moment is the
net linear charge displacement during a transition, and the magnetic dipole
transition moment is the net charge circulation [100]. For the transition from
the electronic and vibrational ground state to the first excited vibrational level
of normal mode a, the dipole and rotational strength are (using Dirac’s nota-
tion) [84, 85]
Da01 =
∣∣∣∣〈ψa0 ∣∣∣µˆ∣∣∣ψa1〉∣∣∣∣2 (2.15)
Ra01 = =
(〈
ψa0
∣∣∣µˆ∣∣∣ψa1〉 · 〈ψa1 ∣∣∣mˆ∣∣∣ψa0〉) (2.16)
where = means the imaginary part, ψ0 and ψ1 are the vibrational ground and
1st excited state wave functions, and µˆ and mˆ are the electric and magnetic
dipole moment operators, respectively:
µˆ =
∑
n
qn~rn (2.17)
mˆ =
∑
n
qn
2mnc
~rn × ~pn (2.18)
where qn, mn, ~rn and ~pn is the charge, mass, position andmomentum of electron
n, respectively (disregarding the nuclear contributions).
In the following, we use Einstein summation notation, where repeated
Greek subscripts means implicit summation over cartesian components x, y, z.
Starting with the electric dipole transitionmoment, it can be expanded in terms
of atomic polar tensor elements and nuclear displacement vectors as [74, 84]
〈
ψa0
∣∣∣µˆβ∣∣∣ψa1〉 =
√
~
2ωa
∑
A
PAαβSAα,a (2.19)
where the atomic polar tensor (APT) consist of electronic and nuclear terms
(subscript 0 means evaluation at equilibrium nuclear positions):
PAαβ =
(
∂µβ
∂RAα
)
0
= EAαβ + ZAeδαβ (2.20)
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and the S-vector or displacement vector for nucleus A and normal mode a is
given by
SAα,a =
(
∂RAα
∂Qa
)
Q=0
=
(
∂R˙Aα
∂Q˙a
)
Q˙=0
=
(
∂R˙Aα
∂Pa
)
P=0
(2.21)
where Q˙a = Pa is the conjugate vibrational momentum. The nuclear contribu-
tion ZAeδαβ to the APT is simply the charges added to the diagonal elements.
The electronic contribution EAαβ to the APT is, expressed in terms of electronic
energy Eel and electric field ~E:
EAαβ = −
 ∂2Eel∂~Eβ∂RAα

0
(2.22)
Similarly, themagnetic dipole transitionmoment canbe expanded as [74,84]
〈
ψa0
∣∣∣ mˆβ∣∣∣ψa1〉 = i
√
~ωa
2
∑
A
MAαβSAα,a (2.23)
where the atomic axial tensor (AAT) componentsMAαβ consist of electronic and
nuclear terms:
MAαβ =
 ∂mβ∂R˙
Aα

0
= IAαβ +
ZAe
2c
εαβγR
0
Aγ (2.24)
The electronic contributions to the AAT is, expressed in terms of electronic
energy Ee and magnetic field ~H:
IAαβ = −
 ∂2Eel∂~Hβ∂R˙Aα

0
(2.25)
Here appears the problem of taking a derivative with respect to nuclear
velocity R˙, which is obviously beyond the Born-Oppenheimer approximation.
Several theoretical formalisms forVCDexist, and theydealwith this problem in
differentways. Among themare vibronic coupling theory (VCT) [83], magnetic
field perturbation (MFP) [108] and nuclear velocity perturbation (NVP) [74].
These theories have also been reviewed [84]. Here, we briefly present the VCT
formalism, since this one is best suited for understanding the enhancement
phenomena in the following section. The formally equivalentMFP formulation
is the one incorporated into the Gaussian 03 software.
In the VCT formalism, the electronic AAT contribution (2.25) is given as [78]
IAαβ = 2i~
∑
e,g
〈
ψ0g
∣∣∣ mˆβ∣∣∣ψ0e〉 〈ψ0e ∣∣∣∣ ( ∂ψg∂RA,α )0
〉
E0e − E0g
(2.26)
where ψ0g and ψ0e are the vibrational ground states of the electronic ground
and first excited state with energies E0g and E0e , respectively. At this point, we
are ready to extend the VCD theory to account for the resonance case when
the denominator becomes small. This will be done mostly in qualitative terms,
since this theory has yet to be implemented in software for practical use.
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2.3.1 Resonance-Enhanced VCD
A few years after the discovery of VCD, it was observed that some transition-
metal compounds displayed differing VCD intensities for different transition
metals, while the IR intensity remained the same. This was first observed in a
sparteine complex [6]. The effect, which typically amounts to an order of mag-
nitude, was also associated with sign changes for some of the transitions. Two
decades later the same compounds were re-investigated in a broader spectral
range as well as theoretically, and the unenhanced VCD has been calculated
using quantum mechanics implemented in Gaussian [52]. Unfortunately, the
theory needed to reproduce the enhancement is not yet fully implemented. In
some cases, however, the present theory is able to reproduce at least part of the
enhancement, as we shall see later (section 4.3).
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Figure 2.4: The approximate electron density clouds of the five d-orbitals.
Equation (2.26) above suggests that we may expect increased VCD inten-
sities when the energy denominator becomes small—just before the theory
breaks down. Recently, a full theory for the emergence of enhancedVCD inten-
sities appeared, which includes non-Born-Oppenheimer terms [78]. According
to this theory, which is based on the VCT formalism, VCD enhancement can
be explained from the presence of underlying electronic CD in the infrared or
near-infrared (NIR) region. The effect has therefore been termed resonance-
enhanced VCD or REVCD. Usually, electronic transitions in molecules take
place at considerably higher energies than vibrational transitions, which is
also assumed in current computational implementations. However, in some
situations there can be low-lying (NIR or IR) electronic transitions, usually
associated with transition metal d-orbitals. In 1994 it was proposed that such
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low-lying d–d transitions could couple with vibrational transitions to enhance
the anisotropy ratio [109]. Only part of this enhancement is taken into ac-
count in existing MFP implementations of VCD, hence one cannot yet expect
reliable comparisons of theory and experiment when there are low-lying d–d
transitions (or f–f transitions in rare earth elements).
∆0
t2g
3
5∆0
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Figure 2.5: The ligand field splitting of the five d-orbitals in an octahedral coordination
geometry. As an example, the low-spin (LS) and high-spin (HS) electron distribution
is shown for a d5 element such as Fe(III).
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Figure 2.6: The ligand field splitting of the five d-orbitals in a tetrahedral coordination
geometry. As an example, the low-spin (LS) and high-spin (HS) electron distribution
is shown for a d7 element such as Co(II).
These low-lying electronic states, which are electric dipole forbidden and
magnetic dipole allowed [78], may appear when the symmetry of the ligand
field around a transition-metal ion is broken. In an isolated transition metal
atom, thed-orbitals (Figure 2.4) are degenerate. Upon coordination, the orbitals
split into different energy levels with some degree of degeneracy depending on
the symmetry of the ligand field. For instance, in octahedral coordination with
six identical ligands, the d-orbitals can be shown to split into three degenerate
lower energy levels and two degenerate upper levels [23]. These levels are
referred to as t2g and eg, respectively (Figure 2.5). If the energy spacing ∆0 is
large enough, the electrons prefer to sit in the t2g levels (low-spin configuration),
otherwise Hund’s rule causes them to populate the eg levels as well (high-spin
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Figure 2.7: The ligand field splitting of the five d-orbitals in a symmetric square planar
coordination geometry with the ligands along the x- and y-axes. As an example, the
low-spin (LS) and high-spin (HS) electron distribution is shown for a d7 element such
as Co(II).
configuration). In tetrahedral coordination, the t2g and eg levels change places
(Figure 2.6). When the coordination symmetry is broken due to chirality at
the metal ion, the degeneracy of the t2g and eg levels is lifted, and if the ap-
peared electronic transitions are near resonance with infrared or near-infrared
radiation, enhanced VCD signals will result.
Square planar coordination can be thought of as a perturbation of the oc-
tahedral geometry, where the z-axis ligands have been pulled infinitely far
apart. This gives a more complicated splitting pattern with at most two degen-
erate levels and other levels which are often close enough to allow electronic
transitions in the IR. An example of an energy diagram is shown in Figure 2.7.
When low-lying electronic states are taken into account, equation (2.26) gets
modified with a correction term depending on the vibrational frequency ωa of
normal mode a [78]:
IAαβ(ωa) = 2i~
∑
e,g
〈
ψ0g
∣∣∣ mˆβ∣∣∣ψ0e〉 〈ψ0e ∣∣∣∣ ( ∂ψg∂RA,α )0
〉
E0e − E0g
1 + ω2a(ω0e − ω0g)2 − ω2a
 (2.27)
This expression, where the bandwidth dependency is left out, is within 1%
of equation (2.26) when ωe ≥ 10ωa, i.e., when no low-lying electronic states are
present. Damping terms can be included to avoid division by zero if ωe = ωg.
The term enhanced VCD does not mean simply that the anisotropy ratio
of every band is similarly increased. Only some of the bands show enhance-
ment, and occasionally they seem to change sign as well [52]. There is a spatial
dependence involved, which only enhances those vibrational modes that can
couple with the orbitals undergoing low-lying electronic transitions. If these
ECD bands are indeed the underlying mechanism, there is obviously a depen-
dence on their frequency—and possibly on intensity and sign. However, the
exact nature of the dependencies is not clear.
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2.3.2 Processing Calculated Results
Frequency data calculated by Gaussian are given in arrays of wavenumbers
and the properties of that normal mode (force constant, reduced mass, IR
intensity etc.). When calculating a VCD spectrum, the dipole strength Di
and rotational strength Ri is added for each normal mode i. The dipole and
rotational strengths, given in terms of electrostatic units as esu2cm2, can be
converted into the more convenient molar absorption coefficient (also known as
molar absorptivity or molar extinction coefficient)  (with units of Lmol-1 cm-1)
using the equations
Di ≈ 9.2 · 10-39i
γ
ν¯i
pi (2.28)
Ri ≈ 2.3 · 10-39∆i
γ
ν¯i
pi (2.29)
where γ is the half-width (HWHM) of a Lorentzian band centered at the
wavenumber ν¯i with the peak height i (for IR) or ∆i (for VCD) [85]. Thus,
we use the dipole strength rather than the IR intensity values from Gaussian
(which are in units of km/mol).
Experimental intensities can be converted from absorbance A to molar ab-
sorption coefficient using Lambert-Beer’s law
A =  c l (2.30)
where c is the concentration and l is the path length (in cm). In this way,
calculated and experimental intensities can be directly compared. We now
have three equivalent expressions for the anisotropy ratio, relating experiment
to theory:
g =
∆A
A
=
∆

=
4R
D
(2.31)
The calculated spectral data can be plotted as a series of spikes. However,
to facilitate graphical comparison of calculated and experimental spectra, we
use the values of  and ∆ from equations (2.28)–(2.29) and convolute them
with Lorentzians (which is the natural band shape of IR absorption). A Unix
script has been written for this purpose, as described below. It generates a
Lorentzian for the IR and VCD signal of each normal mode and adds them
into two functional expressions (the IR and VCD spectra), which are then
tabulated in columns of wavenumber ν¯, molar absorption coefficient , and
molar absorption coefficient difference ∆.
Calculatedwavenumbers are typically scaled by a so-called frequency scaling
factor, which originates from the fact that calculated normal modes have sys-
tematic frequency deviations from reality, typically a few percent. The reasons
for this are the approximate electron structure calculation and the harmonic
approximation, which is assumed for the atomic bonds. Scaling factors for a
range of calculation methods have been tabulated.6
6For a comprehensive list, see http://srdata.nist.gov/cccbdb/vibscale.asp.
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When comparing calculated and experimental spectra, it is very useful to
visualize the calculated vibrational modes in order to assign them. Therefore,
we have made use of the free Java program Jmol, which can open output files
from Gaussian and animate the atomic displacements.
Unix Scripts
Besides the Unix script mentioned above, we have written several other scripts
for various purposes, and they are briefly described here. Their code is listed
in appendix B.
When several conformers of a molecule have been geometry optimized,
the script g03energies.bash can extract the SCF energies from these files and
print a table comparing their relative energies (converted to kJ/mol) as well as
the corresponding population fraction in case of a Boltzmann distribution.
The script g03toCSV.bash reads the output of a Gaussian frequency calcu-
lation and also takes a frequency scaling factor and half-width γ as arguments.
Then it converts the IR and VCD into  and ∆ values tabulated in the 400–
4000 cm-1 wavenumber range.
To make a plot of the spectral data generated by g03toCSV.bash, one
can use the script plotCSV.bash, which returns a list of commands for the
plotting program GnuPlot.7 Furthermore, the scripts annotateIR.bash and
annotateVCD.bash allows for annotating each normal mode in the above plot
with its number. These three scripts simply return the lines of GnuPlot com-
mands to use, so they are only of relevance to GnuPlot users.
To extract a table of vibrational data (wavenumbers and any properties
calculated), the script g03toFrq.bash can be used. It stores the table in a text
file. The scripts for annotation in GnuPlot need this table as input.
2.4 VCD Instrumentation
As mentioned previously, VCD requires carefully optimized instruments. The
starting point for obtaining a VCD spectrum is to have a good IR spectrum
with an absorbance within about 0.2–0.8. If the IR bands absorb more, too
little radiation may reach the detector, and poor signal-to-noise ratio (S/N) will
result. Additionally, longer scan times are needed than for IR spectroscopy.
Two different Fourier transform VCD spectrometers have been used during
the course of this project; one at QuP and one at the Department of Chemistry
at SU. Their characteristics are briefly outlined here, followed by a discussion
of key components and techniques.
The instrument at QuP is a Thermo-Nicolet Nexus 870 FT-IR instrument
(Thermo Electron Corp., Madison, WI) equipped with a VCD accessory mod-
ule. This module contains 3 mirrors, a linear polarizer, PEM-90 modulator,
BaF2 lens, and a detector.
7GnuPlot is freeware and available from http://www.gnuplot.info.
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The instrument used at SU is a modified ChiralIR spectrometer (BioTools,
Inc., Wauconda, IL), equipped with two sources [79] for better S/N and two
photoelastic modulators. The second PEM is used for baseline improvement.
In addition, we have used a Thermo-Nicolet Magna-IR 850 spectrometer
(Thermo Electron Corp., Madison, WI) at the Department of Chemistry at SU
for higher-resolution IR spectroscopy.
2.4.1 Dispersive vs. Fourier Transform Instruments
Generally, there are two types ofVCD instruments, the dispersive and the Fourier
transform (FT) spectrometers. The former uses a monochromator to select
one narrow range of IR wavelengths at a time, thereby scanning through the
spectral region of interest. Of course, the wider that region, the longer time it
takes to collect a spectrum.
A Fourier transform spectrometer, on the other hand, uses a Michelson-
Morley interferometer to simultaneously irradiate the samplewith amultitude
of wavelengths given by the pattern of constructive and destructive interfer-
ence. This is called the multiplex advantage. The pattern changes continually
as one of the mirrors in the interferometer is scanned back and forth. A
longer movement range gives a better resolution (the two are inversely pro-
portional [5]), and a lower mirror speed increases the S/N. The interferogram
modulation typically takesplace at a frequencyof a fewkHz [3,81]. A computer
is used to collect and demodulate the signal.
Recent developments have allowed for FT-VCD measurements in the con-
tinuous spectral range from 800–10000 cm-1, i.e. into the NIR, by combining
three instruments optimized in different regions [15, 82].
Since we have not used dispersive spectrometers, the following discussion
will not deal specifically with that kind of instrument.
2.4.2 Polarization Modulation
In order to measure the difference in absorption of LCP and RCP radiation, we
need to change the polarization state periodically. The modulation of polar-
ization state between RCP and LCP has to take place at a frequency different
from the Fourier modulation in order for the two modulations to be separated.
To that end, an optical component called a photoelastic modulator (PEM) is used
(Hinds Instruments, Hillsboro, OR), which consists of a crystalline slab of ma-
terial (in our case ZnSe) with tunable birefringence depending on the stress
applied to the crystal (Figure 2.8). By periodically changing the stress with
attached piezo elements, incoming light from a linear polarizer is modulated
via elliptic to circular polarization of both orientations (Figure 2.9). Depending
on the amplitude of the stress, the PEM will have its optimum at different
wavenumbers, allowing VCD measurements to be made in a region about
±600 cm-1 from the optimum.
We have used PEMs from Hinds Instruments, Inc. (Hillsboro, OR), which
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y
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Figure 2.8: Schematic of a photoelastic modulator (PEM), which consists of an octa-
hedral slab of crystalline material attached to a piezo element. The incoming light
is linearly polarized 45◦ from the symmetry axis of the crystal. Courtesy of Hinds
Instruments.
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Figure 2.9: For the purpose of VCD spectroscopy, the photoelastic modulator is driven
at periodic quarter-wave retardation (left), which generates interchangeably LCP and
RCP radiation with intermediate states of linear and elliptic polarization. Courtesy of
Hinds Instruments.
typically operate around 50 kHz, i.e., an order of magnitude above the Fourier
modulation. A lock-in amplifier and demodulator is provided with the PEM.
It is possible to use two PEMs simultaneously; one before and one after
the sample, with separate lock-in amplifiers. This allows for a better baseline
with almost no linear birefringence artifacts and thus is especially valuable
when one does not have the racemate or opposite enantiomer of a sample
available for baseline correction. The method implies driving the two PEMs
at slightly different frequencies (37.3 kHz ±15 Hz), whereby two simultaneous
VCD signals are collected and subtracted in real-time [77]. The retardation of
the second PEM can be adjusted to tune the baseline.
2.4.3 Detection
Obviously, a fast detector is needed to keep upwith the PEM frequency. There-
fore, we have used HgCdTe (also called MCT) detectors cooled with liquid
nitrogen. This type of detector has a spectral range of operation in the MIR
region around 800–4000 cm-1, though not optimal above 2000 cm-1 [15]. It is not
sensitive to the frequency or polarization state of impinging radiation.
RecordedVCD intensities have to be calibrated to account for thewavenum-
ber dependency of the PEM. The standard method of calibration is to use a
sample consisting of a quarter-wave plate followed by a linear polarizer. Two
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single-beam spectra are then measured, with the sample rotated so that its
polarizer is parallel or orthogonal to the polarizer before the PEM. When the
resolution or PEM optimum is changed, a new calibration curve has to be ob-
tained. Any recorded VCD spectrum must then be divided by this curve [62].
There are several ways to improve the S/N. The simplest is to measure for a
longer time. Increasing the acquisition time by a factor n increases the S/N by√
n [5]. There are alternatives to this trade-off, as described below, but some of
them are costly.
If possible, on can increase the S/Nby increasing the IR source intensity and
hence the dynamic range. However, this may saturate the detector, so in order
to avoid that one can use optical filters to remove especially the NIR part of the
light source. This allows one to selectively increase the intensity of radiation in
the mid-infrared (MIR) region under study. For a liquid nitrogen cooled MCT
detector, a long-wave pass filter with a cutoff above 2000 cm-1 can be used if
the C–H stretching region is not being considered.
There is a more intelligent way of removing irrelevant photons from the
bundle of radiation hitting the detector, whereby the S/N can be increased
further (actually doubled) [79]. One can use two simultaneous light sources
at adjacent corners of a four-port interferometer, with orthogonal linear po-
larizers in front of them. This makes the interferometer yield two orthogonal
interferograms, which are then passed through the PEM and sample. A stan-
dard FT-VCD instrument has a linear polarizer in front of the PEM, and in
that case, rotating the polarizer by 90◦ would interchange the RCP and LCP
radiation and thus negate the VCD spectrum. With two orthogonally polarized
sources, one removes the linear polarizer in front of the PEM and essentially
subtracts the arising pair of opposite VCD signals. What happens is that the
polarization modulated parts of radiation leaving the sample in the ideal case
combine positively, whereas the rest combines negatively. So the VCD part of
the signal increases at the expense of the ordinary IR part. Since the detector
noise level remains the same, the VCD S/N has increased.
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Small Organic Molecules and
Pharmaceuticals
3.1 Introduction: The Lesson From Thalidomide
Multicellular organisms have a host of small signalling molecules, which are
chiral, typically because they are peptides. Therefore chirality is a crucial aspect
of drug development, which has been apparent ever since the thalidomide
disaster in the mid-20th century. Thalidomide was a drug used as sleeping
aid and to prevent morning sickness of pregnant women. But it turned out to
cause serious birth defects to their children. The reason was that thalidomide
was a chiral drug, and one of its enantiomers had the desired medical effect,
whereas the other caused birth defects [33]. So these days, new drugs have
to be enantiomerically pure in the US1 and many other countries. In the
case of thalidomide, that would in fact not be possible, since the enantiomers
interconvert [33].
This chapter is devoted to the work carried out on small to medium-sized
organic molecules during the course of the project. All of them came from col-
laborators whowere interestedmainly in determining or verifying the absolute
configuration. The methyl-substituted phenyloxiranes were synthesized by
Ph.D. student Peter Fristrup from the Department of Chemistry at DTU as part
of a project on asymmetric catalysis. The remaining compounds are natural
products of pharmaceutical interest, extracted in enantiomerically pure form
by collaborators. Nyasol was supplied by Prof. Søren B. Christensen from the
Department of Medicinal Chemistry at The Danish University of Pharmaceu-
tical Sciences (DFU). The curcuphenol monomer and dimers were supplied by
Dr. Robert Cichewicz at University of California, Santa Cruz. They were sent
to Prof. Nafie’s lab at SU, where we examined them. Finally, ginkgolide B was
supplied by Assoc. Prof. Kristian Strømgaard at DFU.
1FDA’s policy statement for the development of new stereoisomeric drugs. Chirality 4
(1992), 338–40.
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3.2 Methyl-Substituted Phenyloxiranes
This project is related to studies of asymmetric catalysis taking place at the
Department of Chemistry, DTU. A collaboration was established in order to
determine the absolute configuration of the three possible methyl-substituted
phenyloxiranes. These are small, fairly rigid molecules with 1–2 chiral cen-
tres as shown in Figure 3.1. Synthesis of enantioenriched samples was done
by Peter Fristrup from the Department of Chemistry [42], whereas IR/VCD
measurements and most QM calculations were carried out at the Quantum
Protein Centre (QuP), Department of Physics at DTU. The objective was to
determine the absolute configuration by comparison of theoretical and exper-
imental VCD spectra. A paper on our joint efforts has been published and is
enclosed in appendix E as Paper 1.2
Three samples were provided in both enantioenriched and racemic form:
α-MePhOx (95% ee), cis-β-MePhOx (89% ee) and trans-β-MePhOx (99% ee),
where MePhOx is short for methylphenyloxirane. The cis-β-MePhOx sample
was known to contain 10% of its (1S,2S)-diastereomer with 73% ee.
O OO
11 2 1 2
Figure 3.1: Chemical structure of the threemethyl-substitutedphenyloxiranes studied:
(R)-1-methylphenyloxirane (α-MePhOx, left), (1R,2S)-2-methylphenyloxirane (cis-β-
MePhOx,middle) and (1R,2R)-2-methylphenyloxirane (trans-β-MePhOx, right). These
are the enantiomers investigated by theoretical methods.
3.2.1 Theoretical and Experimental Methods
The conformational flexibility of the compounds is limited to phenyl and
methyl rotations relative to the oxirane ring. Initial DFT energy calculations
of different geometries were carried out by Peter Fristrup using B3LYP/6-
311++G(d,p) implemented in Jaguar 4.2 (Schrödinger, Inc., Portland, OR).
Subsequent DFT geometry optimizations and frequency calculations were per-
formed with Gaussian 03 [41] on the Linux cluster at QuP. An earlier study of
phenyloxirane concludes that the B3LYP functional is better than B3PW91 [4],
hence we used B3LYP in the present work.
An extensive theoretical study of methyloxirane using different functionals
and basis sets for HF and DFT calculations has been published [18], which
recommends using the aug-cc-pVDZ or 6-311++G(2d,2p) basis set rather than
2In the paper, the acronym VA has been used, whereas this thesis uses the synonymous
IR. Here, we also use molar absorption coefficient instead of molar extinction coefficient to be
consistent with the rest of the thesis.
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the common 6-31G(d). We have thus included aug-cc-pVDZ in our list of basis
sets, along with its triple-zeta cousin aug-cc-pVTZ, and 6-31++G(d,p).
Gas phase calculations were carried out by Karl Jalkanen and Lars Hem-
mingsen, and are included in Paper 1. Here, we present our additional Gaus-
sian 03 calculations, which are identical to the above except for inclusion of
a self-consistent reaction field (SCRF) polarizable continuum (PCM) solvent
model for CCl4. These calculations were carried out to investigate whether im-
plicit solvation would improve the fit to experimental data. Calculated peaks
were scaled to account for systematic frequency deviations and convoluted
with Lorentzian shapes assuming a half-width of 4 cm-1. Furthermore, two
Unix scripts were used for numbering of calculated normal modes (section
B.5–B.6) in order to facilitate comparison with experiments.
IR and VCD spectroscopic measurements were carried out at QuP on the
Thermo-NicoletNexus 870 FT-IRwith a PEMaccessorymodule. Only the spec-
tra of neat samples are included here, as the solution spectra were measured
by co-authors. Neat samples were contained in a BaF2 cell with ≈15µm path
length and measured at a resolution of 4 cm-1 for 8 h. Racemate spectra were
used for VCD baseline correction. Experimental intensities were calibrated
and converted from absorbance to molar absorption coefficient. To that end,
we use Lambert-Beer’s law (2.30) in a form more suited for neat samples:
A =  c l = 
l ρ
dMW
(3.1)
where ρ is the density and d is a dilution factor (d = 1 for neat samples). The
MW is 134.2 g/mol for all three compounds, and their densities are 1.02 g/ cm3
for α-MePhOx and 1.01 g/ cm3 for both cis-β-MePhOx and trans-β-MePhOx.
3.2.2 Results and Discussion
The initial conformational search by Peter Fristrup identified only one con-
former of each of the methylphenyloxiranes, as shown in Paper 1, Figure 3.
The DFT optimized geometries from our B3LYP/aug-cc-pVTZ calculation of
the three enantiomers from Figure 3.1 are shown in Figure 3.2. There is no
noticeable structural difference compared to the calculation without solvent
model. Furthermore, it turned out that the calculated IR and VCD spectra
barely changed upon inclusion of an implicit solvent model.3
Figures 3.3–3.5 compare our experimental IR and VCD spectra of neat sam-
ples to our calculated spectra of the above enantiomers. Calculated wavenum-
bers are scaled by0.98, since that brings the peaks very close to the experimental
ones. Calculated VCD intensities are scaled with the known ee of the corre-
sponding sample. In the case of cis-β-MePhOx, the known diastereomeric pu-
rity was corrected for in the calculated IR/VCD spectra by adding/subtracting
10% of the calculated (1R,2R)-2-MePhOx IR/VCD, respectively (taking the 73%
ee of the diastereomer into account).
3These calculations were performed after submission of our paper and are therefore not
included in the final version.
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Figure 3.2: Optimized structures of three methylphenyloxiranes calculated using
B3LYP/aug-cc-pVTZ: (R)-1-MePhOx (left), (1R,2S)-2-MePhOx (middle) and (1R,2R)-
2-MePhOx (right).
It is apparent from the three comparisons, that we can assign the absolute
configurations of the three samples to be (R)-1-MePhOx, (1R,2S)-2-MePhOx
and (1R,2R)-2-MePhOx, respectively. Detailed discussion of the observed and
calculated spectra is given in Paper 1.
A major problem during this project was the rather disappointing S/N
characteristics of the VCD measurements, which made it difficult to obtain
detailed spectra. It does not seempossible tomeasuremuch better spectra with
the present experimental setup. Other people using the same spectrometer and
VCD accessory seem to have noise problems as well [32]. However, one of our
colleagues, Dr. Niels H. Andersen, has recently been able to improve the S/Nof
the spectrometerby implementinga set of optical filters. Further improvements
would be rather comprehensive or costly, such as linearizing the design of the
PEM accessory module to avoid the use of mirrors or installing a second PEM
for artifact reduction.
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Figure 3.3: Comparison of experimental and calculated IR (bottom) and VCD (top)
spectra of α-methylphenyloxirane. Calculated spectra are for the (R)-enantiomer with
95% ee, using B3LYP/aug-cc-pVTZ with an implicit solvent model, using 4 cm-1 half-
width and a frequency scaling factor of 0.98. Most fundamentals are numbered.
Experimental spectra are of neat samples, measured for 8 h using 4 cm-1 resolution
and a 17.3µm path length.
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Figure 3.4: Comparison of experimental and calculated IR (bottom) and VCD
(top) spectra of cis-β-methylphenyloxirane. Calculated spectra are for the (1R,2S)-
enantiomer with 89% ee, but include 0.73×10% of the (1S,2S)-diastereomer spectra to
account for its presence in the sample. TheDFTmethodwas B3LYP/aug-cc-pVTZwith
an implicit solvent model, using 4 cm-1 half-width and a frequency scaling factor of
0.98. Fundamentals for cis-β-MePhOx are numbered. Experimental spectra are of neat
samples, measured for 8 h using 4 cm-1 resolution and a 16.5µm path length.
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Figure 3.5: Comparison of experimental and calculated IR (bottom) and VCD (top)
spectra of trans-β-methylphenyloxirane. Calculated spectra are for the (1R,2R)-
enantiomer with 99% ee, using B3LYP/aug-cc-pVTZ with an implicit solvent model,
using 4 cm-1 half-width and a frequency scaling factor of 0.98. Most fundamentals are
numbered. Experimental spectra are of neat samples, measured for 8 h using 4 cm-1
resolution and an 18.6µm path length.
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3.3 Nyasol
The compound nyasol is a natural product with antiplasmodial and anti-
fungal activity, and both of its enantiomers can be derived from different
plants [58, 61, 90, 94, 118]. The IUPAC name of the compound is (Z)-1,3-bis(4-
hydroxyphenyl)-1,4-pentadiene, and its structure is shown in Figure 3.6, where
a single chiral centre can be seen. Our objective was to determine the absolute
configuration of (+)-nyasol from Asparagus africanus and thereby resolve the
uncertainty in a previous attempt to do so [72] and allow for tests of differing
biological activity of the enantiomers. This project was carried out in collabo-
ration with the Department of Medicinal Chemistry at the Danish University
of Pharmaceutical Sciences (DFU), from where the sample was provided. IR
and VCD Measurements were carried out both at QuP and at the Department
of Chemistry at Syracuse University (SU). Our results have been published and
are included as Paper 2.
OH
OH *
Figure 3.6: The chemical structure of nyasol, (Z)-1,3-bis(4-hydroxyphenyl)-1,4-
pentadiene. An asterisk indicates the chiral centre.
Nyasol is soluble in DMSO, acetonitrile, and methanol, but insoluble in
chloroform. The compound is colourless, but is reported to turn red on expo-
sure to air [90].
3.3.1 Conformational Analysis and DFT Calculations
A Systematic Unbounded Multiple Minimum (SUMM) conformational search
(details are in Paper 2) revealed 26 conformers in the gas phase within an en-
ergy range of 20 kJ/mol, 12 of which were within 6 kJ/mol from the ground
state (see Table 1 and Figure 1 of Paper 2). Thus, nyasol is very flexible in
spite of its modest size, and many conformers have to be taken into account
when calculating theoretical spectra. Subsequent DFT geometry optimization
using B3LYP/6-31G(d,p) brought 16 conformers within that energy range due
to pronounced energy shifts when going from MM to DFT methods. These
16 conformers could be divided into groups of four based on their aliphatic
dihedral angles, with each group containing 2×2 different hydroxy group ori-
entations. The lowest energy structure is shown in Figure 3.7. The 8 lowest
energy conformers were reoptimized using B3LYP/aug-cc-pVDZ, which is a
larger basis set with diffuse functions and therefore assumed to yield more
reliable results. For the purpose of Boltzmann weighting, the SCF energies
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Figure 3.7: Optimized structure of (S)-nyasol in its lowest energy conformer, calculated
using B3LYP/6-31G(d,p).
from the larger basis set were corrected with zero-point energy and Gibbs free
energy contributions from the 6-31G(d,p) frequency calculations as suggested
by a recent DFT study [91].
IR and VCD spectra were calculated using both B3LYP/6-31G(d,p) and
B3LYP/aug-cc-pVDZ, as well as B3LYP/6-31G(d,p) with a self-consistent re-
action field (SCRF) solvent model for DMSO.
3.3.2 Results and Discussion
The significant number of conformers posed a problem for recording a good
VCD spectrum of nyasol, because their signals in some cases cancel each other.
The calculated IR and VCD spectra of the 8 lowest energy conformers are
shown in Figure 3.8, from which we can identify the spectral regions where
VCD signals cancel or add up. The latter regions tell us where to look in an
experimental VCD spectrum in order to determine the absolute configuration.
Such regions are the strong positive signal at 1530 cm-1, as well as 800–1000 and
1590–1650 cm-1.
There is no substantial difference between the spectra calculated with these
basis sets, but their peak positions are slightly different, as can be seen in Paper
2, Figure 4.
Our (+)-nyasol sample had turned red when we received it, indicating
some degree of chemical change. An NMR spectrum was recorded at the
Department of Chemistry at DTU, which identified the sample as nyasol, but
with 10–20% of pollution.4 However, our UV-Vis spectrum (Paper 2, Figure 6)
is in agreement with previous results [72].
IR and VCD spectra were recorded both in DMSO-d6 and in a KBr pellet,
using a ChiralIR instrument at SU to get improved baseline and S/N. Only the
KBr pellet reveals the spectral region 800–1000 cm-1, which is blocked by BaF2
windows and DMSO-d6. In Figure 3.9, the observed spectra are compared to
4Per-Ola Norrby, personal communication (data not shown).
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Figure 3.8: Calculated IR (bottom) and VCD (top) spectra of the 8 lowest energy con-
formers of (S)-nyasol in the gas phase, using B3LYP/aug-cc-pVDZ without frequency
scaling. The spectra of conformers 5–8 are offset for clarity.
the Boltzmann weighted averages of the calculated IR and VCD from Figure
3.8. Calculated wavenumbers have been scaled by 0.97.5 Paper 2, Table 2 gives
assignments of most of the peaks present in the calculated spectra of the lowest
energy conformer.
When comparing the calculated and experimental spectra, the crucial VCD
spectral regions identified above display good agreement, especially in the
800–1000 cm-1 region of the KBr pellet measurement and around 1500 cm-1 in
DMSO-d6. Based on this comparison, we can assign the absolute configuration
of the sample as (S)-(+)-nyasol.
There are some discrepancies in other spectral regions, which can be ex-
plained by examining the IR spectra. The intense modes calculated around
1185 cm-1 arise from O–H bending, which appear to be quenched by hydrogen
bonding in both solution and KBr. There is also considerable broadening of
the C–O stretching band around 1250 cm-1, which we likewise suspect to be
influenced by hydrogen bonding. In the KBr pellet, the sample molecules are
still in proximity and can hydrogen bond.6
5According to the Computational Chemistry Comparison and Benchmark DataBase (CC-
CBDB), http://srdata.nist.gov/cccbdb/vibrations.asp.
6We can compare the pellet to a slice of salami, where the sample molecules are the red
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A strange observation is the broad negative VCD signals around 1000–
1100 cm-1. The only reason we can think of is stress-induced birefringence
artifacts from the KBr pellet.
The proposed effect of hydrogen bonding has been verified by DFT calcu-
lations with an explicit DMSO-d6 molecule next to each OH group, see Figure
3.10, which compares implicit and explicit solvent inclusion. The latter is not
shown in Paper 2. The overall agreement with the experimental IR spectrum
improves with explicit solvent molecules, since the intensity of the 1185 cm-1
bands has decreased considerably, and the broad features in the 1200–1300 cm-1
region are better reproduced. The DMSO-d6 modes introduced are primarily
at 860, 1000, and 1040 cm-1, i.e., outside the spectral range of the measurement.
Thus, our calculations with explicit solvent molecules work better than the
SCRF (PCM) implicit solvation calculation shown in Paper 2 (Figure 4), be-
cause they take the specific solvent-solute interaction into account. In fact, the
continuum solvent model turns out to intensify the discrepancy at 1185 cm-1.
The calculated VCD spectrum of the lowest energy conformer with explicit
DMSO-d6 is of little use due to considerable artifacts, which probably arise
because the single nyasol-DMSO-d6 arrangement considered is not representa-
tive of reality. Rather than considering an ensemble of arrangements, we have
only one, thereby losing isotropy and introducing artificial VCD signals from
the chiral nyasol-DMSO-d6 arrangement. The only recognizable experimen-
tal feature seems to be the 1510 cm-1 band. Considerable improvement of the
fit is achieved by including the next three conformers and averaging, which
apparentlymakemost of the DMSO-d6 artifacts cancel each other. The two cor-
responding IR spectra look similar, as wewould expect from their insensitivity
to the additional chirality introduced.
“meat” and the KBr particles play the role of the fatty bits.
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Figure 3.9: IR (bottom) and VCD (top) spectra of nyasol. Calculated spectra are Boltz-
mann weighted averages of the 8 lowest conformers of (S)-nyasol using B3LYP/aug-
cc-pVDZ, with wavenumbers scaled by 0.97 and a half-width of 6 cm-1. Samples
measured are 0.20m nyasol in DMSO-d6 solution (5.0mg of nyasol in 100µL DMSO-
d6 in a BaF2 cell with 100µm path length) as well as a KBr pellet (≈2mg nyasol in
250mg KBr,  13mm × 1mm). Spectra were measured with 8 cm-1 resolution and the
PEMs set at 1400 cm-1, using an acquisition time of 9 h in solution and 31 h for the KBr
pellet. Spectra in DMSO-d6 have had the solvent signals subtracted, and the KBr pellet
spectra have been converted to molar absorption coefficient by scaling the absorbance
to match that of the solution.
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Figure 3.10: Calculated IR (bottom) and VCD (top) spectra of (S)-nyasol with an
implicit PCM solvation model using B3LYP/6-31G(d,p), as well as explicit solvent
calculations with 2 DMSO-d6 molecules for both the lowest energy conformer and the
four lowest (averaged), using B3LYP/6-31G(d,p). Calculated wavenumbers are scaled
by 0.97 and peaks broadened to 6 cm-1. Experimental spectra in DMSO-d6 solution
(solvent background subtracted) are shown above (same data as in Figure 3.9).
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3.4 Curcuphenol Dimer
As part of the collaboration with Prof. Nafie and Freedman’s lab at SU, we
were asked to investigate the curcuphenol dimer isolated from themarine snail
Didiscus aceratus by a group from University of California, Santa Cruz [49]. A
range of pharmaceutically interesting compounds had been isolated from this
snail, all of which were derivatives of (S)-(+)-curcuphenol with the IUPAC
name 2-((S)-1,5-Dimethyl-hex-4-enyl)-5-methyl-phenol [123]. Specifically, we
were asked to elucidate the axial chirality of two curcuphenol dimer atropi-
somers, which hereafter will be referred to simply as the dimers. Samples of
monomeric (S)-curcuphenol and both of its dimers were received. The struc-
ture of (S)-curcuphenol and its dimer are shown in Figure 3.11. The dimer has
two chiral centres in addition to the chiral axis, which emerges upon dimer-
ization and is fixed in (P) or (M) configuration by steric hindrance. Below, we
describe our part of the investigations, which are included in a publication.
This paper is enclosed as Paper 3.
OH
OH
OH
Figure 3.11: Chemical structure of (S)-curcuphenol (left) and its dimer (right). The
dimer has a chiral axis along the bond connecting the phenol rings, which gives two
possible stereoisomers (atropisomers).
3.4.1 Theoretical Model Compound
The optimized structure of one conformer of a dimer is shown in Figure 3.12,
and it suggests the problem of a large conformational space. Each half of
the dimer has five variable dihedral angles in addition to the methyl groups,
so this is an even greater challenge than nyasol (treated in Section 3.3). A
conformational search with HyperChem using the force field MM+ [54] or the
semi-empirical method PM3 [111] gave 20 conformers in the gas phase for
curcuphenol alone, so we could not calculate VCD spectra of all possible dimer
conformers. We also cannot be sure that the conformer displayed in Figure
3.12 is the lowest energy state.
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Figure 3.12: DFT optimized structure of a curcuphenol dimer, calculated using
B3LYP/6-31G(d).
OH
OH
Figure 3.13: Chemical structure of 3,6,2’,5’-tetramethyl-biphenyl-2,4’-diol, a truncated
model compound for the (P)-dimer of curcuphenol. It has axial chirality, but no chiral
centres.
Figure 3.14: DFT optimized structure of the truncated model compound for the (P)-
atropisomer of the curcuphenol dimer, calculated using B3LYP/6-31G(d).
Rather, we chose only to conduct DFT calculations of the most relevant
fraction of the dimer, which contains the axial chirality but cuts away the
flexible chains and chiral centers by turning the latter into methyl groups. This
theoretical model structure is shown in Figure 3.13. The idea was to calculate
the VCD of this chiral axis structure and compare it to the measured difference
VCD of the dimers. Since the axial chirality of the dimers is opposite whereas
their central chirality is identical, this subtraction was hoped to leave us with
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spectral features pertaining primarily to the axial chirality. This strategy turned
out to be successful.
The model compound has very limited conformational flexibility: the lone
pairs of each oxygen can point towards or away from the neighbouring methyl
group. The former orientation is favoured by a total of 18 kJ/mol over the latter,
when both structures are optimized using DFT with the B3LYP functional and
6-31G(d) basis set. Thus, it was assumed adequate to consider only the lowest
energy state. Figure 3.14 shows this optimized structure.
3.4.2 Experimental and Calculated Spectra
DFT calculations of the IR andVCDof themodel compound abovewere carried
out with Gaussian 03 at the B3LYP/6-31G(d) level of theory. The vibrational
frequencies output by Gaussian were scaled by 0.97.7 Furthermore, the calcu-
lated IR and VCD intensities (given in terms of dipole and rotational strength)
were converted into Lorentzians with a half-width of 6 cm-1 for comparison to
experiment.
Themeasured IR andVCDspectra of curcuphenol and its dimers are shown
in Figure 3.15, with the experimental conditions outlined in Table 3.1. Because
the VCD signals of curcuphenol are largest between 1100–1300 cm-1, we must
expect that region of the VCD spectra for the dimers to be a poor indicator of
the axial chirality. In turn, only the dimers have significant VCD bands above
1400 cm-1, so these must arise from the chiral interaction of the two monomers
and therefore bear a fingerprint of the axial chirality. This is confirmed by the
opposite sign of those VCD bands. The dimer VCD signals below 1400 cm-1
are not opposite in sign, because the identical chiral centers contribute nearly
equally. Thus, the region above 1400 cm-1 will be the most important one to
compare with the calculated spectra.
The IR spectrum of curcuphenol has many similarities with those of the
dimers, since they have large parts in common. The two dimer IR spectra
look almost identical, except for minor discrepancies around 1000–1050 cm-1
and 1700 cm-1, arising either from impurities or the fact that the dimers are
diastereomers.
Sample Concentration Path length Acq. time
Curcuphenol 0.59m (8.4mg in 65µL) 54µm 20 h
Dimer #1 0.11m (8.3mg in 180µL) 98µm 10 h
Dimer #2 0.23m (10.8mg in 110µL) 98µm 10 h
Table 3.1: Experimental conditions for spectra of (S)-curcuphenol and its atropisomer
dimers. All spectra were recorded using CDCl3 solutions in BaF2 cells, with the same
acquisition time for sample and solvent. The resolution was 4 cm-1, and the two PEMs
of the ChiralIR instrument were set at 1400 cm-1.
7This scaling factor lies within the range suggested by the CCCBDB database,
http://srdata.nist.gov/cccbdb/vibrations.asp.
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The calculated VCD spectrum of the model compound can be compared
to difference VCD spectra of the two atropisomers, because this subtraction
almost eliminates the spectral features of the alkyl side chains and their chiral
centers, which are identical in the two atropisomers. The calculated spectra of
the model compound along with the dimer IR and difference VCD (#2 − #1)/2
of the atropisomers is shown in Figure 3.16. The overall agreement between
observed and calculated VCD indicates that dimer #2 is the (P)-atropisomer
(and vice versa).
Although the calculated and observed IR spectra do not pertain to the same
compound and so do not have to coincide, the bands around 1500 cm-1 and
higher compare well.
The success of this VCD comparison is partly because some spectral fea-
tures of the axial chirality are in a spectral region with negligible signals from
the chiral centres. But even the spectral region below 1400 cm-1 shows very
good agreement between calculated and experimental spectra, confirming the
assumption made about the cancellation of central chirality features.
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Figure 3.15: Observed IR (lower traces) and VCD spectra (upper traces, with the
VCD noise level shown above) of (S)-curcuphenol (left) and its dimers (right), #1 (—)
and #2 (····). Experimental conditions are given in Table 3.1 above. Solvent spectra are
subtracted, andabsorbance converted intomolar absorption coefficient usingLambert-
Beer’s law (2.30).
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Figure 3.16: Observed IR spectrum (bottom) and difference VCD (#2 − #1)/2 of the
atropisomers (top) vs. DFT calculated spectra for the (P)-atropisomer of the model
compound in Figure 3.13, using B3LYP/6-31G(d). Experimental conditions are given
in Table 3.1.
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3.5 Ginkgolide B
Wehave embarked on another collaboration with the Department ofMedicinal
Chemistry at DFU, where Assoc. Prof. Kristian Strømgaard is involved in in-
vestigating derivates of ginkgolides [113,114,120], which are natural products
from the Ginkgo biloba tree. Extracts from this tree have been used for med-
ical purposes for millenia. The benefits should include anti-asthmatic effects
and memory improvement [60, 86, 112]. A number of terpene trilactones have
been extracted from Ginkgo biloba, among them the ginkgolides. Most of their
known physical properties and spectroscopic data are summarized in a recent
review [119]. However, to the best of our knowledge no VCD spectra have
been published previously.8
We were asked to obtain theoretical and experimental VCD spectra to ver-
ify the absolute configuration of Ginkgolide B (GB), one of several related
ginkgolides as illustrated in Figure 3.17. Dr. Niels H. Andersen initiated mea-
surements of GB and one of the ginkgolide derivates under study at DFU. Part
of our measurements were carried out at SU. Our VCD studies are presented
in a preliminary manuscript attached as Paper 4.
Of the compounds studied during this Ph.D. project, GB is the one with the
most chiral features, since it has an impressive 11 chiral centres among its 54
atoms. The absolute configuration is known from the published X-ray struc-
ture [31]. A DFT study of the structure and IR spectrum of GB has also been
published, where a conformational search and subsequent geometry optimiza-
tion of the lowest energy structure matched the X-ray structure [126]. There
are two intramolecular hydrogen bonds, one of which becomes intermolecular
upon crystallization.
O
O
O
O
O
H
R3 H
R2
H
OH
O
O
R1
Structure R1 R2 R3
Ginkgolide A H H OH
Ginkgolide B OH H OH
Ginkgolide C OH OH OH
Ginkgolide J H OH OH
Ginkgolide M OH OH H
Figure 3.17: Chemical structure of a family of ginkgolides [119], where the residues
R1–R3 differ as listed to the right. Hydrogens at chiral centres are shown for clarity.
Depending on the residues, there are 10–12 chiral centres. Only ginkgolide B (with 11
chiral centres) has been studied in the present work.
8Readers looking for the references should be aware that two of them have been published
with typos in their titles [31, 86].
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3.5.1 Theoretical and Experimental Methods
DFT calculations were performed with Gaussian 03 [41], using the B3LYP
functional and 6-31G(d,p) basis set. An augmented basis set of Dunning, aug-
cc-pVDZ [29], was also tried but failed to converge. A set of six conformers
were provided, optimized with B3LYP/6-31G(d).9 We calculated the IR and
VCD spectra of the lowest energy conformer using the 6-31G(d) and 6-31G(d,p)
basis sets.
Ginkgolides are very stable compounds, soluble inCH3OH,CH3CN,DMSO
and others, but insoluble in CH3Cl and CCl4 [119]. In order to reduce solvent
absorbance and solvent-solute interactions, we decided to use deuterated ace-
tonitrile, CD3CN, wherein 1.8mg of GBwas dissolved to obtain a total volume
of 50µL, corresponding to an 85mm solution when using the calculated MW
= 424.4 g/mol.
Aftermeasuring the IR andVCDspectra inCD3CN, the samplewas restored
by letting the solvent evaporate. Roughly half of the GB left was then ground
with 250mg KBr in a Wig-L-Bug R© for 30 s and pressed into a pellet under
13000 lbs for 4 min in order to record the solid-state spectra of GB.
The spectra presented below were measured on the modified ChiralIR FT-
VCD at SU, using a resolution of 4 cm-1 with the instrument optimized at
1400 cm-1 and acquisition times of 4–12 h.
3.5.2 Results and Discussion
A population analysis of the provided B3LYP/6-31G(d) conformers using one
of our Unix scripts (section B.1) found of a dominating lower energy conformer
(95%), with energy differences 7.3 kJ/mol and 16 kJ/mol from the next available
conformers (the structural difference lies in the orientation of the three OH
groups). Hence, it was reasonable only to consider the dominating conformer,
the structure of which is shown in Figure 3.18.
Reoptimization and VCD calculation of the lowest energy conformer with
the 6-31G(d,p) basis set gave only minor changes compared to the 6-31G(d)
calculated, most notably a slight intensity increase at 1250 cm-1. So the extra
polarization functions do not contribute much, and in fact the fit to the exper-
imental band at 1250 cm-1 is better with 6-31G(d,p). Figure 3.19 compares the
experimental spectra in CD3CN solution and KBr pellet to the B3LYP/6-31G(d)
calculation. We have used a frequency scaling factor of 0.98 for the calculated
spectra, which is a compromise between the higher and lower wavenumber
regions, where the scaling factor seems too high or too low, respectively. Ide-
ally, one should use a nonuniform scaling. Our scaling factor deviates from
the factor 0.945 suggested in an earlier IR study [126]. Their spectrum was of
poorer quality, though.
The IR spectra have many bands that overlap, and the condensed ring
structure of GB also makes a rigorous assignment difficult. But a good overall
9From a master student project by Niels Johan Christensen.
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Figure 3.18: DFT optimized structure of ginkgolide B in the lowest energy structure,
using B3LYP/6-31G(d,p).
agreement can be seen. The most notable difference is improper scaling of
the lactone C=O stretches just below 1800 cm-1, which also do not appear
as a doublet band in CD3CN, presumably due to hydrogen bonding or other
solute-solute interactions. Such interactions are also likely to influence theO–H
bendingmodes, one ofwhich (1170 cm-1) appears too intense in the calculation.
Water traces can be seen in the IR of the KBr pellet at 1625 cm-1, and the
CD3CN solution seems to have a small negative band there, suggesting that the
solvent spectrum used for subtraction had more water than the sample. Both
KBr and CD3CN are hygroscopic, so this is not unusual, even though care was
taken to keep the samples dry.
As we turn to the VCD spectra, we see very good agreement, in particular
between calculation and measurement in solution. The aforementioned dis-
crepancies of C=O stretch frequency scaling and O–H bending persist. In turn,
the C=O stretching VCD couplet is resolved also in CD3CN, where the IR dou-
blet was not. For the KBr pellet, the VCD features in this region are sharper, as
one would generally expect for the solid state, but there is also a broad positive
feature just above 1700 cm-1, which has no visible parent IR absorbance and is
not readily interpreted. The calculated spectrum has two closely spaced neg-
ative bands at 1867 and 1874 cm-1 and one positive band at 1892 cm-1, which
matches the sign pattern of the sharp features, because there is a shoulder on
the negative band. So the origin of the broad feature is uncertain.
From the excellent agreement of calculated and observed VCD spectra, we
have verified the absolute configuration of GB. That is an impressive achieve-
ment, considering the 11 chiral centres present, and it would most likely not
be possible if there had been more conformational flexibility in the compound.
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Figure 3.19: Observed vs. DFT calculated IR (bottom) and VCD (top) spectra of
ginkgolide B. Calculated spectra are for the lowest energy conformer in the gas phase,
using B3LYP/6-31G(d) with a scaling factor of 0.98 and half-width 5 cm-1 (left axis).
Experimental spectra are recorded in CD3CN solution (solvent subtracted, left axis)
and in a KBr pellet (right axis). VCD noise levels are shown at the very top. Spectra
were measured on the modified ChiralIR instrument, with 4 cm-1 resolution and the
PEMs set at 1400 cm-1. Further conditions for the CD3CN solution: 1.8mg GB in 50µL
(85mm), in a 54µm BaF2 cell using 12 h acquisition time for sample and solvent. For
the KBr pellet: ≈1mg GB in 250mg KBr ( 13mm × 1mm, pressed for 4 min at a load
of 13000 lbs) using 4 h acquisition time.
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3.6 Summary
During this chapter, we have studied several small or medium-sizedmolecules
(from aDFT viewpoint). Their number of chiral centres ranges from 1 to 11, and
their conformational degrees of freedom range from 1 to 11 dihedral angles,
as can be seen from table 3.2, which compares the basic features of the organic
sample molecules studied.
Sample Atoms MW (g/mol) Angles Chiral features
α-Me-phenyloxirane 20 134.2 1 1 centre
cis-β-Me-phenyloxirane 20 134.2 1 2 centres
trans-β-Me-phenyloxirane 20 134.2 1 2 centres
Nyasol 35 252.3 6 1 centre
Curcuphenol dimer 74 434.7 11 2 centres, 1 axis
Ginkgolide B 54 424.4 4 11 centres
Table 3.2: Comparison of physical properties of the molecules treated in this chapter.
“Angles” is the number of variable dihedral angles apart from methyl rotations.
Since the size and conformational flexibility of these samples vary consid-
erably, we have provided a good overview of the capabilities of the methods
used, primarily for absolute configuration determination.
In all cases, we have successfully determined or verified their absolute
configuration by comparing experimental and calculated VCD intensities. The
IR spectra have also been compared as a structural fingerprint. Although IR
lacks the information on chirality, often other features are more clearly seen
in IR than VCD, such as the presence of water contamination or whether
calculated wavenumbers have been scaled appropriately.
We have used two different experimental setups, either the Thermo-Nicolet
Nexus 870 FT-IR spectrometer at QuP or a BioTools ChiralIR FT-VCD instru-
ment in Syracuse, NY. The latter has amore advanced setupwith simultaneous
operation of two IR sources and two PEMs, and it obviously outperforms the
other instrument in terms of S/N and baseline flatness.
Some solvent effects have been observed. Polar solvents interact more with
the solute, as we saw primarily in the case of nyasol in DMSO-d6, where O–H
bending featureswere disturbedby intermolecular hydrogenbonding. Explicit
inclusion of solvent molecules resolved some discrepancies between gas phase
calculations and solution measurements. On the other hand, using implicit
solvent models gave only minor corrections to the gas phase calculations.
The use of a solid-state matrix (KBr pellets) allowed for spectroscopy in
the solid phase, although for a viscous sample like nyasol it was rather like
a neat sample. KBr has the benefits of allowing a wider spectral range and
usually better resolved peaks than in solution. But the pellet also influences
the VCD measurements by introducing birefringence artifacts which cannot
be subtracted using a pure KBr pellet, since the two pellets would not have
identical stress profiles. So there is less reproducibility.
49
CHAPTER 3. SMALL ORGANIC MOLECULES AND PHARMACEUTICALS
Our most flexible sample was the curcuphenol dimer, in which case we
did not bother to perform a conformational analysis, because the subsequent
number of DFT jobs was anticipated too large to be feasible. Fortunately, we
were able to come up with a smaller model structure able to reproduce the
spectral features in question. Hence, nyasol was our most computationally
demanding DFT study so far, with 26 conformers geometry optimized using
B3LYP/6-31G(d).
The largest molecule studied was the curcuphenol dimer, but a smaller
model strategy provided the theoretical foundation of the conclusion. So
ginkgolide B with its 11 chiral centres is the largest structure, for which we
have calculated IR/VCD spectra in this chapter. That could be achieved within
about a week. So we have not reached the system size limit of the present QM
methods. The next chapter will bring us closer to that limit as we bring heavy
metal centres into play, with theirmany electrons and different spin states—not
to mention the large complexes they form.
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Chapter 4
Transition Metal Complexes and
Metalloproteins
4.1 Introduction
VCDcalculations onmetal complexes have only recently beenundertaken, pio-
neered by our collaborators at SU [39,52]. The ability to compare experimental
and calculated VCD spectra of such (usually electron-rich) compounds opens
new possibilities, especially when REVCD theory becomes implemented in
DFT software to yield more reliable calculations of complexes with low-lying
electronic transitions.
We became involved in some studies of transition metal complexes and
metalloproteins while staying at SU, the results of which are presented in this
chapter. First, there is a thorough characterization of some rhenium (Z = 75)
complexes. These are not of direct biological relevance, except for the use of
rhenium in radiopharmaceuticals [68]. These rhenium compounds are used
in a search for parity violation (PV) at the sub-atomic level, which indirectly
may be highly relevant to biology if PV turns out to have an influence on what
we may call the enantiomeric excess of life, i.e., the overwhelming natural
predominance of one enantiomer over the other in the basic building blocks in
biology [71, 99].
REVCD effects were not the issue with the rhenium complexes, but were
observed in several other cases, which are reviewed in Sections 4.3–4.4. Two
complexes were being studied experimentally, while we were running DFT
calculations on them. Additionally, we ran a series of VCD experiments on
myoglobin with different ligands, where new REVCD features were observed.
Unfortunately, proteins are well beyond the exponential wall of DFT [66], so
we were restricted to running calculations on just the heme group and ligands,
hoping that they would reproduce some of the observed REVCD in spite of the
presently lacking theoretical implementations.
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4.2 Rhenium(V) Complexes
The rhenium complexes studied in this project are part of an ongoing search
for parity violation (PV) in IR spectroscopy, i.e., slightly different absorption
frequencies of opposite enantiomers induced by interaction with the weak
nuclear force, which is chiral in itself. The absorption frequency difference is
predicted by the standard model to be infinitesimal, requiring very advanced
techniques for its observation, which are currently investigated in a French
lab [24, 25, 106]. More specifically, the Re=O stretching mode of several chiral
oxorhenium(V) complexes is studied with an ultra-stable tunable CO2 laser.
It has turned out that the PV energy difference scales with atomic number
approximately asZ5, therefore the present rhenium samples are very promising
candidates for its observation [24, 103, 104].
Here, we present our benchmark analysis of two oxorhenium(V) complexes
containing the hydrotris(1-pyrazolyl)borate (Tp) ligand. We recorded IR and
VCDspectra of the compounds andperformed density functional theory (DFT)
calculations of those same spectra using several basis sets in order to find a
good methodology for further studies. The synthesis was done by collabora-
tors in France, and our spectroscopic measurements were carried out at the
Department of Chemistry at SU, while calculations were running in Denmark.
These studies are included in the attachedPaper 5, which describes somenewer
rhenium complexes as well. To the best of our knowledge, this is the first VCD
study involving rhenium compounds.
Previous publications containing DFT calculations on Re complexes have
used different functionals, primarily B3LYP [45, 67, 93, 122], but also BPW91
[122] and B3PW91 [20]. Basis sets used for Re include LanL2DZ [67], SDD [122],
Hay-Wadt VDZ (n+1) ECP [45], and Stuttgart basis sets [20,104]. We present a
comparison of spectra calculated using these four basis sets at the B3LYP level.
Four samples (two enantiomeric pairs) were received: (SRe,SO-C,RC-N)-Tp-
ReO(ephedrine), (SRe,SC)-TpReO(proline) and their enantiomers, which we
refer to as (S, S,R)-1, (R,R, S)-1, (S, S)-2 and (R,R)-2, respectively.1 They were
synthesized in enantiopure form according to literature procedures [34], and
their structures are shown in Figure 4.1. The calculatedMW is 578.45 g/mol for
1 and 528.35 g/mol for 2.
4.2.1 Theoretical and Experimental Methods
IR andVCDspectra of all sampleswere recordedunder several conditions, both
in solid state (in KBr pellets) and in solution (CHCl3 and CDCl3) contained in
BaF2 cells. KBr pellets were prepared by grinding 3mg of the sample, then
mixing that with dry KBr and grinding again. Part of that mixture was then
mixed with more KBr to yield a pellet with the desired level of absorbance.
Pellets were pressed for typically 5 min at a load of 13000 lbs. The IR and VCD
1When assigning an R or S to the chiral Re centre, the Tp ligand can be considered as a
whole, allowing one to use the Cahn-Ingold-Prelog rules.
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Figure 4.1: Chemical structures of the two rhenium complexes studied in this the-
sis: (SRe,SO-C,RC-N)-TpReO(ephedrine) (1, left) and (SRe,SC)-TpReO(proline) (2, right),
where Tp=hydrotris(1-pyrazolyl)borate. In addition to Re being a chiral centre, the
ephedrine and proline ligands add 2 and 1 chiral centre, respectively, where indicated.
Solvent/matrix Chloroform
Sample amount ≈5mg in 150µL
Spectrometer ChiralIR Magna-IR 850
Path length 94µm 106µm
Spectral range (cm-1) 800–2000 800–4000
Acquisition time 12 h 90 min
KBr pellets
≈0.5mg in 250mg
ChiralIR Magna-IR 850
1mm 1mm
800–2000 400–4000
5–20 h 35–90 min
Table 4.1: Experimental conditions for IR and VCD spectroscopy of the rhenium(V)
complexes.
spectra were obtained on a ChiralIR spectrometer with two PEMs optimized at
1400 cm-1. The resolution was 4 cm-1. Higher resolution (0.25 cm-1) IR spectra
were recordedonaMagna-IR 850 spectrometer (ThermoNicolet, Madison,WI),
where the actual data spacing was 0.12 cm-1. Further experimental conditions
are given in Table 4.1.
Prior to running DFT calculations, structures of the sample molecules were
constructed in HyperChem, and their possible conformers were considered.
The proposed structures were relaxed in HyperChem using the MM+ force
field [54], with Re temporarily replaced by Mn because no force field for Re
was available. These two elements have similar valence and coordination
properties, so apart from the size difference, the geometry estimate should be
useful. Both complexes have distorted octahedral coordination around Re(V).
DFT calculations were carried out with Gaussian 03 [41] using the B3LYP
functional and different basis sets: either LanL2DZ or SDD for all atoms, or
6-31G(d) for elements H through O combined with a larger basis set for Re
(Hay-Wadt VDZ (n+1) ECP or Stuttgart RSC 1997 ECP [1]). Molecular geome-
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tries were optimized, and vibrational spectra for isolated (gas phase) species
were calculated, primarily utilizing the IBM cluster at Centre for Scientific
Computing, Aarhus, Denmark. The calculated vibrational frequencies were
scaled by 0.97, a typical value for B3LYP calculations. Furthermore, the calcu-
lated IR andVCD intensitieswere converted into Lorentzians (HWHM=5 cm-1)
for comparison with experiments.
4.2.2 Conformers and IR/VCD Spectra
Only one conformer for 1 was identified (1a), whereas 2 has two different ways
of puckering the five-membered proline ring (2a and 2b). The optimized struc-
tures fromGaussian 03 are shown in Figure 4.2. In the gas phase, the calculated
energies for the latter two conformers differ by 0.4696 kJ/mol according to the
LanL2DZ basis set, corresponding to a 55 vs. 45% population, if we assume a
Boltzmann distribution. With the Stuttgart and 6-31G(d) basis sets, the differ-
ence is smaller: 0.0548 kJ/mol, suggesting almost equal populations. Wedenote
the two conformers 2a and 2b, where 2a has the lower energy. No systematic
conformation search was performed, so there could be more conformers pos-
sible. However, two other proline ring conformers were investigated, but they
both converged back to one of the previous ones. Similarly, an alternative
orientation of the phenyl group in 1a was tried, but it converged to the one
previously found. Very little variation is seen in the structures when different
basis sets are used for geometry optimization.
We also calculated the energy of alternative diastereomers by inverting the
chirality of the rhenium, which is equivalent to removing the bidentate pro-
line or ephedrine ligand and putting it back the other way around. Geometry
optimization with B3LYP/LanL2DZ resulted in a 1a diastereomer 12.6 kJ/mol
higher in energy, suggesting a population fraction of 0.6%. For 2a, the differ-
ence was even more pronounced: 21.2 kJ/mol. Thus, it is reasonable to assume
diastereomeric purity of the samples. IR and VCD spectra were calculated for
both conformers 2a and 2b, since they were expected to be present in roughly
equal amounts and thus both contribute to the observed spectra.
We obtained good quality experimental IR and VCD spectra, especially for
the samples in solution. CHCl3 and CDCl3 are chemically identical but have
different spectral windows, allowing us to get continuous spectral coverage
from 800–4000 cm-1. Because the BaF2 windows cut off below 800 cm-1, only
the KBr pellets can be studied in the region 400–800 cm-1, and only with the
Magna-IR 850 instrument, because this region is outside reach of the VCD
instruments used, which both have a BaF2 lens in front of the detector.
Generally, the enantiomeric pairs of 1 and 2 yield practically indistinguish-
able IR spectra and negated VCD spectra, as exemplified by their IR and raw
VCD spectra in CDCl3 solution shown in Figure 4.3. These VCD spectra are
very close to opposite (within a low noise level), when one takes the baseline
shift and curving into account. To eliminate absorption artifacts, one can either
use the solvent or racemic VCD as baseline. Thus, the average VCD spectrum
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Figure 4.2: DFT optimized geometries of the two Re(V) complexes, calculated us-
ing B3LYP/6-31G(d) with Stuttgart RSC 1997 ECP for rhenium. Only one con-
former of (RRe,RO-C,SC-N)-TpReO(ephedrine) was found (1a, left), whereas (RRe,RC)-
TpReO(proline) has two (2a, middle and 2b, right).
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Figure 4.3: Observed IR (lower traces) and VCD spectra (upper traces, with the
VCD noise level shown above) of each enantiomer of TpReO(ephedrine) (left) and
TpReO(proline) (right) in CDCl3 solutions. Solvent IR spectra have been subtracted.
The resolutionwas 4 cm-1, with the instrument optimized at 1400 cm-1. Collection time
is 12 h. The region below 925 cm-1 has been left out because of high solvent absorbance
and thus higher noise.
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Figure 4.4: Observed IR (lower traces) and VCD spectra (upper traces, with the
VCD noise level shown above) of both enantiomers of TpReO(ephedrine) (left) and
TpReO(proline) (right) in KBr pellets containing ≈0.5mgof sample in 250mgKBr. Col-
lection times are 12–20 h at a resolution of 4 cm-1, with the instrument optimized at
1400 cm-1. VCD baselines have been adjusted for two of the measurements using a
straight line.
(corresponding to the racemic sample) was subtracted from the pair of VCD
spectra, yielding a pair of exactly opposite spectra with a better S/N. The VCD
spectra in solution in the subsequent figures have been subtracted in that way.
The IR and VCD spectra measured for the same samples in KBr pellets are
shown in Figure 4.4. Both pellets of 1 and 2 have narrower bands compared
to spectra in solution, which is expected. However, there is no clear indication
of crystal field splitting, e.g., a doubling of peaks if there are two molecules
in the unit cell. There is a weak water band at 1625 cm-1 and more notably at
3300-3600 cm-1 (not shown).
In the VCD spectra, we can clearly see bands of opposite sign, but the
baselines are less well defined than in solution due to sample inhomogeneity.
Strain-induced birefringence cannot be completely avoided, and there is less
reproducibility in pellet preparation. Although the anisotropy ratio goes up
by about three times compared to the solution state, the VCD spectra are some-
what noisier and have less well-defined baselines. For KBr pellets, sometimes
baseline shift due to scattering can be observed, thus two of the VCD baselines
in Figure 4.4 have been adjusted.
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An interesting difference between solution and solid state spectra appears
in the two carbonyl (C=O) VCD signals for 2 around 1700 cm-1, which are of
the same sign in solution, but bisignate in the KBr pellets. We were unable to
explain that feature.
When comparing the observed IR andVCDspectra to the arrayof calculated
ones (Figures 4.5–4.6), we can verify the absolute configuration of the samples
and assign most of the observed peaks. Experimental spectra from both CHCl3
and CDCl3 are shown combined. A progressively better fit to the experimental
spectra can be seen when increasing the basis set size. One basis set has been
left out (the B3LYP/SDD calculation), because those results look very similar to
the B3LYP/LanL2DZcalculation. In general, the comparison is very reasonable.
However, the C=O stretching frequency observed for 2 is systematically wrong
by about 100 cm-1 (Figure 4.6); but it is underestimated by LanL2DZ and SDD,
and overestimated by 6-31G(d). Other spectral regions have incorrectly scaled
frequencies, but the uniform scaling factor corrects most of it. Furthermore,
the relative intensities of VCD peaks differ somewhat between the observed
and calculated spectra. We find the best agreement using the combination of
the Stuttgart basis set for rhenium and 6-31G(d) for the other elements. In the
region around 1200 cm-1 there are several bands involving the proline, which
are not readily assigned, but a larger basis set on the light elements should
improve the fit.
The observed C=O stretch has a splitting not reproduced by the calcula-
tions. Two distinct peaks are observed at 1689 and 1704 cm-1, indicating two
significantly different environments, which could be either two conformers or
an intermolecular association. Indeed, we have identified two possible con-
formers of 2, but their calculated C=O stretches differ by 2 cm-1, which is too
little to explain the observed splitting of 15 cm-1. Furthermore, the relative
intensities of the observed C=O bands is more like 1:4 than the 1:1 suggested
by gas phase population analysis.
Apart from that, it appears that the average of the 2a and 2b conformers
indeed fits the experiments better than any one of them, suggesting that the
gas-phase population estimate is valid in solution. The calculated spectra for
2a and 2b do not differ much, but the observed IR has two adjacent peaks
around 1500 cm-1, whereas only one band is found there in each of the two
calculated IR spectra. If both conformers are present in solution with a larger
frequency separation than calculated, that would explain the observation. Fur-
thermore, only the calculated 2b VCD has a negative VCD feature at 980 cm-1,
corresponding to the observed feature at 1000 cm-1, so we cannot rule out the
presence of 2b.
The two large basis sets for rhenium yield different results for the Re=O
vibrations at ≈930 cm-1. In the case of Hay-Wadt, they are less reliably re-
produced than by the Stuttgart basis set (which has an additional 15 basis
functions), since the calculated Re=O frequency for 1a is too close to and cou-
pled with the C–O stretch vibration at 970 cm-1, whereas for 2a–b the Re=O is
coupled with the proline breathing mode at 980 cm-1, judging from the assign-
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Figure 4.5: Observed vs. calculated IR (bottom) and VCD (top) spectra for
TpReO(ephedrine), 1. The calculated spectra are at the DFT/B3LYP level with dif-
ferent basis sets: either LanL2DZ on all atoms or 6-31G(d) on elements H through
O, with Hay-Wadt VDZ (n+1) ECP or Stuttgart RSC 1997 ECP on Re. Observed IR
spectra are solvent subtracted (CHCl3 and CDCl3), and VCD is baseline corrected us-
ing the average of the two enantiomers. The resolution is 4 cm-1, with the instrument
optimized at 1400 cm-1. Collection time is 12 h for both the sample and its enantiomer.
58
4.2. RHENIUM(V) COMPLEXES
 0
 200
 400
 600
 800
 1000
 1200
 1400
 1600
 1800
 2000
 2200
 2400
 2600
 2800
 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800
M
ol
ar
 a
bs
or
pt
io
n 
co
ef
fic
ie
nt
 ε
Wavenumber (cm-1)
Observed IR
6-31G(d)/Stuttgart
6-31G(d)/Hay-Wadt
LanL2DZ
-400
-200
 0
 200
 400
 600
 800
 1000
 1200
 1400
 1600
 1800
 2000
 2200
 2400
 2600
 2800
∆ε
 
x 
10
4
Observed VCD
6-31G(d)/Stuttgart
6-31G(d)/Hay-Wadt
LanL2DZ
Figure 4.6: Observed vs. calculated IR (bottom) and VCD (top) spectra for
TpReO(proline), 2. The calculated spectra are at the DFT/B3LYP level with differ-
ent basis sets: either LanL2DZ on all atoms or 6-31G(d) on elements H through O,
with Hay-Wadt VDZ (n+1) ECP or Stuttgart RSC 1997 ECP on Re. Both conformers
are included: 2a (—) and 2b (····). Observed IR spectra are solvent subtracted (CHCl3
and CDCl3), and VCD is baseline corrected using the average of the two enantiomers.
The resolution is 4 cm-1, with the instrument optimized at 1400 cm-1. Collection time
is 12 h for both the sample and its enantiomer.
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Figure 4.7: Experimental vs. calculated IR spectra of Re(V) complexes (R,R,S)-1 (bot-
tom) and (R,R)-2 (top) in KBr pellets, showing the 400–1000 cm-1 region compared to
the B3LYP/6-31G(d)/Stuttgart RSC 1997 ECP calculations. Both conformers 2a (—) and
2b (····) are included. The experimental resolution is 0.25 cm-1, and the collection times
90 min.
ments by Gaussian 03. An earlier publication erroneously assigned the Re=O
stretches to be around 980 cm-1 [34]. The overestimated frequency from the
Hay-Wadt basis set can be lowered by reducing the force constant of the Re=O
stretch, the effect of which was simulated by substituting the oxygen with its
17O isotope and evaluating the vibrations using the Gaussian 03 freqchk utility.
Doing so brings the Re=O stretching frequencies calculated with Hay-Wadt
very close to those calculated with the Stuttgart basis set (data not shown).
4.2.3 Higher resolution IR spectra
On closer inspection, the Re=O stretching bands at ≈930 cm-1 reveal several
shoulders on the lower wavenumber side, just below the CDCl3 cutoff, which
are not readily assigned by the calculations. This inspired us tomeasure a series
of higher (though not ultra-high) resolution IR spectra, using theMagna-IR 850
spectrometer at 0.25 cm-1 resolution. The Re=O stretching band is the primary
target for the ultra-high resolution IR spectroscopy in France, so a thorough
characterization here is obviously of interest.
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Figure 4.8: Experimental IR spectra of Re(V) complexes (R,R,S)-1 (bottom) and (R,R)-2
(top) in CHCl3 (—) and KBr pellets (····), showing the B–H stretching (left) and Re=O
stretching regions (right). The resolution is 0.25 cm-1, and the collection times 90 min.
The calculated and experimental IR in the lower wavenumber region 400–
1000 cm-1 are shown inFigure 4.7,where the spectra ofKBrpellets are compared
to the B3LYP/6-31G(d)/Stuttgart calculations. Towards lower ν¯, the applied
uniform frequency scaling factor of 0.97 becomes too low, but we can still
correlate nearly all of the peaks.
It turns out that there is fine structure not only in the Re=O stretch, but
also in the region of the lone B–H stretch around 2500 cm-1. The latter is
theoretically the only normalmode between the fingerprint andC–H stretching
regions, so no other bands should be around. The fine structure of the bands
around 930 cm-1 might be due to nearby normal modes, which are found in the
calculations, but their calculated IR intensity is 2 orders of magnitude smaller
than the Re=O stretching intensity. These spectral features are shown in detail
in Figure 4.8 in both CHCl3 solution and KBr pellets (notice that the Re=O
bands are the ones below 960 cm-1). All four samples seem to display at least
three shoulders on the lower ν¯ tail of the Re=O stretch and two or three on the
higher ν¯ tail of the B–H stretch band, with an additional shoulder to lower ν¯.
Several explanations must be invoked in order to explain the observed
shoulders. Both rhenium and boron have naturally occurring stable isotopes,
i.e., 37% 185Re and 20% 10B, which will generate shoulder bands when present.
The size of these wavenumber shifts can be estimated from the reducedmasses
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Figure 4.9: Experimental IR spectra of Re(V) complexes (S,S,R)-1 (bottom) and (S,S)-2
(top) in CHCl3, using lower (—) and normal (····) concentrations (1: 61mm vs. 4.3mm;
2: 95mm vs. 4.7mm). The intense CHCl3 band around 1200 cm-1 has been blanked.
The resolution is 1 cm-1, and the collection times 35–90 min.
or calculated by Gaussian (using freqchk) to be +0.37 cm-1 for Re=O and
+11 cm-1 for B–H, making only the B–H shift noticeable here. Additional split-
ting may come from Fermi resonance with overtones and combination bands
of B–H deformations, which indeed are assigned by the calculation at around
half the stretching frequency. Also the Re=O shoulders can be due to Fermi
resonance, since the calculated Re=O stretching at 970 cm-1 (unscaled) matches
combination bands of 146 and 823 cm-1 (involving the N-Re=O angle), as well
as 301 and 669 cm-1 (involving ephedrine chelate ring deformation).
The calculated Re=O and B–H stretching frequencies of the conformers
2a and 2b nearly coincide: ∆ν¯ for the largest basis set is 1.5 and 0.06 cm-1,
respectively. So this is an insufficient explanation. Besides, the same effect is
seen for 1 with its single conformer.
Alternatively, the observed splitting could be an intramolecular effect. Be-
cause no hydroxyl groups are present and only tertiary amines, there is no
obvious possibility for hydrogen bonding as the splitting mechanism. Besides,
hydrogen bonding tends to broaden rather than split bands. However, there is
negative partial charge on the oxygens and positive partial charge on the boron
hydrogen, so some splitting may result. There could also be interactions with
solventmolecules, which could cause splitting even inKBrpellets, if the sample
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has crystallized with solvent molecules in the unit cell. The published crystal
structures have two complexes in the unit cells, but no solvent molecules [34]
In an attempt to reduce the degree of solute-solute interactions, two IR spec-
tra at a roughly 15 times lower concentration were recorded. As can be seen
in Figure 4.9, there is practically no difference when converting absorbance to
molar absorption coefficient (which makes the peak heights independent of
concentration). So whatever the interactions are, they persist at lower concen-
tration. This evidence supports the possibility of intramolecular effects like
Fermi resonance and precludes solute-solute interactions.
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4.3 Chiral Schiff-Base Complexes
As part of our collaboration with the lab of Professors Nafie and Freedman
at SU, we performed theoretical studies of some transition metal complexes
which were being synthesized and characterized spectroscopically, primarily
by Ph.D. student Yanan He [51].
Early observations of an enhancement effect in VCD spectroscopy were
made in the C–H stretching region on transition metal complexes with (−)-
M(sparteine)Cl2 in 1980 (M=Co, Ni, Zn) [6]. Another kind of VCD enhance-
ment involving ring currents rather than transition metals was found a few
years later [37]. The mechanism under study here is the resonance-enhanced
type (REVCD) from transition elements, cf. Section 2.3.1.
The first combined theoretical and experimental study of REVCD revisited
the sparteine complexes above, but in a broader spectral range, where it was
found that the enhancement effect reaches into the fingerprint region as well
[52]. Calculations of VCD spectra were made, but only compared favourably
for the unenhanced (closed shell) Zn(II) complex [51], because current DFT
implementations of VCD (using MFP) do not include the full enhancement
theory. Yet, it will appear below that in some cases part of the observed
enhancement can be reproduced by calculations, depending on the geometric
details and choice of method. We cannot offer any solid explanation to why
this is so, except that there could be some fortuitous cancellation of errors in
the MFP formalism. Several Schiff-base complexes with REVCD effects have
been studied at SU and are described in the manuscript enclosed as Paper 6.
In this section, we review our contribution to that work.
NN
O
M
O
* *
N
O
M
N
O
Figure 4.10: Chemical structures of the (R,R)-saldiphenyl complex (left) and (R)-
salbinaphtyl complex (right), where M indicates the metal centre.
The chemical structures of the transition metal complexes considered in
this section are shown in Figure 4.10. These complexes reveal enhanced VCD
for Co(II) relative to Ni(II) (and Zn(II) in the case of salbinaphtyl), and this
is explained by the presence of low-lying d–d transitions in Co(II) [51]. We
present VCD calculations which reproduce part of that enhancement.
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4.3.1 Co(II)saldiphenyl Complex
The IUPAC name of this complex is [N,N’-Bis(salicylidene)-1,2-diphenyl-1,2-
ethanediaminato]-Co(II).A crystal structure of this complexhasbeenpublished
(withNi(II) though) [56]. The complex features two chiral centres, which prefer
to have the same chirality. Contrary to the Ni(II) complex, its Co(II) cousin has
a low-lying electronic transition at 2100 cm-1 [51]. The low-spin cobalt centre is
in distorted square planar coordination (cf. Figure 2.7 on page 21) and therefore
effectively chiral, which makes it an interesting study case for REVCD. Given
that the orbitals below dx2−y2 are closely spaced at the outset and only shift a
little by the structural perturbation, we may expect REVCD effects.
Conformers and Geometries
Two distinct conformers of both the Co(II) and Ni(II) complexes were con-
structed in HyperChem, with the phenyls in axial or equatorial position, i.e.,
directed perpendicular or parallel to the salen moiety. Their geometries were
subsequently DFT optimized in the gas phase using unrestricted B3LYP with
6-31G(d) on H through O and Ahlrichs VTZ on the metal [101].
The electronic energy of the equatorial conformer is 4.84 kJ/mol higher than
that of the axial one. This indicates that 87% of a Boltzmann distributed
ensemblewould be the axial conformer. When calculated thermal free energies
are taken into account, the energy gap grows to 7.94 kJ/mol. We chose to
calculate the VCD spectra of both structures.
It turned out that the (R,R)-axial and (S, S)-equatorial conformers have
similar distortion of the tetrahedral coordination site. Therefore, these config-
urations are compared below. Their optimized geometries are shown in Figure
4.11.
Figure 4.11: Geometries of Co(II)saldiphenyl in the conformers with axial/equatorial
phenyls, optimized using B3LYP/6-31G(d) with Ahlrichs VTZ on Co. The enantiomers
shown are (R,R)-axial (left) and (S, S)-equatorial (right).
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Figure 4.12: Observed vs. calculated IR (bottom) and VCD (top) spectra of
Co(II)saldiphenyl. Calculated spectra (using B3LYP with 6-31G(d) on H through O
and Ahlrichs VTZ on Co) are for the (R,R)-axial and (S, S)-equatorial conformers, with
a frequency scaling factor of 0.97 and 5 cm-1 half-width. Experimental spectra of both
the Co(II) (—) and Ni(II) complexes (····) are shown for their (R,R)-enantiomers (0.12m
in CDCl3), courtesy of Yanan He [51]. The acquisition time was 6 h, using 54µm path
length at 8 cm-1 resolution with the PEMs at 2000 cm-1.
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Figure 4.13: Observed vs. calculated IR (bottom) and VCD (top) spectra of
Ni(II)saldiphenyl. Calculated spectra (using B3LYP with 6-31G(d) on H through O
and Ahlrichs VTZ on Ni) are for the (R,R)-axial and (S, S)-equatorial conformers, with
a frequency scaling factor of 0.97 and 5 cm-1 half-width. Experimental spectra of the
(R,R)-enantiomer (0.12m in CDCl3) are courtesy of Yanan He [51]. The acquisition
time was 6 h, using 54µm path length at 8 cm-1 resolution with the PEMs at 2000 cm-1.
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Calculated IR and VCD Spectra
Our calculated spectra are shown in Figure 4.12, compared to experimental
data for the (R,R)-enantiomer. The experimental VCD of the unenhanced
Ni(II) complex has been included and looks very flat on this scale. One can see
the tail of the broad negative ECD band above 1700 cm-1, which is suspected
of causing the observed enhancement. Prominent normal modes for the axial
conformer have been numbered. It turns out that the Ahlrichs VTZ calculation
yields REVCD for both conformers considered. Moreover, the enhanced peaks
have the same sign even though the absolute configurations are opposite. We
ascribe this to the similar distortion of the coordination site.
In order to takeBoltzmannweighting into account for the (R,R)-enantiomer,
one should combine the calculated VCD spectra as 0.87×(R,R)-axial minus
0.13 × (S, S)-equatorial. Doing so renders the calculated VCD intensities closer
to reality, but otherwise there are small changes, because the conformers have
very similar spectra.
From the calculation of the (R,R)-axial conformer, we can assign some of the
observed REVCD modes. Numbers in parentheses refer to calculated normal
modes. Except for an ethylendiamine C–H bending mode at 1390 cm-1 (119),
there are salen in-plane deformations at 1610 cm-1 (137), 1590 cm-1 (133, with
C=N stretching), 1520 cm-1 (129, with C=C stretching), and 1300 cm-1 (112, with
C–O stretching). All of these vibrations occur in the vicinity of the Co(II) centre,
and so it is reasonable that they experience enhancement.
Figure 4.13 compares the calculated and experimental data for the Ni(II)sal-
diphenyl complex, which has no REVCD. As seen clearly in Figure 4.12, these
VCD intensites aremore than anorder ofmagnitude smaller. Again, prominent
normal modes have been numbered for the axial conformer, and the vertical
position of these numbers (roughly corresponding to the intensity) indicate that
some VCD bands are cancelled by their neighbours. Apparently the Ahlrichs
VTZ basis set also reproduces the unenhanced signals well, although some of
the experimental VCD intensities (around 1310 and 1625 cm-1) look more like
the equatorial than the axial conformer. The electronic energy difference is
5.65 kJ/mol in favour of the axial conformer, suggesting a 91% population.
The most prominent observed VCD modes can be assigned to phenyl
in-plane deformation at 1460 cm-1 (122) and salen in-plane deformations at
1620 cm-1 (137), 1610 cm-1 (136), and 1530 cm-1 (128), in the latter case domi-
nated by C=C stretching.
For direct comparison, most of the calculated normalmodes and anisotropy
ratios of the two saldiphenyl complexes are given in Table 4.2. The normal
modes for the two complexes often correspond if their number is identical, but
one should rather match the pattern of IR intensities—or even better, animate
each normal mode for direct comparison (which would be rather tedious). For
the Co(II) complex, the maximum g is 0.135 at normal mode #120.
In conclusion, we have achieved a good fit of the calculations to given
experimental data, and we demonstrated the ability of the Ahlrichs VTZ basis
set to reproduce both unenhanced VCD and some enhanced signals.
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Co(II)Saldiphenyl
# ν¯ ε ∆ε · 103 g·103
74 945 8.030 22.520 11.22
75 946 28.189 44.733 6.35
84 1018 12.424 49.134 15.82
85 1018 11.756 28.887 9.83
86 1027 27.053 18.798 2.78
87 1028 19.173 0.653 0.14
88 1052 14.014 4.183 1.19
89 1054 146.132 274.783 7.52
90 1086 5.952 0.040 0.03
91 1090 35.875 69.787 7.78
93 1130 99.462 -63.053 -2.54
94 1143 16.310 74.848 18.36
95 1151 95.856 -88.423 -3.69
98 1174 13.723 -45.480 -13.26
99 1177 20.242 38.764 7.66
100 1180 9.660 -22.142 -9.17
102 1200 16.257 120.922 29.75
103 1217 140.262 -154.991 -4.42
104 1237 36.784 -82.460 -8.97
105 1239 65.090 -195.013 -11.98
109 1306 31.544 60.427 7.66
110 1324 18.851 80.214 17.02
112 1331 209.120 826.169 15.80
113 1342 2.526 1.364 2.16
115 1350 13.584 97.811 28.80
116 1370 15.789 169.928 43.05
118 1390 214.101 124.105 2.32
119 1396 65.128 -418.042 -25.68
120 1414 25.073 843.485 134.57
121 1456 66.233 49.989 3.02
122 1456 11.060 41.329 14.95
123 1458 436.517 -275.169 -2.52
125 1471 99.926 -186.549 -7.47
126 1498 28.423 -41.718 -5.87
127 1498 65.385 18.348 1.12
128 1526 497.635 -293.189 -2.36
129 1528 496.448 -1328.950 -10.71
130 1593 136.007 -18.650 -0.55
131 1594 13.713 -95.801 -27.94
132 1601 816.504 -536.873 -2.63
133 1607 274.455 -1486.030 -21.66
134 1613 8.487 10.631 5.01
135 1613 24.115 19.238 3.19
136 1622 1121.600 94.321 0.34
137 1625 489.860 -1714.350 -14.00
Ni(II)Saldiphenyl
# ν¯ ε ∆ε · 103 g·103
74 947 2.173 0.743 1.37
75 950 32.757 28.212 3.45
84 1018 16.839 -0.698 -0.17
85 1019 15.097 6.742 1.79
86 1027 25.524 10.827 1.70
87 1028 22.294 -1.722 -0.31
88 1055 13.659 11.539 3.38
89 1058 193.244 -14.818 -0.31
90 1087 17.486 -3.861 -0.88
91 1091 28.772 31.617 4.40
93 1130 121.709 9.070 0.30
94 1151 3.282 15.368 18.73
95 1151 103.742 -4.760 -0.18
98 1173 16.371 -7.737 -1.89
99 1177 20.904 11.950 2.29
100 1181 9.096 0.936 0.41
102 1213 6.459 40.520 25.09
103 1217 148.475 -8.600 -0.23
104 1238 42.212 -16.217 -1.54
105 1240 72.026 1.298 0.07
109 1302 31.910 11.873 1.49
110 1325 17.861 12.291 2.75
112 1340 9.844 8.063 3.28
113 1343 209.376 3.470 0.07
115 1348 21.401 3.255 0.61
116 1374 39.208 -3.082 -0.31
118 1394 236.975 33.807 0.57
119 1400 20.560 -6.108 -1.19
120 1453 130.861 -4.995 -0.15
121 1456 84.796 7.302 0.34
122 1458 206.731 150.972 2.92
123 1465 603.687 -38.158 -0.25
125 1472 20.283 -0.132 -0.03
126 1499 27.462 -3.711 -0.54
127 1499 66.356 12.171 0.73
128 1527 396.322 50.398 0.51
129 1529 456.576 -28.090 -0.25
130 1594 55.165 15.666 1.14
131 1595 4.028 -0.440 -0.44
132 1612 206.402 -3.449 -0.07
133 1613 26.796 -3.194 -0.48
134 1614 142.207 36.915 1.04
135 1616 20.406 -6.729 -1.32
136 1625 2377.730 80.764 0.14
137 1634 840.954 -93.791 -0.45
Table 4.2: Comparison of selected calculated normalmodes for Co(II)Saldiphenyl (left)
and Ni(II)Saldiphenyl (right), using unrestricted B3LYP/6-31G(d) with Ahlrichs VTZ
on themetal. Entries are (scaled) wavenumbers ν¯/ cm-1, IR intensities ε/m-1cm−1, VCD
intensities ∆ε/m-1cm−1, and anisotropy ratios g.
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4.3.2 Co(II)salbinaphtyl Complex
Complexes like this are useful in asymmetric catalysis, as described in a re-
cent review [17]. Similar complexes were reported as early as 1968 [88]. The
synthesis of the present complex was reported 10 years ago [10]. It has the IU-
PAC name [[2,2’-[[1,1’-binaphthalene]-2,2’-diylbis(nitrilomethylidyne)]bis[4,6-
dichlorophenolato]](2-)-N,N’,O,O’]-Co(II). The literature has differing nomen-
clature regarding the chirality. There are no chiral centres, but the tetradentate
ligand consists of two identical halves with axial chirality, and their intercon-
nection is also a chiral axis. The Co(II) centre is distorted tetrahedral, and thus
we may expect low-lying d–d transitions introduced by the lifted degeneracy
(cf. Figure 2.6 on page 20). Indeed, there is an electronic transition centered at
2540 cm-1, with positive ECD for the (R)-enantiomer [51].
Conformers
The binaphtyl bridge assures very limited conformational flexibility, hence
only one conformer was constructed in HyperChem and subsequently geom-
etry optimized using DFT/B3LYP. To that end, we used both LanL2DZ and
6-31G(d) basis sets, in the latter case combined with Ahlrichs VTZ on Co.
The optimized geometries are shown in Figure 4.14, which also illustrates our
chirality nomenclature.
Figure 4.14: DFT optimized geometries of the (R)-Co(II)salbinaphtyl complex in low-
spin (left) and high-spin (right) states, calculated using B3LYP/6-31G(d) with Ahlrichs
VTZ on Co.
Depending on the spin state of the complex, the coordination around Co(II)
becomes either distorted square planar (for LS) or distorted tetrahedral (for
HS), which appear to be the only conformers possible. The basis sets used give
only minor structural differences.
Calculated IR and VCD Spectra
Our calculated IR and VCD spectra of (R)-Co(II)salbinaphtyl in the high-spin
state are shown in Figure 4.15, compared to experimental spectra. The latter
shows a tail towards higher ν¯ of the aforementioned positive ECD band.
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Figure 4.15: Observed vs. calculated IR (bottom) and VCD (top) spectra of (R)-
Co(II)salbinaphtyl, using B3LYP with 6-31G(d) on H through O and Ahlrichs VTZ
on Co), with a frequency scaling factor of 0.97 and 5 cm-1 half-width. Experimental
spectra (95mm in CDCl3 solution) are shown, courtesy of Yanan He [51]. The acqui-
sition time was 6 h, using 54µm path length at 8 cm-1 resolution with the PEMs at
2000 cm-1.
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Spectra of the low-spin complex were calculated by Prof. Freedman and are
shown in Paper 6 (Figure 18). In both the LS and HS calculations, there is good
agreement with the experimental IR, but only poor agreement with the VCD,
although both calculated VCD spectra seem to have REVCD effects, since the
signals around 1450 cm-1 are about as intense as the observed spectrum. In
the present calculation, there is a couplet consisting of two positive and two
negative VCD signals. The remaining VCD bands are relatively small. The
absolute configuration cannot be verified based on this comparison, since only
some of the sign patterns agree.
Both thedistorted square planar geometry (LS) and thedistorted tetrahedral
coordination (HS) reveal similar calculated VCD intensities. They do not differ
enough to discern which spin state matches the experiment better, although
the coordination is reported to be nearly tetrahedral, i.e., high-spin [17]. To
make things worse, the calculated VCD is not quite reproducible, since the
HS calculation by Prof. Freedman (included in Paper 6) shows two positive
bands around 1450 cm-1. This interesting (though somewhat disillusioning)
result suggests that even structural variations within the convergence criteria
are sufficient tomarkedly perturb the subsequent VCD calculation. Apart from
this notable discrepancy, the smaller VCD signals of the two HS calculations
agree perfectly.
Compared to the previous case of Co(II)saldiphenyl, this agreement is less
favourable. It serves to illustrate that unexpected results may occur when we
approach the limits of current DFT implementation of VCD theory in Gaus-
sian 03. In the following section about myoglobin, even more pronounced
variations in calculated VCD will appear.
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4.4 Myoglobin and Ligands
A research area that can obviously benefit from REVCD is the study of metal-
loproteins, where signals from the active site can stand out in VCD spectra if
there are suitable IR electronic transitions to resonate with.
The primary example of enhanced VCD in metalloproteins is myoglobin
(Mb), which is properly calledmetmyoglobin (metMb) when the Fe is oxidized
to Fe(III). Enhanced VCD intensities have been observed for ligand stretching
modes when azide (N3−) or cyanide (CN−) is bound, and several explanations
were proposed before the theory of REVCD was established [12, 13, 116, 117].
Interestingly, both of these systems have a low-spin Fe(III) centre with octahe-
dral coordination (cf. Figure 2.5 on page 20), which is subject to distortions of
the heme plane (called hemin in its oxidized form) by the surrounding apopro-
tein as well as upon ligand binding. In metMb-N3, there is a temperature-
dependent equilibrium between LS and HS Fe(III) with N−3 absorption bands
at 2043 and 2021 cm-1, respectively, of which only the latter (LS form) has strong
VCD [116].
Low-lying electronic transitions have been calculated from ESR data for
the above mentioned systems; at 959 cm-1 and 2375 cm-1 for metMb-N3 and at
340 cm-1 and 1264 cm-1 for metMb-CN [92]. We believe that such transitions
may cause REVCD in hemeproteins, appearing as an enhancement of LS Fe(III)
relative to HS Fe(III).
Fragments ofpublishedmetMbstructures from theProteinDataBank (PDB)
are shown in Figure 4.16, including the hemin active site, proximal histidine
(His93), and distal azide or cyanide ligand, aswell as a fewnearby amino acids.
In this project, we made a survey of a range of small ligands in order to
determine whether they would bind metMb and possibly reveal enhanced
VCD signals. We were focusing on distal ligand-induced spectral changes in
the fingerprint region, where several bands attributed to hemin and ligands
have displayed REVCD for cytochrome c, another heme protein [51]. Hence,
we are expanding the spectral region of metMb VCD studies.
Alongside the experiments, DFT calculations on model systems consisting
of just the hemin group and ligands were carried out. Our theoretical studies
were primarily concentrated on the diatomic ligands azide and cyanide. These
calculations are on the border of what is feasible with our current computer
resources.
4.4.1 Experimental Methods
Horse skeletal muscle myoglobin was purchased in lyophilized form from
Sigma (M0630-1G). Mb was dissolved in 0.135m phosphate buffer at pH 8.41
with ametMb concentration of 11mm (200mg/mL).Weused a 22µmdemount-
able CaF2 cell (BioTools) to get a suitable absorbance in the 1000–1500 cm-1
region. CaF2 windows cut off below 1000 cm-1. The amide II and especially
amide I regions have higher absorbance and should ideally be studied at a
lower concentration (possibly in D2O) or shorter path length.
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Figure 4.16: Crystal structure fragments from a) metMb-N3 (left, PDB ID 1AZI) and
b) metMb-CN (right, PDB ID 1EBC), showing hemin with proximal histidine (His93),
distal ligand and nearby amino acid residues. Hydrogens are omitted from the hemins
for clarity.
Anumber of ligandswere considered andadded tometMb solutions: Azide
(N−3 ), thiocyanate (SCN
−), imidazole (Im), 1-Me-Im, 2-Me-Im, 4-Me-Im, and
pyridine (Py). The deuterated varieties Py-d5 and Im-d4 were also considered
(the latter becomes Im-d3 in solution, since the acidic deuterium will be ex-
changed). The chemical structures of all but the linear molecules are shown in
Figure 4.17.
The strong UV-Vis heme absorption band around 430 nm (the Soret band)
is known to shift upon ligand binding [36], especially if the ligand changes the
spin state of Fe(III) from HS to LS. In such cases we can directly see if there is
binding, as the colour turns more red.
N
N
N
N
N
N
N
N N
Figure 4.17: Chemical structures of the small metMb ligands considered. From the left:
imidazole, 1-Me-imidazole, 2-Me-imidazole, 4-Me-imidazole, pyridine. Deuterated
imidazole and pyridinewere also used. The nitrogens towards the bottomare possible
coordinating atoms.
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IR and VCD spectra were recorded on amodified ChiralIR (BioTools) at SU.
The resolution was 8 cm-1, and the spectral range was 1000–3000 cm-1 or 1000–
2000 cm-1 when an optical filter was used. Both PEMs were set at 1400 cm-1,
and the acquisition time was up to 12 h.
4.4.2 Computational Model Structures
Fe
NN
N N
R1
R2
O
OH
O
OH
Figure 4.18: The chemical structure of heme, with proximal and distal binding sites R1
and R2, respectively (as defined in Figure 4.16).
Figure 4.18 shows the chemical structure of heme b, also known as protopor-
phyrin IX, which is a widespread prosthetic group [16]. In reduced form (with
an Fe(II) centre) it is called heme, whereas the oxidized Fe(III) form is often
called hemin.
The hemes in proteins will be more or less distorted from steric interac-
tions with the peptide chain. Therefore, rather than starting a DFT geometry
optimization from a hemin group taken out of the azidometMb crystal struc-
ture 1AZI (Figure 4.16a), we built a hemin group in the gas phase and then
positioned the Fe(III) ligands according to the crystal structures. The primary
difference in hemin structure from the native protein is that the propionic acids
form an intramolecular hydrogen bond on the distal side rather than hydrogen
bonding to amino acid residues on either side. The proximal and distal sides
are defined by the two histidines in the crystal structure. Imidazole was used
in place of proximal histidine (His93) for simplicity, and different distal ligands
were substituted. At the pH 8.4 used experimentally, His and Im should be
protonated [59].
The geometries were optimized using Gaussian 03, and vibrational spec-
tra were calculated. We used the B3LYP functional and different basis sets:
LanL2DZ and in a few cases 6-31G(d). For isolated ligand molecules, 6-31G(d)
or 6-31++G(d,p) was used. The calculated intensities were convoluted with
Lorentzians with a half-width of 5 cm-1.
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Ligand Ligand:protein ratio Colour change Keq/dm3mol-1
Azide 1:1 Yes 43.3·103
Imidazole 10:1 Yes 255
1-Me-imidazole 10:1 Yes
2-Me-imidazole 10:1 and 100:1 No
4-Me-imidazole 10:1 Yes
Pyridine 10:1 No
Thiocyanate 10:1 No 277
Table 4.3: Overview of the metMb ligand binding attempts, indicating the relative
concentrations of ligand and protein, our observed colour changes and some reported
equilibrium constants Keq [97].
4.4.3 Results and Discussion
As expected, most of our ligands were readily able to bind metMb and simul-
taneously change the spin state from the native HS to LS (Table 4.3) or at least
an equilibrium in favour of LS. Samples with pyridine or thiocyanate added in
10-fold excess did not change the spin state, but SCN− has been shown to bind
metMb [22]. However, it binds to Fe(III) in the HS state, so even though it has
a strong IR band at 2006 cm-1, there is no observable VCD [116]. Pyridine (Py)
does not bind very easily; Fe(III) is in rapid equilibrium between LS and HS,
and the proteinmay denaturate [19]. Most of the imidazoles bind, but 2-Me-Im
did not seem to bind even at 100-fold excess, which is presumably due to the
methyl group next to the coordinating N (Figure 4.17). Therefore, no spectra
of this sample were recorded.
Our recorded VCD spectra in the fingerprint region of metMb with and
without ligand are shown in Figure 4.19. The IR spectra are not included,
because they have only vanishing contributions from the ligands in this region
and therefore look practically identical.
Samples of metMbwith Py or SCN− added in 10-fold excess, which showed
no colour change as an indication of entering the LS state, also showVCD spec-
tra identical to that of metMb (within the noise level). On the other hand, all
remaining five spectra (with N−3 or imidazoles) reveal several new spectral fea-
tures, which we interpret as REVCD due to the LS Fe(III) centre. Some of these
new signals are similar among the different ligands: Positive bands at 1090,
1210, 1235, 1250, 1375 and 1400 cm-1, and a negative band at 1100 cm-1. Apart
from metMb-Im and metMb-Im-d3 having more negative VCD at 1515 cm-1,
this seems to be the only place where the REVCD signals are negative. These
similar signals supposedly arise from hemin or the proximal ligand, while
differing signals must be attributed to the distal ligands. The couplet around
1100 cm-1 is more intense for N−3 than for the other ligands, which may be due
to the more ionic character of the former.
Figure 4.20 compares the difference VCD spectra of metMbwith Im and Im-
d3 bound, i.e., the metMb-ligand VCD spectra with metMb VCD subtracted.
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Figure 4.19: Experimental VCD spectra of metMb (11mmmetMb in 0.135m phosphate
buffer at pH 8.4 with 22µm path length) and metMb with various distal ligands:
Thiocyanate, pyridine, and the imidazoles are added in 10-fold excess, whereas azide
is equimolar. MetMb, metMb-SCN and metMb-Py-d5 have HS Fe(III) centres (Py-d5
may not be bound). The resolution was 8 cm-1, with the PEMs set at 1400 cm-1 and 12
h acquisition time. Spectra are offset for clarity, but not solvent subtracted.
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Figure 4.20: Experimental VCD difference (metMb subtracted) spectra of metMb-Im
(—) and metMb-Im-d3 (····) (top), compared to IR spectra of ligands Im (—) and Im-d3
(····) (bottom) in 0.44m and 1.8m solutions, respectively. The resolution is 8 cm-1, with
the PEMs set at 1400 cm-1. All spectra are solvent subtracted. An optical filter with
cutoff above 2000 cm-1 was used.
This makes the REVCD and any other different features stand out, and should
be comparable to calculations on just hemin and ligands. VCD noise levels are
included to show which bands are reliable. The noise increases towards the
CaF2 cutoff at 1000 cm-1 and the intense water/amide I bands above 1600 cm-1.
In the present case of imidazoles, we did not perform model DFT calcula-
tions and therefore merely compare experiments to each other. The IR spectra
of the ligands alone have been included in Figure 4.20, in order to see whether
some of the enhancement occurs at ligand vibrational modes. For Im, this is
the case at 1135 and 1330 cm-1, which are assigned by a B3LYP/6-31G(d) cal-
culation (not shown) as ring breathing and C–N stretching at the coordinating
N, respectively. A very similar story goes for Im-d3, which has two breathing
modes at 1160 and 1190 cm-1 andC–N stretching at 1430 cm-1, all of which seem
to arise in VCD as well. Caution should be exercised in these assignments, as
the normal mode positions of ligands in solution and bound states will shift to
some degree. But it sounds plausible that the above modes, if any, should be
enhanced.
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Figure 4.21: Experimental VCD difference (metMb subtracted) spectra of metMb-1-
Me-Im (—) andmetMb-4-Me-Im (····) (top), compared to IR spectra of ligands 1-Me-Im
(—) and 4-Me-Im (····) (bottom) in 1.9m solutions. The resolution is 8 cm-1, with the
PEMs set at 1400 cm-1. All spectra are solvent subtracted.
The difference VCD spectra of metMb-1-Me-Im and metMb-4-Me-Im are
compared to ligand IR spectra in Figure 4.21. Once again, we have calculated
the ligand IR spectra at the B3LYP/6-31G(d) level in order to assign the ligand
modes. There are not many significant differences between the two VCD spec-
tra overall. But for 1-Me-Im, the prominent C=C IR band at 1525 cm-1 matches
a distinct VCD signal. Also the C–N stretch at 1110 or the ring breathing at
1085 cm-1 could cause the sharp negative VCD band there. In case of 4-Me-Im,
there is a similar correspondence between C=C stretching and negative VCD
at 1595 cm-1. The weak, broad feature at 1150 cm-1 seems associated with a
positive VCD signal, but is not readily assigned by the calculated ligand IR. It
could be both an N–H bending mode or (less likely) C–N stretching.
To summarize, we have identified common REVCD signals for all the low-
spin Fe(III)metMb-ligand complexes investigated, aswell as distinct enhanced
VCD signals for each of them which coincide with ligand IR modes. In the fol-
lowing paragraphs, we look closer at the metMb-N3, metMb-CN and metMb-
H2O complexes, for which model calculations have been undertaken.
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Azidometmyoglobin
Figure 4.22: DFT optimized structures of hemin-Im-N3, calculated using
B3LYP/LanL2DZ. a) Without geometry constraints ( top left). b) With Im fixed in the
dihedral angle of His93 from 1AZI (top right). c) With two explicit water molecules
near the propionic acids and no geometry constraints (bottom).
When the hemin-Im-N3 complex was geometry optimized without constraints
(Figure 4.22a), the proximal Im rotated 45◦ (around the coordination bond) from
the 1AZI starting orientation to become coplanar with azide. The calculated
IR/VCD spectra of this structure are shown in Figure 4.23a. Spectra calculated
with proximal 4-Me-Im are almost indistinguishable from the case with just Im
(data not shown).
In order to maintain Im in the right orientation, its torsional angle was fixed
andgeometry optimization repeated (Figure 4.22b). As expected, the frequency
calculation of the resulting structure gives one imaginary mode corresponding
to Im rocking. The calculated spectra (Figure 4.23b) look almost identical to the
case without geometry constraints, except for the VCD showing a three times
more intense N−3 stretching mode at 1990 and a very significant Im in-plane
deformation mode at 1500 cm-1. Calculated N−3 anisotropy ratios are -3.54·10-5
(a), -1.08·10-4 (b), and -6.84·10-5 (c). They are all below the range of experimental
values, which is -6.4– -9.5·10-3 [12, 116].
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Figure 4.23: Calculated IR (lower half) andVCD (upperhalf) spectra of low-spin hemin
with distal azide and other ligands as indicated. The DFT/B3LYP/LanL2DZ level was
used, with no frequency scaling and Lorentzian broadening (HWHM=5 cm-1). a)
Without fixed Im, its rotation is 45◦ off from 1AZI His93. b) With fixed Im (1 imaginary
frequency at Im rocking). c) With 2 explicit water molecules holding the propionic
acids in place.
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Figure 4.24: Experimental VCD difference of metMb-N3 and metMb vs. calculated
VCD of low-spin hemin-Im-N3 at the DFT/B3LYP/LanL2DZ level, with frequency
scaling factor 0.97 and HWHM=5 cm-1. The experimental resolution was 8 cm-1, and
the acquisition time was 12 h for both samples, with the PEMs set at 1400 cm-1. The
very noisy amide I region has been left out.
Finally, a geometry optimization of hemin-Im-N3 was started out from the
1AZI structure, with two explicit water molecules added to keep the propionic
acids in place. They succeeded in doing so by forming a hydrogen bonding
chain, but at the same time Im rotated 45◦ away from its starting orientation
(Figure 4.22c). The calculated spectra at this geometry, shown in Figure 4.23c,
not surprisingly introduce several strong O–H bending modes, some of which
give strong VCD signals too (at 1100, 1350, and 1400 cm-1). Additionally, in the
VCD the propionic C–H bending is prominent at 1310 cm-1, and the signs of
the propionic C=O stretches at 1670–1700 cm-1 are inverted. We tend to believe
that the stronger VCD features are O–H artifacts rather than REVCD effects.
The experimental VCD of azidometMb is shown in Figure 4.24, where
the VCD of metMb has been subtracted to obtain only the enhanced VCD
signals from hemin and ligands. Calculated VCD for hemin-Im-N3 at the
B3LYP/LanL2DZ level is shown, with the Im fixed (similar to Figure 4.23b, but
with wavenumbers scaled by 0.97). The experimental VCD is 10 times more
intense, and beyond that the correspondence is not convincing, although some
of the sign pattern fits. We tentatively assign the intense 1100 cm-1 couplet to
calculated hemin in-plane deformations at 1110–1115 cm-1. The C=O stretches
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cannot be seen in the experiment because they are buried in the water/amide I
region, but the azide stretch at 1925 cm-1 has the correct sign. Other interesting
calculated modes are Im N=C–N stretch at 1455 cm-1, Im N–H bending at
1390 cm-1, hemin deformation coupled to N−3 stretch at 1220 cm
-1 and O–H
bend at 1200 cm-1. From the poor ability to reproduce the observed intensities,
it seems that LanL2DZ is an insufficient basis set for calculating REVCD. A
paper on sparteine complexes reached a similar conclusion [52].
Cyanometmyoglobin
Figure 4.25: DFT optimized structure of hemin-Im-CN without geometry constraints.
With B3LYP/LanL2DZ, Im stays oriented as in the crystal structures (left), but with
B3LYP/6-31G(d) Im rotates 45◦ away (right).
Figure 4.16b shows a crystal structure fragment from sperm whale cyano-
metMb (PDB ID 1EBC), since no crystal structure of the cyanide complex with
horse heart Mb was found. But the hemin is distorted in a fashion roughly
similar to 1AZI, and the proximal His is similarly oriented. As our starting
structure for gas phase DFT calculations we took the already optimized hemin-
Im-N3 and simply replaced the distal ligand. In the crystal structure, CN− is
not quite normal to the heme plane, but inclines by 9◦ due to electrostatic
interactions with His64.
During geometry optimization, CN− came to lie along the ligand axis nor-
mal to hemin. Depending on the starting orientation of the proximal Im, it was
able to find at least two equilibrium orientations, either in the correct one or
about 90◦ away from it. Their electronic energies differ by merely 7.5 J/mol. In-
terestingly, when a reoptimization was performed with the 6-31G(d) basis set,
Im rotated 45◦ to lie between the first two orientations. Furthermore, the hemin
became slightly saddle shaped. Figure 4.25 compares two of these structures.
The calculated VCD spectra in the three optimized structures are compared
in Figure 4.26. Remarkably, the VCD of the two alternative structures at the
B3LYP/LanL2DZ level differ by an order of magnitude and have somewhat
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Figure 4.26: Calculated IR (lower half) andVCD (upper half) spectraof low-spin hemin
with proximal Im and distal cyanide. The DFT/B3LYP level was used with basis sets
as indicated and Lorentzian broadening (HWHM=5 cm-1) without frequency scaling.
a) With Im rotated 90◦ off from 1EBC His93. b) With Im oriented as 1EBC His93. c)
With Im rotated 45◦ off and 1 imaginary frequency (Fe–C≡N bending mode).
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Figure 4.27: Experimental VCD difference of metMb-CN and metMb vs. calculated
VCD of low-spin hemin-Im-CN at the DFT/B3LYP/LanL2DZ level, with frequency
scaling factor 0.97 and HWHM=5 cm-1. The experimental resolution was 8 cm-1 at
11mm concentration and 30.4µm path length. Acquisition times were 28 h, with the
PEMs set at 1200 or 2000 cm-1 respectively. The very noisy amide I region has been left
out. Experimental data courtesy of David A. Dunmire/Teresa B. Freedman.
differing sign patterns, while their IR spectra look indistinguishable. We also
note that the positions of the cyanide and C=O stretching modes are consider-
ably higher for the 6-31G(d) basis set, a pattern seen earlier for a Re(V) complex
(Figure 4.6). The cyanide stretching mode is too weak to be discerned in the
IR spectra, but is visible in the VCD. This mode has a theoretical anisotropy
ratio g, which varies by an order of magnitude among the calculations as 0.012
(a), 0.23 (b), and 0.028 (c). Part of this variation may be due to the uncertainty
of dividing two small numbers. Two of these g values are similar to reported
values of 2.4–2.8·10-3 [13,116], but recentmeasurements suggest a value as large
as 0.01 (David A. Dunmire, Syracuse University, unpublished result).
Just before the 6-31G(d) frequency calculation, the structure took one step
away from the located minimum with Im turned 45◦, resulting in one imagi-
nary normal mode (Fe–C≡N bending). This makes the calculated results less
reliable.
A comparisonof experimentalVCDdifference (kindlyprovided fromDavid
A. Dunmire) to the B3LYP/LanL2DZ calculation with Im in correct orientation
is shown in Figure 4.27. Remarkably, the roles are reversed compared to the
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previous case of azidometMb (Figure 4.24): This theoretical VCD spectrum has
higher intensity overall than the experimental results, which seems to overturn
the previous conclusion about the LanL2DZ basis set showing no REVCD.
Our calculated CN− stretching mode at 2090 cm-1 has both correct intensity
and sign. Othermodes that appear to correspond to experiment (apart from the
intensity discrepancy) are hemin in-plane breathing at 1470 cm-1 and deforma-
tions at 1220, 1230, 1350, 1360, 1380, 1390, 1480, and 1550 cm-1, propionic acid
C–H twisting, wagging and scissoring at 1260–1290, 1352, and 1490 cm-1, re-
spectively. Modes involving Im include in-plane ring deformation at 1320 cm-1
andN–H bending at 1390 cm-1. Wewould expect such vibrations to experience
enhancement. Even the propionic acidmodes may not be too far away for that.
Experiments with Co(II)salbinaphtyl and Co(II)Cl4salbinaphtyl show that the
metal site orbitals are sensitive to substitutions taking place 5–7Å away [51].
High-Spin Hemin Calculations
Figure 4.28: DFT optimized structure of hemin with proximal Im and distal H2O
bound, calculated using B3LYP/LanL2DZ.
As a final example of unexpected VCD intensities, we show a calculation of
heminwith proximal Im and either distal H2Obound or no distal ligand, which
should have a HS Fe(III) centre [89]. The optimized structure with distal water
is shown in Figure 4.28, where the proximal Im stays in the correct orientation
during optimization. When water is removed, Fe is simply pulled slightly
out of the hemin towards Im. Our calculated IR and VCD spectra of these
structures are displayed in Figure 4.29. Apparently, the structure with water
boundhas an order ofmagnitude larger VCD intensity overall, with onlyminor
differences in the IR spectra.
No enhanced VCD was expected in these HS complexes. The reason for
the intense VCD in the case with distal water could simply be the fact that
this geometry is more chiral around the Fe(III). Possibly, we are seing artificial
VCD signals because only one orientation of the water molecule is considered,
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Figure 4.29: Calculated IR (bottom) and VCD (top) of HS Fe(III) hemin with proximal
Im and either distal H2O or no distal ligand, calculated using B3LYP/LanL2DZ.
whereas in reality it is most likely more dynamic and therefore may average
out some of the artifacts.
4.5 Summary
To the best of our knowledge, this chapter has presented the first VCD spectra
of rhenium compounds, both experimentally and theoretically. We have made
a DFT/B3LYP survey of the performance of different basis sets and success-
fully reproduced our experimental spectra of two Re(V) complexes by using
the Stuttgart RSC 1997 ECP basis set on Re, thereby verifying their absolute
configuration and predominant conformers. Thus, the applicability of VCD
has been expanded to heavy elements, which may become a valuable tool for
investigations of chiral transition metal complexes.
In the subsequent sections, we have continued undergoing research at SU
into the effect of resonance-enhanced VCD (REVCD). Our first study case
was purely theoretical, since corresponding measurements were already being
carried out. We therefore calculated the IR andVCDspectra of some Schiff-base
transition metal complexes, for which REVCD is seen in case of Co(II), but not
with Ni(II) or Zn(II). Here, the Co(II) complexes are the only ones which have
low-lying (IR) electronic CD signals from d–d transitions. We successfully
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calculated enhanced VCD intensities of Co(II)saldiphenyl and unenhanced
VCD of Ni(II)saldiphenyl using B3LYP/6-31G(d) with the Ahlrichs VTZ basis
set on themetal, which verified the absolute configurations and established the
predominant conformers of the samples. In the case of Co(II)salbinaphtyl, we
found two possible geometries with different spin states, but were only able to
reproduce part of the observed VCD enhancement with the same method as
before.
We also got involved in a major project about metmyoglobin (metMb) and
various small ligands, with which a range of VCD measurements were car-
ried out, along with theoretical calculations on just hemin and ligands. We
have seen effects of REVCD in both cases and were able to correlate the results
to some degree. With various imidazole ligands, we measured characteristic
REVCD features, some of which were coincident with ligand IR modes. Other
REVCD modes were assigned to hemin or ligand modes by DFT/B3LYP cal-
culations on isolated hemin with proximal imidazole and distal N−3 or CN
−.
Theoretical anisotropy ratios for the CN− stretching were similar to experimen-
tal values. Strangely, when comparing metMb-N3 and metMb-CN results, the
calculated VCDwith LanL2DZ misses the experimental REVCD intensities by
about an order of magnitude, but in opposite direction. Hence, LanL2DZ may
be an insufficient basis set. This is hard to judge yet, with an incomplete com-
putational implementation and system sizes on the border of what is tractable,
since frequency calculations often exceeded a month of CPU time. Besides,
using the 6-31G(d) basis set for comparison was not always feasible.
Currently, the VCD intensities one gets from calculations of systems with
low-lying d–d transitions seem somewhat random, depending partly on basis
set and partly on minor structural changes. Apparently, these calculations
become difficult due to size, shallow energy minima and the fact that we are
approaching the limit of the MFP theory, which does not entirely take the
low-lying electronic transitions into account.
With the discovery of REVCD, the applicability of VCD might become ex-
panded to include transition metal complexes embedded in biological systems,
i.e., metalloproteins. Our hope for REVCD is to get a selective probe of their
active sites, if the present teething troubles can be overcome by a reliable im-
plementation of recent theory in DFT software.
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Concluding Remarks
This Ph.D. thesis has investigated a number of organic and bioinorganic mole-
cules by using the VCD technique experimentally as well as theoretically. We
haveused this combinedmethodon several pharmaceutically interesting cases,
thereby further illustrating the applicability of VCD in drug development,
where structural elucidation is essential. Several smallmoleculeswere studied,
and their absolute configurations were determined, along with identification
of prominent conformers. These molecules range from 20 to 74 atoms in
size, and some are challenging cases either by being very flexible (nyasol and
curcuphenol dimers), whereas another (ginkgolide B) has 11 chiral centres.
Most of our DFT calculations were carried out in the gas phase, but solvent
effects have also been treated at different levels. Implicit solvation models gave
only minor changes compared to gas phase spectra, whereas introduction of
explicit solvent molecules was more successful.
Much of our research during the stay at SU was devoted to the study
of transition metal complexes containing primarily Re(V) or Co(II). In these
cases, the absolute configurations were known from elsewhere and verified by
VCD analysis, whereas the conformers in solution were not fully identified.
Very few examples of VCD applied to transition metal complexes exist, so our
work was mainly feasibility studies. Thus, we have successfully measured the
first VCD spectra of rhenium compounds and reproduced them theoretically.
Furthermore, we have looked into the phenomenon of resonance-enhanced
VCD (REVCD), which has been observed for several complexes having partly
filled d-orbitals with associated infrared electronic transitions. At present,
commercial DFT software does not have the full theory needed to account
for the contributions of these electronic states to the VCD. However, we were
able to reproduce some of the observed enhancement using the current VCD
implementation (magnetic field perturbation).
Transition metals with open d-shells are often present in biology (metallo-
proteins), where they take part in various catalytic or transportation processes.
Here, REVCD might become a selective probe of the active sites around metal
ions. We have studied metmyoglobin with a number of small ligands bound,
some of which reveal markedly different VCD in the fingerprint region. It is
believed that the Fe(III) centre can cause REVCD in its low-spin state. DFT
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calculations on model systems consisting of hemin and ligands were carried
out, and they revealed considerable VCD intensity variations while the IR
spectra remained similar. It seems like the anisotropy ratio is very sensitive to
geometrical details and maybe the basis set employed.
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Appendix A
List of Abbreviations
1AZI Myoglobin-azide crystal structure (PDB ID)
1EBC Myoglobin-cyanide crystal structure (PDB ID)
AAT Atomic Axial Tensor
ANO Atomic Natural Orbital
APT Atomic Polar Tensor
aug-cc-pVDZ cc-pVDZ augmented with diffuse functions
BaF2 Barium fluoride
B3LYP Becke 3-parameter functional, Lee-Yang-Parr correlation functional
B3PW91 Becke 3-parameter with Perdew-Wang 1991 correlation functional
CADPAC The Cambridge Analytic Derivatives Package
CaF2 Calcium fluoride
cc-pVDZ Dunning’s Correlation-Consistent Valence Double Zeta basis set
CCCBDB Computational Chemistry Comparison and Benchmark DataBase
CD Circular Dichroism
D95V Dunning/Huzinaga Valence double zeta
DFT Density Functional Theory
DFU Danish University of Pharmaceutical Sciences
DMSO Dimethylsulfoxide
DNA DeoxyriboNucleic Acid
DTU Technical University of Denmark
DZ Double Zeta
ECD Electronic Circular Dichroism (often called CD)
ECP Effective Core Potential
ee Enantiomeric Excess
ESR Electron Spin Resonance
FT-IR Fourier-Transform Infrared
FT-VCD Fourier-Transform Vibrational Circular Dichroism
GB Ginkgolide B
GTO Gaussian-Type Orbital
HF Hartree-Fock
His Histidine
HS High-Spin
HWHM Half-Width at Half Maximum
Im Imidazole
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IR Infrared
IUPAC International Union of Pure and Applied Chemistry
KBr Potassium bromide
LanL2DZ Basis set with D95V on H–Ne, Los Alamos ECP plus DZ on Na–Bi
LCP Left Circularly Polarized
LS Low-Spin
Mb Myoglobin
MCT Mercury Cadmium Telluride (HgCdTe)
Me Methyl
MePhOx Methylphenyloxirane
MetMb Metmyoglobin
MFP Magnetic Field Perturbation
MIR Mid-Infrared
MM Molecular Mechanics
MMFF Merck Molecular Force Field
MW Molecular Weight
NIR Near-Infrared
NMR Nuclear Magnetic Resonance
NVP Nuclear Velocity Perturbation
ORD Optical Rotatory Dispersion
PCM Polarizable ContinuumModel
PDB Protein Data Bank
PEM PhotoElastic Modulator
PES Potential Energy Surface
PM3 Parameterised Model 3, a semi-empirical method
PV Parity Violation
Py Pyridine
QM Quantum Mechanics
QuP The Quantum Protein Centre
RCP Right Circularly Polarized
REVCD Resonance-Enhanced Vibrational Circular Dichroism
ROA Raman Optical Activity
RSC Relativistic Small Core
SDD Stuttgart/Dresden/Dunning basis set
SCF Self-Consistent Field
SCRF Self-Consistent Reaction Field
S/N Signal-to-Noise ratio
STO Slater-Type Orbital
SU Syracuse University, Syracuse, NY
SUMM Systematic Unbounded Multiple Minimum
Tp Hydrotris(1-pyrazolyl)borate
UV-Vis Ultraviolet-Visible
VA Vibrational Absorption
VCD Vibrational Circular Dichroism
VCT Vibronic Coupling Theory
VDZ Valence Double Zeta
VOA Vibrational Optical Activity
VTZ Valence Triple Zeta
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Unix Scripts
Introduction
Listed on the following pages is a selection of scripts written during this project,
which ease the processing of Gaussian calculations, such as generating a plot
of spectral data present in a Gaussian output file or comparing calculated
energies of different conformers. The present scripts are written in the Bash
shell language, which is common on Unix-flavoured platforms. These scripts
have been usedwithGaussian 03, but shouldworkwith Gaussian 98 too. Some
of the scripts (plotCSV.bash and annotate*.bash) are specifically designed to
work with GnuPlot, a command-line plotting utility. However, one can plot
the tables generated by g03toCSV.bash with a number of other programs.
Software requirements
A Bash shell and the Awk text-processing language, and in some cases the
GnuPlot program. All of these programs are freely available for several plat-
forms.
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B.1 g03energies.bash
# Reads SCF energies from named Gaussian files in directory (default is all)
# Prints an array of energies in Ha and kJ/mol relative to the lowest energy
# Also gives Boltzmann fractions
# Version 2 18-11-2004 Peter R. Lassen
if [ $# -lt "1" ]
then
files=*.out
else
files=$*
fi
for file in $files; do grep -H "SCF Done" $file | tail -1;
done | sort -r +5 | awk ’
BEGIN {
OFS="\t";
print "SCF energies"
print "Filename","Hartrees","kJ/mol","Fraction"
}{
if (NR==1) min=$6;
name[NR]=$1;
Ha[NR]=$6;
weight[NR]=exp(-($6-min)/0.000950044487);
w+=weight[NR]}
END {for (i=1; i<=NR; i++)
printf("%s\t%5.9f\t%7.4f\t%.3f\n",
name[i],Ha[i],(Ha[i]-min)*2625.5,weight[i]/w);
}’
B.2 g03toCSV.bash
# Generates a table with IR and VCD spectra from a Gaussian output file
# Units are cm^-1 and epsilon (L/(mol*cm))
# Arguments:
# - Gaussian output file,
# - frequency scaling factor (default=1),
# - Lorenzian linewidth (default=5 cm-1),
# - output filename (optional, default is csv-extension)
# Version 2.2 27-10-2005 Peter R. Lassen
# Argument handling
if [ $# -lt "1" ]
then
echo "Usage: ‘basename $0‘ <Gaussian output> <scaling> <linewidth> [<output>]"
exit 65
fi
if [ $# -ge "1" ]
then
input=$1
output=${input%.out}
output=${output%.log}
104
B.2. G03TOCSV.BASH
output=$output.csv
scaling=1
linewidth=5
if [ $# -ge "2" ]
then
scaling=$2
fi
if [ $# -ge "3" ]
then
linewidth=$3
fi
if [ $# -ge "4" ]
then
output=$4
fi
fi
# Write comment string
echo "# ‘pwd‘/$input scaling=$scaling linewidth=$linewidth" > "$output"
# Get lines that contain frequencies, dipole and rotational strengths
awk ’BEGIN {
FS="--"
}{
if($1 ~ /(^ Frequencies)|(^ Dip. str.)|(^ Rot. str.)/) print $2
}’ "$input" > _awk_tmp1
# Transpose arrays into sorted columns
awk ’BEGIN {
n=3;
} {
r=(NR-1)%n+1;
for(s=1; s<=NF; ++s) array[r,s]=$s;
if(r==n) {
for (i=1; i<s; ++i) {
for (j=1; j<=r; j++) {
printf array[j,i];
printf " ";
}
print "";
};
r=0;
}
} END {print "\n"}’ _awk_tmp1 > _awk_tmp2
# Generate table of frequencies, IR and VCD intensities
awk -v sc="$scaling" -v D="$linewidth" ’BEGIN{
OFS=" ";
}
{for (i=1;i<=3;i++) M[NR,i]=$i}
function IR(x) {
ir=0
for (i=1; i<=NR; i++)
ir+=M[i,1]*M[i,2]*sc/(92*D*3.1415927)*D*D/((x-sc*M[i,1])**2+D*D);
printf ir;
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}
function VCD(x) {
vcd=0
for (i=1; i<=NR; i++)
vcd+=M[i,1]*M[i,3]*sc/(230000*D*3.1415927)*D*D/((x-sc*M[i,1])**2+D*D);
printf vcd;
}
END{
for (x=400; x<=4000; x++) print x,IR(x),VCD(x);
}’ _awk_tmp2 >> "$output"
# Cleanup
rm -f _awk_tmp1 _awk_tmp2
B.3 plotCSV.bash
# Returns a GnuPlot script for plotting tables generated by g03toCSV.bash
# Argument: The table file
Version="1.6 26-01-2006 Peter R. Lassen"
echo \#Generated by plotCSV.bash version $Version
if [ $# -lt "1" ]
then
echo "Usage: ‘basename $0‘ <CSV file>"
exit 65
fi
if [ $# -ge "1" ]
then
input=$1
fi
folder=‘pwd‘
folder=${folder##$HOME"/"}"/"
echo set terminal postscript eps 14 enhanced
echo set grid xtics
echo set key noautotitles
echo set lmargin 9
echo set xrange [2000:800] reverse
echo
echo "set xlabel ’Wavenumbers (cm^{-1})’"
echo "set ylabel ’Molar absorptivity {/Symbol e}’"
echo "set output ’"${input%.csv}"_IRVCD.eps’"
echo set multiplot
echo set size 1,0.5
echo set origin 0,0
echo set tmargin 0
echo set autoscale yfixmax
echo "#set yrange [0:400]"
echo "plot ’$input’ u 1:2 w lines lw 2"
echo set xlabel
echo "set ylabel ’{/Symbol De} x 10^4’"
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echo set origin 0,0.5
echo "set bmargin 0; set tmargin; set format x ’’; set autoscale yfixmin"
echo "#set yrange [-80:80]"
title=${input%.csv}
echo "set title ’"$folder${title//_/\\_}"’"
echo "plot ’$input’ u 1:(""$""3*10000) w lines lw 2"
echo set title
echo unset multiplot
echo set output
B.4 g03toFrq.bash
# Generates tables of frequencies and properties from Gaussian output
# Adds scaled freq’s and IR/VCD intensities derived from Dip./Rot. strength
# Dip./Rot. strength must be column 5-6
# Arguments:
# - Gaussian file,
# - frequency scaling factor (default=0.97),
# - Lorenzian bandwidth (default=5),
# - output filename (optional, default is *.frq)
# Version 1.3 01-09-2005 Peter R. Lassen
if [ $# -lt "1" ]
then
echo "Usage: ‘basename $0‘ <Gaussian output> <scaling> <linewidth> [<output>]"
exit 65
fi
if [ $# -ge "1" ]
then
input=$1
output=${input%.out}
output=${output%.log}
output=$output.frq
scaling=0.97
linewidth=5
if [ $# -ge "2" ]
then
scaling=$2
fi
if [ $# -ge "3" ]
then
linewidth=$3
fi
if [ $# -ge "4" ]
then
output=$4
fi
fi
echo -n "#" > "$output"
grep "#p" "$input" >> "$output"
awk ’$1 ~ /^Job/ && $2 ~ /^cpu/ {
print "#" $0
}’ "$input" >> "$output"
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awk ’BEGIN {
FS="--";
ORS="\t";
printf("#")
}
$1 ~ /^ Frequencies/,$1 ~ /^ Atom AN/ {
if($1 ~ / Atom AN/) exit;
print $1
} END {
printf("\n")
}’ "$input" >> "$output"
awk ’$1 ~ /^Frequencies/,$1 ~ /^Atom/’ "$input" >> "$output"
awk ’BEGIN {
FS="--"
}{
if($1 ~ /^#/) print;
print $2
} END {print
}’ "$output" > _awk_tmp_
awk -v sc="$scaling" -v D="$linewidth" ’BEGIN {r=1} {
if($1 ~ /^#/) print;
else {
if(NF>1) {
for(s=1; s<=NF; ++s) array[r,s]=$s;
r++}
else {
for(i=1; i<s; ++i) {
for(j=1; j<r; ++j) printf("%s \t ",array[j,i])
printf("%s \t ",array[1,i]*sc);
printf("%s \t ",array[5,i]*array[1,i]*sc/(92*D*3.1415927));
printf("%s \t ",array[6,i]*array[1,i]*sc/(230000*D*3.1415927));
printf("\n");
};
r=1;
}
}
}’ < _awk_tmp_ > "$output"
rm -f _awk_tmp_
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B.5 annotateIR.bash
# Makes GnuPlot commands for annotating a calculated IR spectrum
# Arguments:
# - Output from g03toFrq.bash,
# - wavenumber range [min,max]
# - minimum epsilon value
# Version 1.1 08-12-2005 Peter R. Lassen
if [ $# -lt "3" ]
then
echo "Usage: ‘basename $0‘ <g03toFrq output> <min> <max> [<epsilon_min>]"
exit 65
fi
input=$1
min=$2
max=$3
eps=1e-5
if [ $# -ge "4" ]
then
eps=$4
fi
awk -v min="$min" -v max="$max" -v eps="$eps" ’BEGIN{
print "h=0"
}{
if ($1 ~ /^#/) n=0; else {
n+=1;
if ($7>min && $7<max && sqrt($8**2)>eps) {
printf("set label \"^{%d}\" at %d,%d+h c\n",n,$7,$8+5);
}
}
}’ < "$input"
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B.6 annotateVCD.bash
# Makes GnuPlot commands for annotating a calculated VCD spectrum
# Arguments:
# - Output from g03toFrq.bash,
# - wavenumber range [min,max]
# - minimum epsilon value
# Version 1.1 27-10-2005 Peter R. Lassen
if [ $# -lt "3" ]
then
echo "Usage: ‘basename $0‘ <g03toFrq output> <min> <max> [<epsilon_min>]"
exit 65
fi
input=$1
min=$2
max=$3
eps=1e-5
if [ $# -ge "4" ]
then
eps=$4
fi
awk -v min="$min" -v max="$max" -v eps="$eps" ’BEGIN{
print "h=0"
}{
if ($1 ~ /^#/) n=0; else {
n+=1;
if ($7>min && $7<max && sqrt($9**2)>eps) {
if ($9>0) printf("set label \"^{%d}\" at %d,%d+h c\n",n,$7,$9*10000+5);
else printf("set label \"_{%d}\" at %d,%d+h c\n",n,$7,$9*10000-5);
}
}
}’ < "$input"
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Abstract
Structural Characterization of Chiral Molecules Using Vibra-
tional Circular Dichroism Spectroscopy
Chiral molecules, i.e., molecules with handedness, are essential to biology,
because most amino acids and sugars are chiral. A pair of molecules which
are mirror images of each other have identical physical properties, but they
differ in their interaction with other chiral molecules. This is the cornerstone
of biological specificity.
Chiral molecules also interact differently with different polarization states
of electromagnetic radiation, because the absorption coefficient depends on
the state of polarization. This is called dichroism and gives rise to several
spectroscopic techniques targeting chiral molecules.
This project is about application of one such technique, circular dichroism
(CD) spectroscopy, which measures the difference in absorption of left- and
right circularly polarized light—hence the name circular dichroism. This study
has focused on the infrared (IR) range because there are many vibrational tran-
sitions here compared to the number of electronic transitions in the ultraviolet
or visible range—hence the term vibrational circular dichroism (VCD).
VCD was used to identify the absolute configuration (chirality) and pre-
dominant conformers of chiralmolecules by direct comparison of experimental
and calculated spectra. Theoretical structures of the sample molecules were
constructed and optimized using molecular mechanical force fields followed
by the quantum mechanical method density functional theory (DFT). Calcula-
tions of IR absorption and VCD spectra were then carried out using the same
DFT methods. Here, VCD has the advantage over CD that time-independent
DFT calculations are sufficient.
During the course of this project, the above methodology has been ap-
plied to a range of molecules. Some of them (nyasol, curcuphenol dimers and
ginkgolide) are purely organic compounds of pharmaceutical interest. Oth-
ers are transition metal complexes relevant for the search for parity-violation
effects in vibrational spectroscopy (rhenium complexes), for asymmetric catal-
ysis (Schiff-base complexes), or as model systems for metal centres in biology
(Schiff-bases and heme). Proteins (primarily myoglobin) have been studied
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experimentally by VCD, but are far too large for DFT calculations, in which
case one must resort to model systems.
In the case of organic compounds, the absolute configuration has been
determined for molecules as large as ginkgolide B with 11 chiral centres or
as flexible as the curcuphenol dimer with 11 variable dihedral angles. This
illustrates the capabilities of the method, which are primarily limited by the
duration of DFT calculations.
In the case of metal complexes, they have only recently become within
reach of DFT, which opens new possibilities. Interesting VCD enhancement
effects in the vicinity of some transition metal centres have been discovered by
a group at Syracuse University, with whom a collaboration was established.
A theory for the enhancement has been developed by that group, but is not
yet fully implemented in available DFT software. Currently, only part of the
enhancement can be reproduced theoretically, as demonstrated for the Schiff-
bases. Their conformers and absolute configurations were also identified.
As for proteins, the interpretation of their spectra is different, because the
immense number of overlapping vibrational modes makes it difficult to obtain
information beyond the predominant secondary structure. However, the dis-
covery of enhancedVCD signals around somemetal centres allows for probing
of the active site. This has been done for myoglobin with a range of different
ligands attached. Corresponding DFT calculations have been carried out for
just the heme group and ligands.
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Dansk resumé
Strukturel karakterisering af kirale molekyler ved anvendelse
af vibrationel cirkulær dikroisme spektroskopi
Kirale molekyler, dvs. molekyler med håndethed, er afgørende for biologien,
idet stort set alle aminosyrer og kulhydrater er kirale. To sådanne molekyler
vil, hvis de er hinandens spejlbilleder, have identiske fysiske egenskaber men
forskellige kemiske egenskaber.
Kirale molekyler vekselvirker ikke blot forskelligt med andre kirale mole-
kyler, men også med forskellige polarisationstilstande af elektromagnetisk
stråling, fordi absorptionskoefficienten afhænger af polarisationen. Dette
kaldes dikroisme og giver anledning til en række spektroskopiske teknikker
målrettet kirale molekyler.
Dette projekt omhandler en af disse teknikker, nemlig cirkulær dikro-
isme (CD) spektroskopi, som bestemmer forskellen i absorption af venstre-
og højredrejende cirkulært polariseret lys—heraf navnet cirkulær dikroisme.
Der findes både vibrationel cirkulær dikroisme (VCD) og elektronisk cirkulær
dikroisme (ECD), som måler vibrationelle hhv. elektroniske overgange.
VCD blev anvendt til at bestemme den absolutte konfiguration (kiralitet)
og fremherskende konformerer af kiralemolekyler ved direkte sammenligning
af målte og beregnede spektre. Teoretiske strukturer af disse molekyler blev
konstrueret og optimiseret ved hjælp af først molekylær mekanik (kraftfel-
ter) efterfulgt af den kvantemekaniske metode tæthedsfunktionalteori (DFT).
Beregninger af infrarøde absorptions- og VCD-spektre blev herefter foretaget
med de samme DFT metoder.
I løbet af projektet er dennemetodik anvendt på en rækkemolekyler, hvoraf
nogle er rent organiske stoffer af farmaceutisk interesse (nyasol, curcuphenol-
dimerer og ginkgolid). Andre er overgangsmetal-komplekser, som først for-
nylig er kommet inden for rækkevidde af de teoretiske metoder: Rhenium-
komplekser, som er relevante for jagten på paritetsbrud i vibrationel spek-
troskopi; Schiff-base-komplekser, som bruges til assymmetrisk katalyse eller
som model for biologiske metalcentre. Forskellige hæm-komplekser er også
blevet undersøgt teoretisk sommodel for hæm-proteiner (primærtmyoglobin).
Endelig er myoglobin blevet undersøgt eksperimentelt, men proteiner er alt
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for store til DFT-beregninger, hvorfor man er henvist til modelsystemer.
Hvad angår organiske stoffer, så er den absolutte konfiguration blevet
bestemt for molekyler så store som ginkgolid B med 11 kirale centre eller så
fleksible som curcuphenol-dimeren med 11 variable dihedrale vinkler. Dette
illustrerer metodens anvendelighed, som hovedsagelig begrænses af DFT-
beregningernes omfang.
Hvad overgangsmetal-komplekser angår, så er nogle interessante forstærk-
ningseffekter omkring metal-centrene blevet opdaget af en gruppe ved Syra-
cuse University, som der blev etableret et samarbejde med. De har udviklet
en teori for denne forstærkning, men den er endnu ikke indarbejdet i nogen
DFT-software. Derfor kan kun en del af den målte forstærkning reproduceres
teoretisk, som det er demonstreret for Schiff-base-komplekserne.
Når det gælder proteiner, så er deres vibrationelle spektre vanskeligere at
fortolke pga. det store antal overlappende svingninger, som gør det vanskeligt
at bestemmemere end den dominerende sekundære struktur. Men opdagelsen
af forstærkede VCD-signaler omkring visse metal-centre åbner mulighed for
selektivt at studere disse aktive områder. Dette er gjort for myoglobin med en
række ligander bundet, hvoraf nogle giver anledning til forstærkede signaler.
Tilhørende beregninger er foretaget på en model bestående af hæm-gruppen
med ligander, og de har reproduceret en del af den målte forstærkning.
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Direct Determination of Absolute Configuration of Methyl-Substituted Phenyloxiranes:
Combined Experimental and Theoretical Approach
Peter Fristrup,*,† Peter R. Lassen,‡ Christian Johannessen,‡ David Tanner,§ Per-Ola Norrby,§
K. J. Jalkanen,‡,⊥ and Lars Hemmingsen‡,|
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DK-1871 Frederiksberg C, Denmark, and Nanochemistry Research Institute, Department of Applied Chemistry,
Curtin UniVersity of Technology, GPO Box U1987, Perth WA 6845, Australia
ReceiVed: January 9, 2006; In Final Form: May 15, 2006
Three possible methyl-substituted phenyloxiranes have been synthesized in enantioenriched form (89-99%
enantiomeric excess (ee)), and their vibrational absorption (VA) and vibrational circular dichroism (VCD)
spectra have been recorded. The experimental spectra are compared to theoretical spectra obtained from quantum
mechanical calculations (density functional theory with the B3LYP hybrid exchange correlation functional
with 6-31++G**, aug-cc-pVDZ, or aug-cc-pVTZ basis set) and related to the physical structure of the
compounds. The absolute configuration could be established directly in each case by comparing experimental
and theoretical spectra. In addition, we have been able to document the changes that occur both in structures
and in the VA and VCD spectra due to substituent effects on the oxirane ring.
Introduction
Asymmetric synthesis in general, and enantioselective ca-
talysis in particular, is one of the major areas of interest in
contemporary organic chemistry.1 In any research program
devoted to the chemical synthesis of chiral compounds in
nonracemic form, it is essential to have reliable methods for
the determination of absolute configuration. While indirect
methods for this (e.g., derivatization and/or degradation followed
by chemical correlation) are available, it is highly desirable to
develop and refine methods for the direct determination of
absolute configuration.2
Advanced chiroptical methods such as vibrational circular
dichroism (VCD)3 and Raman optical activity (ROA),4 along
with improved theoretical understanding,5 have allowed the
direct determination of the absolute configuration of an impres-
sive range of small to medium-sized molecules by simple
comparison of the calculated and experimental spectra.6 In
addition, for biomolecules, where multiple conformers are the
rule rather than the exception, vibrational absorption (VA) and
VCD have been used to monitor the conformational changes
that occur for these flexible molecules as a function of solvent,
pH, and ionic strength (for those molecules that can exist as a
mixture of conformers, a Boltzmann-weighted average of the
calculated spectra is compared to the experimental data).3,7
Natural products have recently proved to be useful test cases
for theoretical developments,8 but small synthetic molecules
such as phenyloxirane have also been important in the refine-
ment and benchmarking of theory.9 Oxiranes (three-membered
rings containing two carbons and an oxygen) are important
intermediates in synthetic organic chemistry, and a number of
methods have been developed for the synthesis of chiral oxiranes
of high enantiomeric and diastereomeric purity.10 However, the
direct determination of the absolute configuration of even simple
chiral oxiranes is often not a trivial task. In this paper we present
a comparison between experiment (VCD) and theory (DFT/
B3LYP) for the three methyl-substituted phenyloxiranes shown
in Figure 1. Our work complements an earlier study by Ashvar
et al.,9 in which the molecular structure of phenyloxirane itself
was studied by a combination of vibrational unpolarized
absorption and circular dichroism spectroscopies and ab initio
theory. Here we also wish to underline the importance of earlier
studies using even simpler oxiranes in the development and
benchmarking of theoretical methods.11
Materials and Methods
Synthesis. The oxiranes were prepared in enantioenriched
form (1, 95% enantiomeric excess (ee);12 2, 89% ee;10c 3, 99%
ee13) according to literature procedures. The (1R,2S)-2-meth-
ylphenyloxirane (2) sample contained 10% (1R,2R)-2-meth-
ylphenyloxirane (3) (73% ee with surplus of (1S,2S)-2-
methylphenyloxirane, the enantiomer of 3) as a consequence
of lack of stereospecificity in the enantioselective Mn(salen)-
catalyzed epoxidation. The racemic epoxides were synthesized
as reported previously using either m-chloroperoxybenzoic acid
(MCPBA) in dichloromethane (2 and 3) or quinuclidine as
achiral ligand in the osmium-catalyzed dihydroxylation (1).12
The enantiomeric excess for each sample was determined by
chiral gas chromatography (GC) using either Chrompack CP
Chirasil-Dex CB 0.25 mm × 25 m column (90 °C isothermal
used for 2 and 3) or Supelco -Dex 120 0.25 mm × 30 m
column (100 °C isothermal used for 1).
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Vibrational Absorption and VCD Experiments. All VA
and VCD experiments were carried out on a Thermo-Nicolet
Nexus 870 Fourier transform infrared (FTIR) instrument
equipped with a VCD compartment. The following properties
were used to convert experimentally determined absorbances
to molar extinction coefficients: Mw 134.2 g/mol; densities at
20 °C for (R)-1-methylphenyloxirane (1), (1R,2S)-2-methylphe-
nyloxirane (2), and (1R,2R)-2-methylphenyloxirane (3), respec-
tively, 1.02, 1.01, and 1.01 g/cm3.14 The diastereomeric purity
of 2 was taken into account when converting absorbance to
molar extinction coefficients.
Experiments on neat samples were carried out using a cell
with BaF2 windows and a 15 µm spacer. Experiments on 1.3
M samples of 1-3 in CCl4 were carried out in a sealed KBr
cell with a path length of 100 µm. VA measurements were
carried out on samples diluted by a factor of 10 to ensure that
no significant solute-solute interactions exist in the concentrated
samples. In all cases the VCD spectrum was determined using
an optically active sample and the corresponding racemic sample
as background, running 8000-30 000 scans with a resolution
of 4 cm-1. Collection times ranged from about 2 to 8 h. The
photoelastic modulator was set at either 1400 or 1500 cm-1.
The standard deviation has been plotted to allow an estimation
of the uncertainty in the measurements.
Theoretical Methods. The initial investigations of the
potential energy surface for the methyl-substituted phenylox-
iranes were carried out using DFT/B3LYP15 in Jaguar v. 4.2
build 7716 employing the 6-311++G** basis set.17 Calculations
of vibrational and electronic properties were carried out using
the Gaussian03 program package18 on Linux-based PCs at the
Technical University of Denmark. The method employed was
DFT/B3LYP with the 6-31++G**, aug-cc-pVDZ, or aug-cc-
pVTZ basis set19 on all atoms for both geometry optimizations,
and for calculation of VA and VCD spectra.20 Lorentzian line
shapes were assumed with a half-width of 4 cm-1 in the
theoretical VA and VCD spectra, and a frequency scaling factor
of 0.98 was used throughout to account for the combined error
resulting from anharmonicity and basis set. This scaling factor
was selected based on our experimental results and lies within
the uncertainty of values listed for similar methods in the
Computational Chemistry Comparison and Benchmark Data-
Base.21 The calculations were all carried out with the (R)-
configuration at the benzylic position, which is the expected
enantiomer for all three compounds with the asymmetric
reactions used in this work.10c,12,13 For the reported VCD spectra,
molar extinction coefficients were scaled according to the
enantiomeric purity as determined by chiral GC (see Materials
and Methods, Synthesis). For sample 2, which contains a minor
amount of 3 having the (S)-configuration at the benzylic
position, the theoretical VCD spectrum was corrected by
subtracting 10% of the calculated VCD spectrum of 3.
Results and Discussion
Conformational Search. Calculations were performed to
explore the potential energy surface of the methyl-substituted
phenyloxiranes using DFT/B3LYP with the 6-31++G** basis
set in Jaguar. In particular, the rotation of the phenyl ring with
respect to the remainder of the molecule was investigated by
performing a series of geometry optimizations with different
values for the appropriate dihedral angle R in intervals of 10°
(Figure 2).
For all three compounds there exists only one minimum
energy conformation (Figures 3 and 4), which is stabilized by
an electrostatic interaction between an ortho-H on the phenyl
ring and the oxygen atom (typical Mulliken charges22 with aug-
cc-pVTZ basis: O -0.30 and H +0.16, distance 2.5 Å). In
compounds 1 and 2 the steric influence from the proximal
methyl causes the phenyl ring to occupy a position coplanar
with the closest C-O bond, resulting in an R close to zero. In
compound 3 the methyl group is situated at the opposite side
of the oxirane ring and cannot obstruct rotation of the phenyl
group, thus leading to a minimum energy conformation with R
equal to 20°. The use of a polarized continuum (PCM) solvation
model does not affect the overall structural features of the
minimum energy conformation.
Since the three phenyloxiranes are constitutional isomers, we
have plotted the energies obtained by the calculations in the
gas phase relative to the most stable conformation of compound
3, which is the overall energy minimum for all three compounds.
In 2 there is additional internal energy due to unfavorable steric
interactions between the methyl group and the phenyl ring,
which are situated in a cis fashion on the oxirane backbone. In
3 the two groups point in opposite directions and the energy
barrier for rotation of the phenyl group is only ca. 12 kJ/mol.
In both 1 and 2 the position of equilibrium has the plane of the
phenyl ring coplanar with the proximal C-O bond, correspond-
ing to R ) 0° or 180°. For these two compounds the minimum
energy is higher than for 3, by 6 kJ/mol for 2 and 11 kJ/mol
for 1.
The validity of the minimum energy structure was verified
further by also performing restricted minimizations for the
rotation of the methyl group in each of the three compounds.
For all three compounds the rotational barriers were symmetrical
with heights of 8-10 kJ/mol.
Figure 1. The three methyl-substituted phenyloxiranes under investiga-
tion: (1R)-1-methylphenyloxirane (1), (1R,2S)-2-methylphenyloxirane
(2), and (1R,2R)-2-methylphenyloxirane (3). Hydrogen atoms were
omitted for clarity.
Figure 2. Sign convention used for the dihedral angle R.
Figure 3. Energy profiles for the rotation of the phenyl group in the
three phenyloxiranes. All energies are relative to the minimum for
(1R,2R)-2-methylphenyloxirane (3).
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Having established an approximate structure for the minimum
energy conformation of each methyl-substituted phenyloxirane,
a full energy minimization in Gaussian03 was undertaken
followed by calculations of spectroscopic properties. The
dihedral angles R in the fully minimized structures are listed in
Table 1.
Comparison of Calculated Spectra. To estimate the im-
portance of the basis set on the calculated spectra (in particular
VCD), the VA and VCD spectra for all three compounds were
calculated using three different basis sets. The smallest basis
set was 6-31++G**, which is a split valence double- basis
set with an additional diffuse function and a polarization function
on all atoms. We have also included Dunning’s augmented
correlation-consistent double-23 and triple- basis sets, denoted
aug-cc-pVDZ and aug-cc-pVTZ.24 Inclusion of solvation using
a polarized continuum model did not lead to significant changes
in the calculated spectra; thus the discussion in the following
text has been based on the gas-phase calculations only.
The numbering is based on the calculated fundamentals,
starting with the lowest wavenumber mode, and the modes in
the mid-IR (800-1800 cm-1) correspond to modes 18-44 out
of a total of 3N - 6 ) 54 (with 20 atoms in the molecules).
The calculated VA and VCD spectra for (R)-1-methylphenyl-
oxirane (1) are shown in Figure 5, and a visualization of the
most prominent absorptions can be found in the Supporting
Information. When examining the calculated VA spectra, it is
Figure 4. Structures of the three methyl-substituted phenyloxiranes optimized with the aug-cc-pVTZ basis set in Gaussian03.
TABLE 1: Dihedral Angle, r, in the Fully Optimized Structures Used To Calculate Spectroscopic Properties
R (deg)
6-31++G** aug-cc-pVDZ aug-cc-pVTZ
(1R)-1-methylphenyloxirane (1) 0.8 3.3 0.0
(1R,2S)-2-methylphenyloxirane (2) 2.8 1.7 2.0
(1R,2R)-2-methylphenyloxirane (3) 16.6 19.1 18.6
Figure 5. Calculated VA (bottom) and VCD (top) spectra for (R)-1-
methylphenyloxirane (1) with DFT/B3LYP and three different basis
sets as indicated. Spectra are offset for clarity, and most fundamentals
have been numbered.
Figure 6. Calculated VA (bottom) and VCD (top) spectra for (1R,2S)-
2-methylphenyloxirane (2) using DFT/B3LYP and three different basis
sets.
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clear that there are only small differences among the three basis
sets. Also, for the VCD spectra there are many similarities
among the three basis sets, although some differences can also
be noted, for example, the relative intensity of the two negative
VCD signals arising from fundamentals 18 and 19. With the
largest basis set (aug-cc-pVTZ) the two are of equal intensity,
whereas for both of the smaller basis sets the intensity of
fundamental 18 is predicted to be larger than that of 19. For
the two medium-intensity negative signals, 35 and 36, the latter
is predicted to be of larger intensity using 6-31++G** and aug-
cc-pVTZ basis sets, whereas the prediction from aug-cc-pVDZ
is equal intensity for these two fundamentals. For the two very
weak signals arising from fundamentals 38 and 39, there is a
difference in sign when the aug-cc-pVDZ basis set is used.
The calculated VA and VCD spectra for (1R,2S)-2-meth-
ylphenyloxirane (2) are shown in Figure 6, and a visualization
of the most prominent absorptions can be found in the
Supporting Information. Upon examination of the calculated VA
spectra it is clear that there are only small differences among
the three basis sets except for the splitting of fundamentals 40
and 41, which is also seen for the spectra calculated with the
aug-cc-pVDZ basis set. Also for the VCD spectra, there are
many similarities among the three basis sets, although minor
differences must be noted. For example, the relative intensity
of the absorption arising from the fundamentals 28 and 29 shifts
with increasing size of the basis set, with the latter having the
strongest absorption with the largest basis set. Also, the sign of
fundamental 34 is different with the largest basis set compared
to the two smaller basis sets. The pattern around 1350-1450
cm-1 is quite different with the aug-cc-pVDZ basis set,
compared to the two other basis sets used in this work.
The calculated VA and VCD spectra for (1R,2R)-2-meth-
ylphenyloxirane (3) are shown in Figure 7, and a visualization
of the most prominent absorptions can be found in the
Supporting Information. For the calculated VA spectra it is clear
that there are only small differences among the three different
basis sets, although it seems that the aug-cc-pVDZ basis set
once again gives results different from those obtained using the
two other basis sets. When the VCD spectra are compared, there
is an overall good agreement in the low wavenumber range
(800-1200 cm-1), but for fundamentals 34, 35, and 36 there
are relatively large differences. The intensity of the VCD signal
arising from fundamental 34 is somewhat larger with the largest
basis set when compared to the two smaller ones. Fundamental
35 is predicted to be very small with the largest basis set,
whereas the two smaller basis sets predict an absorption of
medium intensity. This is also the case for fundamental 36.
The relative intensity and the splitting are very different for
fundamentals 40 and 41 when using the aug-cc-pVDZ basis
set compared to the two other basis sets.
Comparison between Isomers. The calculated VA and VCD
spectra with the largest basis set for all three methyl-substituted
phenyloxiranes have been collected in Figure 8. By simple
examination of the VA spectra all three compounds can be easily
distinguished. For example, the presence of the strong absorption
around 960 cm-1 (fundamental 20) arising from having an H
and a methyl attached to the same carbon in the oxirane ring is
present in 2 and 3 but not in 1. Interestingly, due to the opposite
Figure 7. Calculated VA (bottom) and VCD (top) spectra for (1R,2R)-
2-methylphenyloxirane (3) using DFT/B3LYP and three different basis
sets.
Figure 8. Comparison of calculated VCD spectra (top) and VA spectra
(bottom) for 1, 2, and 3 using DFT/B3LYP with the augmented cc-
pVTZ basis set.
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absolute configuration of the carbon atom in the oxirane, the
VCD signal from this particular absorption is positive for 2 and
negative for 3, allowing for easy discrimination of these two
compounds. This is also the case for fundamental 24 in 2 and
3, which is the asymmetric pendant to fundamental 20.
Fundamental 26 in compounds 1 and 2 can also be used to
discriminate efficiently between these two compounds since it
gives a positive VCD signal for 1, a negative VCD signal for
2, and practically no signal for 3. Fundamental 33 gives a
positive VCD for 1 from a vibration involving the ortho-
hydrogens and the oxirane ring. In compounds 2 and 3
fundamental 33 corresponds to a C-C stretching motion within
the phenyl ring coupled to the oxirane ring. This vibration results
in negative VCD for 3 but does not give any signal for 2.
Fundamental 36 gives negative VCD for 1 from a C-C stretch
within the three-membered ring, a motion not responsible for
significant VCD in 2 and 3. The fundamental also numbered
36 in these compounds reflects a symmetric bending motion of
the -hydrogen attached directly to the oxirane ring. This
vibration gives a positive VCD for 2, but almost no signal
for 3 despite the structural similarity between the two com-
pounds.
Fundamental 38 is a symmetric stretch/bend motion of the
meta- and para-hydrogens on the phenyl ring. This vibration
gives a dominant negative VCD for 2, a much less intense signal
for 3, and no signal for 1.
The symmetric and asymmetric stretch/bend motion of the
methyl group was located as fundamentals 41 and 42 in 1 and
40 and 41 in compounds 2 and 3. In all three cases these
vibrations give rise to VCD absorptions but with different
appearances. The absorption is medium intensity for 1 and is
located at a higher wavenumber than for 2 and 3. In 2 only a
single absorption is seen, whereas for 3 these vibrations give
two dominant positive VCD signals, which are among the
strongest ones in the entire spectrum.
Experimental Results
The experimental VA and VCD spectra for 1 obtained neat
and in CCl4 solution are shown in Figure 9, along with
calculated spectra using the large aug-cc-pVTZ basis set. The
experimental and calculated spectra display a high degree of
similarity, allowing for assignment of the individual peaks in
the experimental spectra. The similarity of the calculated and
experimental VA spectra implies that the theoretically optimized
structure lies very close to the real molecular structure. There
are, however, minor differences between the calculated and
experimental spectra. For 1 the dipole strength of fundamentals
27/28 and 33 seems to be overestimated in the theoretical
calculation, whereas modes 37 and 38 seem to be slightly
underestimated. In the VCD spectrum obtained using the neat
liquid, the fundamentals 24 and 28 give rise to positive signals.
The positive VCD signal from fundamental 30 is more clearly
seen in CCl4 solution than in the neat liquid. The signals from
fundamentals 33 (positive) and 36 (negative) are easily recog-
nized in both experimental spectra. The strong VA absorption
from fundamentals 38 and 39 combined with very small
predicted VCD intensity gives rise to artifacts in this region
(∼1450 cm-1), which is documented by the higher noise level.
Figure 9. Comparison of experimental and calculated (B3LYP/aug-
cc-pVTZ) VCD spectra (top) and VA spectra (bottom) for (R)-1-
methylphenyloxirane (1).
Figure 10. Comparison of experimental and calculated (B3LYP/aug-
cc-pVTZ) VCD spectra (top) and VA spectra (bottom) for (1R,2S)-2-
methylphenyloxirane (2).
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From comparison of theory and experiment, we conclude that
the synthesized enantiomer of 1 is the (R)-enantiomer at the
benzylic position based primarily on the strong VCD absorptions
from fundamentals 33 and 36, and further substantiated by the
weaker absorptions from fundamentals 24, 26, 30, and 33.
The experimental VA and VCD spectra for 2 obtained neat
and in CCl4 solution are shown in Figure 10 along with
calculated spectra using the large aug-cc-pVTZ basis set. Also,
for 2 there are small discrepancies between experimental and
calculated absorption spectra. In particular, for fundamentals
26 and 28 the calculated dipole strength is too small, whereas
for fundamental 38 the calculated dipole strength is too large.
When the low wavenumber region of the VCD spectra of the
neat liquid is examined, fundamental 20 gives rise to a large
positive VCD signal which is in accordance with the calculated
spectrum, although the large absorbance gives rise to a relatively
high noise level. Fundamentals 24, 26, and 29 are all clearly
seen in the experimental spectra; however, it seems that the
rotational strength of fundamental 29 is underestimated in the
calculation. At higher wavenumbers fundamentals 36, 37, and
38 also give rise to well-defined absorptions in the experimental
spectra, thus clearly identifying 2 as having the (R)-configuration
at the benzylic position. Also, for this compound the intense
absorbance at ∼1460 cm-1 makes the VCD signal there
unreliable.
The experimental VA and VCD spectra for 3 obtained neat
and in CCl4 solution are shown in Figure 11 along with
calculated spectra using the large aug-cc-pVTZ basis set. Here,
the calculated dipole strengths of fundamentals 20 and 38 appear
to be overestimated, whereas fundamental 37 seems to be
slightly underestimated. The assignment of fundamentals 34-
36 was difficult due to overlapping signals and/or insufficient
resolution in the experimental spectra.
When the VCD spectra are examined, the agreement between
experiment and theory is markedly better for 3 than for 1 and
2, which is probably a consequence of the fact that the sample
consists of essentially a single enantiomer (ee ) 99%). In the
VCD spectra of the neat liquid the absorption from fundamental
20 was too large to allow for VCD measurements; however, in
CCl4 the VCD signal seems to be reliable. Fundamentals 24,
28/29, 32, 33, 38, 40, and 41 were all easily interpretable in
the experimental spectra, and we can confidently assign the
synthesized enantiomer as having the (R)-configuration at the
benzylic position. The weak absorptions arising from funda-
mentals 26 and 34 could be clearly distinguished from the
background noise only in the spectrum of the neat liquid. In
this respect the measurements on the neat liquid and in CCl4
solution complement each other.
Conclusions
Theoretical calculations of dipole strengths and rotational
strengths were carried out for the three methyl-substituted
phenyloxiranes 1-3 having the (R)-configuration at the benzylic
position using DFT/B3LYP with 6-31++G**, aug-cc-pVDZ,
and aug-cc-pVTZ basis sets. Differences among these three basis
sets were commented upon, and an overall good agreement
between the 6-31++G** basis set and the aug-cc-pVTZ basis
set was noted, whereas the aug-cc-pVDZ basis set often yielded
markedly different results.
Oxiranes 1-3 have been synthesized in enantioenriched form,
their VA and VCD spectra were recorded, and the experimental
spectra were compared to theoretical spectra obtained using the
largest basis set (aug-cc-pVTZ). There was very good agreement
between the experimental and calculated VA spectra, allowing
for direct assignment of most absorptions to the fundamental
vibrations determined by calculation, indicating that the mol-
ecules in solution or as neat liquid indeed possess the physical
structure obtained by energy minimization in the gas phase, or
that the changes which occur at ambient temperature do not
affect the overall spectral properties of the molecules. The
absolute configuration of all three compounds could be estab-
lished directly by comparing experimental and theoretical VCD
spectra.
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Figure 11. Comparison of experimental and calculated (B3LYP/aug-
cc-pVTZ) VCD spectra (top) and VA spectra (bottom) for (1R,2R)-2-
methylphenyloxirane (3).
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The absolute configuration of the norlignan (+)-nyasol was determined to be S by comparison of the
experimental vibrational circular dichroism data with first-principle calculations taking into account the
eight lowest energy conformations. The established absolute configuration of (+)-nyasol enables
establishment of the absolute configuration of (-)-hinokiresinol, which is concluded to be S. A total
synthesis and resolution of hinokiresinol has been performed to resolve the conflicting reports of the
coupling constant of the vinylic protons of the disubstituted double bond in this molecule. Racemic
hinokiresinol was resolved. Both enantiomers possess the same antiplasmodial activity.
Nyasol (1) and the E-isomer hinokiresinol (2) (Chart 1)
possessing the skeleton C6C5C6 are typical examples of
naturally occurring norlignans. The confusion concerning
the nomenclature of these two compounds should have been
settled by Minami et al.1 and Oketch-Rabah et al.,2 who
agreed that the Z-isomer should be named nyasol and the
E-isomer hinokiresinol. Unfortunately, confusion concern-
ing the magnitude of the coupling constant of the vinylic
protons of the disubstituted double bond in 2 has still not
been settled.3-5
The first report on the isolation of hinokiresinol from
Chamaecyparis obtusa did not specify the optical rotation,6
but a later report established that this plant forms (-)-
(2).1 Similarly, no rotation was reported for hinokiresinol
isolated from Libocedrus yateensis7 or from Agathis aus-
tralis.8 Both antipodes of nyasol are naturally occurring.
(+)-Nyasol has been isolated from Asparagus africanus2
and A. cochinchinensis,9 and (-)-nyasol has been obtained
from Anemarrhena asphodeloides.10,11 A chiral analysis
revealed that the nyasol with a specific rotation of [R]D
-67° consisted of 77% of the levorotatory enantiomer and
23% of the dextrorotatory enantiomer, corresponding to a
specific rotation of-124° for enantiomeric pure (-)-nyasol.1
The absolute configuration of hinokiresinol (2) isolated
from Agathis australis has been assigned as S on the basis
of correlation with 3 and 4 (Chart 2).8 However, no specific
rotation for the isolated hinokiresinol (2) was reported,
which makes the determined absolute configuration less
authoritative.8 The correlation is based on comparison of
the ORD curve of the dimethyl ether of 2, formed by
thermal conversion of an orthoformate of the dimethyl
ether of agatharesinol (4), with the ORD curve of the free
phenol 2.8 The specific rotation of the phenol 2 isolated from
Chamaecyparis obtusa is -3,1 whereas the dimethyl ether
is reported to have a specific rotation of+8.4.12 Comparison
of the ORD curves of these two compounds, thus, should
take this shift of sign of the rotation into consideration.
The thermal conversion of the orthoformate apparently
isomerizes the disubstituted double bond into the Z-isomer,
since later studies showed that the 3J coupling of the two
vinylic protons at the disubstituted double bond is 12 Hz.4,5
Such a coupling constant is similar to that reported for
nyasol,2,9 whereas the coupling constant in 2 is 15.9 Hz.1
This isomerization further questions the conclusion con-
cerning the configuration.
The poor basis for the suggested absolute configuration
of hinokiresinol (2) and nyasol (1) has encouraged us to
reinvestigate the absolute configuration of (+)-2, isolated
from Asparagus africanus, by vibrational circular dichroism
spectroscopy (VCD). This technique permits comparison of
a recorded spectrum with a spectrum calculated from first-
principle quantum mechanical methods, i.e., in a nonem-
pirical way.13 A total synthesis of 2 and comparison of the
1H NMR spectra of 1 and 2 should finally settle the
confusion of the magnitude of the coupling constant. Finally
advantage was taken of access to the two optical antipodes
of 2 to reveal if the antiplasmodial activity was related to
the configurational variations. (+)-Nyasol is a modest
antiplasmodial agent,2 but a possible relationship between
configuration and antiplasmodial activity has not been
investigated.
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Results and Discussion
Despite the moderate size of 1, a considerable number
of conformers exist at room temperature (Table 1 and
Figure 1), with the eight lowest energy structures within
2.1 kJ/mol at the B3LYP/AUG-cc-pVDZ level of theory.
Thus, 1 is among the most flexible small organic mol-
ecules studied by VCD spectroscopy. Spectral assignments
of theoretical VCD signals are given in Table 2 and Figure
2.
The challenge arises from the fact that the VCD signals
from the various conformers tend to extinguish one an-
other, putting high demands on the signal-to-noise ratio
of the instrument. There are, however, spectral regions
where the first-principle calculations predict that most
conformers give similar VCD signals, allowing determina-
tion of the absolute configuration of nyasol (Figure 3).
In particular the strong positive signal at 1510 cm-1
observed for nyasol dissolved in DMSO-d6 (Figure 4) and
the spectral signatures at 800-1000 and 1590-1650 cm-1
observed for nyasol in a KBr pellet (Figure 5) are such
regions.
The pronounced similarities between the recorded spec-
trum of (+)-nyasol and the calculated spectrum for (S)-
nyasol in these regions therefore show that (+)-nyasol
possesses the S-configuration. There are discrepancies
between experimental and calculated spectra, particularly
in the region from 1100 to 1300 cm-1, for both the IR
absorption and VCD signals. The most intense signals in
this region originate from vibrations involving the two
hydroxy groups of nyasol, indicating that the broadening
and changes in frequencies and relative intensities of the
signals are due to nyasol-solvent and/or nyasol-nyasol
interactions. These intermolecular interactions tend to
broaden the signal from the C-O stretching vibration at
1270 cm-1 and almost extinguish the O-H bending at 1170
cm-1. Their combined vibration at 1620 cm-1 is less
affected. The quenched O-H bending has been reproduced
theoretically by calculating spectra with one explicit DMSO
molecule next to each of the two hydroxy groups, putting
the qualitative interpretation on more firm theoretical
grounds. UV-vis absorption and conventional (electronic)
CD spectra were also recorded for nyasol from A. africanus
(see Figure 6), and given the assignment derived from the
VCD experiments, we conclude that the CD spectrum
corresponds to (S)-nyasol.
Minami et al.1 have similarly utilized CD data in the
assignment of absolute configuration of nyasol and hi-
nokiresinol, in agreement with the data presented in
Figure 6. Their findings prove that (-)-nyasol is hydroge-
nated to the antipode of the tetrahydro derivative of (-)-
hinokiresinol. Consequently the parent compounds (-)-
nyasol and (-)-hinokiresinol must possess opposite absolute
configurations as well. Since (+)-nyasol is S-configured, (-)-
nyasol must possess the R-configuration. (-)-Hinokiresinol
has the opposite configuration, that is, S, and consequently
(+)-hinokiresinol possesses the R-configuration as previ-
ously concluded.8
Synthesis of Hinokiresinol (2). Some synthetic meth-
ods for the dimethyl ether of 2 have been published.6,14 The
synthesis of the dimethyl ether of hinokiresinol is initiated
by an addition of a Grignard reagent to an oxo compound,
preventing the direct synthesis of hinokiresinol with free
phenolic groups.
In the only reported synthesis of the free diphenol 215
the phenolic hydroxyl groups were protected as tert-
butyldimethylsilyl ethers (TBDMS). The TBDMS group
was cleaved during the initial Claisen-Schmidt condensa-
tion and had to be reintroduced in a modest yield. This
problem was overcome by protecting the phenolic groups
as tetrahydropyranyl ethers. This protecting group sur-
vived the condensation of the ketone and the aldehyde to
give 5, which smoothly reacted with vinylmagnesium
bromide to give 6. Addition of copper(I) iodide ensured 1,4-
addition of the Grignard reagent. Sodium borohydride
Table 1. Calculated Energies of Gas-Phase Nyasol Conformers
(kJ/mol), Relative to the Lowest Energy Structure, as Found
Using the MMFF Force Field and Two DFT Methods, B3LYP/
6-31G** and B3LYP/AUG-cc-pVDZa
no. MMFF B3LYP/6-31G** B3LYP/AUG-cc-pVDZ
1 0.330200 0.0000 0.0567
2 0.000000 0.0105 0.0000
3 0.402573 0.1444 0.2133
4 0.729980 0.1864 0.1895
5 2.226303 0.2547 1.5526
6 3.039871 0.9321 1.8797
7 2.559570 1.0502 1.9229
8 2.368820 1.2025 2.1405
9 5.528778 4.3426
10 5.008957 4.4450
11 6.133102 4.5631
12 5.669357 4.9753
13 14.325104 5.4190
14 14.631180 5.4715
15 15.171234 5.6002
16 14.964020 5.6632
17 19.457092 19.1898
18 16.850830 19.2134
19 19.126968 20.7913
20 19.592728 21.0276
21 18.936859 21.3007
22 19.799881 21.5002
23 19.873138 24.8189
24 14.858643 24.9974
25 16.962799 25.3807
26 17.427505 25.6984
a The conformations are numbered according to the B3LYP/6-
31G** energies. The DFT results include thermal free energy
contributions calculated using B3LYP/6-31G**.
Figure 1. DFT-optimized structures of four (S)-nyasol conformers (top
left: 1, top right: 5, bottom left: 9, bottom right: 13; numbered
according to relative energies, see Table 1), representing the 16 lowest
energy conformers. Each structure represents a group of four conform-
ers, which differ only in the relative orientation of the hydroxy groups.
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reduction of the ketone yielded a mixture of the diastere-
omeric alcohols 7. A further advantage of the tetrahydro-
pyranyl group was that a hydrochloric acid-catalyzed
elimination of water from 7 simultaneously cleaved the
protecting groups. In addition all the steps in the reaction
sequence in Scheme 1 afforded better yields than the
reaction sequence using the TBDMS protecting group. No
nyasol was detected in the reaction mixture. The vinylic
coupling constant was found to be 15.9 Hz, as expected for
a trans coupling.
Optical resolution was performed by chiral HPLC to give
the two enantiomers having identical 1H NMR spectra.
The antiplasmodial effect of the two enantiomers of 2
was determined. Surprisingly, the enantiomers were equi-
Table 2. Assignment of Selected Peaks in the B3LYP/AUG-cc-pVDZ-Calculated IR and VCD Spectra for the Lowest Energy
Conformera
ν (cm-1)  (M-1 cm-1) 104∆ (M-1 cm-1) assignment
846 43.267 -263.076 phenol C-H oop bend
849 96.499 323.353 phenol C-H oop bend
859 54.035 -49.5495 phenol C-H oop bend
888 79.521 -42.1694 methine C-H bend
949 23.575 26.0106 vinyl C-H oop bend
959 55.749 -4.53252 vinyl C-H oop bend
1005 22.618 -4.70156 vinyl C-H oop bend
1025 36.633 13.4051 vinyl C-H ip bend
1120 33.284 -75.0412 phenol C-H ip bend
1127 33.226 -7.48434 phenol C-H ip bend
1184 482.469 96.6739 O-H bend
1186 161.730 -92.2848 O-H bend
1189 253.009 -23.8879 O-H bend
1269 124.863 78.9772 C-O stretch, methine C-H bend
1273 207.496 -39.1544 C-O stretch, methine C-H bend
1279 197.746 -84.5487 C-O stretch, methine C-H bend
1322 15.465 97.8881 vinyl C-H ip bend
1367 87.202 -40.1792 phenol C-C stretch, C-H and O-H ip bend
1369 73.435 33.0594 Phenol C-C stretch, C-H and O-H ip bend
1423 57.911 -27.8639 vinyl C-H ip bend
1434 35.367 -19.088 vinyl C-H ip bend
1464 37.615 111.113 phenol C-H, O-H ip bend
1535 276.918 22.9206 phenol C-O stretch, C-H ip bend
1539 257.528 146.532 phenol C-O stretch, C-H ip bend
1625 42.569 -55.4286 phenol C-C stretch
1634 48.017 -5.691 phenol C-C stretch
1653 186.086 2.0246 phenol C-C stretch
1654 94.705 -5.97896 phenol C-C stretch
1689 7.045 -25.3217 vinyl C-C stretch
1693 38.819 -76.3316 vinyl C-C stretch
a Columns are wavenumbers ν, molar absorptivities , differential absorptivities ∆, and assignments. Abbreviations: ip ) in-plane,
oop ) out-of-plane.
Figure 2. Relative amplitudes of selected vibrational modes assigned in Table 2 for the lowest energy conformer, calculated using B3LYP/AUG-
cc-pVDZ. Each mode is labeled with the corresponding wavenumber (cm-1).
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potent [IC50 values: rac-2, 51 ( 10 µM; (+)-2, 55 ( 14 µM;
(-)-2, 80 ( 25 µM]. The antiplasmodial activity, thus, is
not dependent on the absolute configuration.
Experimental Section
General Experimental Procedures. IR and VCD spectra
were obtained on a ChiralIR FT-VCD spectrometer (BioTools,
Inc., Wauconda, IL), equipped with two sources16 and two
photoelastic modulators17 optimized at 1400 cm-1. An optical
band-pass filter was used to allow only the spectral region
800-2000 cm-1 to reach the detector. Spectra were calibrated
automatically, using the standard calibration files.
VCD spectra were recorded both in DMSO-d6 solution (5
mg of nyasol in 100 µL of DMSO-d6 in a BaF2 cell with 100
µm path length) and in KBr pellets (250 mg KBr, φ 13 mm ×
1 mm). The resolution was 8 cm-1, and the acquisition time
was 9 h for DMSO-d6 solution and 31 h for the KBr pellet. In
the latter case, spectra from two different orientations of the
KBr pellet were averaged to reduce the baseline offset. 1H
NMR spectra were recorded on a Varian Mercury spectrometer
or Varian Gemini 2000 spectrometer at 300 MHz using
tetramethylsilane as internal standard. Splitting patterns are
described as singlet (s), doublet (d), triplet (t), doublet of
doublets (dd), doublet of double doublets (ddd), and multiplet
(m). Uncorrected melting points were determined on a Bu¨chi
SMP-20 apparatus, and optical rotation was measured on a
Perkin-Elmer 241 polarimeter. Column chromatography was
performed on silica gel 60 (Merck 107734). For HPLC a Waters
6000A pump and a Shimadzu SPD 6A detector was used. THF
was distilled from LAH and kept over molecular sieves. UV-
vis absorption spectra were recorded on a Cary 5 spectrometer,
and conventional (electronic) CD spectra were recorded on a
JASCO-720 CD instrument using a cylindrical quartz cuvette
with a light path of 5 µm and a 61 mg/mL solution of nyasol
in MeCN. Using MeOH as solvent does not change the spectra
significantly. The instrument was purged with N2. All spectra
were baseline corrected using a baseline recorded with no cell
in the instrument and collected at room temperature.
Computational Methods. Conformational searches and
geometry optimizations of (S)-nyasol were performed with
MacroModel (Schro¨dinger, Portland, OR).18 Conformational
searches were made in the gas phase using systematic
torsional search (SUMM) and an energy window of 20 kJ/mol.
For each structure the structure was optimized using the
MMFF force field, with 500 steps, 1000 iterations, and a
threshold of 0.05. The (unique) structures from the conforma-
tional search were subsequently geometry optimized using
density functional theory (DFT) as implemented in Gaussian
03,19 using the B3LYP functional20 with the 6-31G** and AUG-
cc-pVDZ basis sets and default convergence criteria.21,22 Vi-
brational spectra were calculated with the same methods.
Dipole and rotational strengths from Gaussian were converted
into molar absorptivities13 (M-1 cm-1), and each spectrum was
plotted as a sum of Lorentzian bands with half-widths of 6
cm-1 for comparison with experiments. The relative energies
presented include free energy corrections from molecular
vibrations.
Nyasol Conformers. In both the gas phase and solvent,
the conformational searches of (S)-nyasol yielded 26-29
structures within the energy window. A few of these structures
converged to the same local minimum at the B3LYP/6-31G**
level of theory. All energies from gas-phase geometry optimi-
zations in MacroModel and Gaussian 03 are shown in Table
1, where the conformations are numbered in order of the
B3LYP/6-31G** energies. In most cases the MMFF force field
performs very well, but there are cases where the relative
energy deviates by up to 8 kJ/mol from the first-principle
calculations.
Figure 3. Calculated IR absorption (lower half) and VCD spectra
(upper half) for the eight lowest energy conformers of (S)-nyasol, at
the B3LYP/AUG-cc-pVDZ level of theory. Frequencies are not scaled.
The bands are plotted as Lorentzians with half-widths of 6 cm-1. Half
of the spectra are offset for clarity.
Figure 4. Comparison of observed and calculated IR absorption (lower
half) and VCD (upper half) spectra of nyasol. Experimental spectra
are measured in DMSO-d6, using a resolution of 8 cm-1 and 9 h
acquisition time, with the instrument optimized at 1400 cm-1. VCD
noise is shown in the uppermost (dashed) trace. Experimental IR
absorption spectra are corrected for the presence of solvent, and spectra
are offset for clarity. Calculated spectra are Boltzmann-weighted
averages of the eight lowest energy conformers of the S-enantiomer,
with three different DFT methods as indicated. The B3LYP/6-31G**
SCRF uses a continuum solvent model for DMSO.
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A representative selection of the gas-phase structures are
shown in Figure 1, arranged in order of increasing energy. The
conformational energy displays gaps of about 3 kJ/mol between
conformers 8 and 9 and of about 14 kJ/mol between conformers
16 and 17. In the analysis of the VCD spectra we have
therefore included only the eight lowest energy conformers.
Furthermore, the conformational energies of the 16 lowest
energy conformers fall into groups of four having rather similar
energies, because both hydroxy groups can point in two almost
equally favorable orientations. Within each group of four
conformers, the carbon skeleton is basically fixed, and only
the hydroxy group orientations differ. No considerable geom-
etry changes in the gas-phase structures occur when DFT
optimization includes a self-consistent reaction field (SCRF)
solvent model (polarizable continuum model)23 for DMSO.
Infrared and VCD Spectra. Figure 3 depicts the calcu-
lated IR and VCD spectra for the eight lowest energy struc-
tures, calculated using the B3LYP functional and AUG-cc-
pVDZ basis set. The spectra of conformers 5-8 are offset for
clarity. All of the conformations have very similar IR spectra,
differing mostly in frequency and intensity of some minor
peaks. However, in the calculated VCD spectra, considerable
differences arise between the conformers To determine the
absolute configuration, we identified the spectral regions in
Figure 3 with the least variability. These regions will be
optimal for determinations of the absolute configurations of
nyasol, as the signals from different conformers do not
extinguish each other to any significant extent. These regions
are 800-1000, 1250-1350, and 1510 cm-1, and the negative
amplitude signals around 1650-1700 cm-1. To distinguish
conformers in the observed spectra, we note that the band
around 1530 cm-1 has a different shape for the two groups of
conformers (1-4 and 5-8). Additionally, around 1300 and 1650
cm-1, there seem to be consistent differences between these
two groups.
Assignments for the lowest energy conformer are shown in
Table 2.
In Figure 4 the recorded spectrum (DMSO-d6 solution) of
(+)-nyasol isolated from A. africanus as previously reported8
is compared to the Boltzmann weighted average of the
calculated spectra for the eight lowest energy conformers,
using B3LYP/6-31G**, B3LYP/6-31G** with an SCRF con-
tinuum solvent model for DMSO, and B3LYP/AUG-cc-pVDZ,
respectively. The solvent DMSO-d6 obscures the spectrum
below 1100 cm-1. In the 1250-1350 cm-1 region the VCD
signals are too weak to reliably determine the absolute
configuration, but above 1400 cm-1 the experimental spectrum
of (+)-nyasol and the calculated spectrum for S-nyasol compare
well. Similarly, there are considerable differences between the
calculated and observed IR absorption signals in the 1180-
1300 cm-1 region. In Figure 5 the (+)-nyasol containing a KBr
pellet measurement is compared to the B3LYP/AUG-cc-pVDZ
calculation for S-nyasol, which shows very good agreement in
the region 800-1000 cm-1 and reasonable agreement above
1300 cm-1. The nyasol concentration differs between the
DMSO-d6 solution and KBr pellet experiments, and conse-
quently different spectral regions have optimal IR absorption
for VCD measurements. Thus the two measurements comple-
ment each other by probing different spectral regions, and
consequently, VCD signal intensities should not be compared
between the two observed spectra. KBr pellets can easily show
birefringence artifacts, which is probably the case in the 1000-
1100 cm-1 region, and possibly other spectral regions as well.
The noise level does not identify such artifacts.
Synthesis of Hinokiresinol. (E)-1,3-Bis(4-[(tetrahydro-
2H-pyran-2-yl)methyl]phenyl)pent-4-en-1-one (6). A solu-
tion of vinylmagnesium bromide (1.0 M solution in THF, 60.0
mmol, 60.0 mL), in an inert nitrogen atmosphere, was added
to a suspension of cuprous iodide (2.7 mmol, 0.520 g) in THF
(60 mL) and cooled to 0 °C. After stirring for 15 min at 0 °C a
solution of (E)-1,3-bis(4-[tetrahydro-2H-pyran-2-yloxy]phenyl)-
prop-2-en-1-one (5)24 (11.13 g, 27.3 mmol) in THF (30 mL) was
added to the reaction mixture, and the mixture was stirred
for an additional 2 h at 0 °C. After quenching with an aqueous
saturated NH4Cl solution the mixture was diluted with Et2O
(400 mL) and successively washed twice with water (400 mL)
Figure 5. Observed IR absorption (lower half) and VCD (upper half)
spectra of nyasol in a KBr pellet, compared to the DFT calculation for
(S)-nyasol using B3LYP/AUG-cc-pVDZ. The experimental resolution
is 8 cm-1, with the instrument optimized at 1400 cm-1. The total
acquisition time is 31 h, and spectra from two different orientations
of the KBr pellet were averaged to reduce the baseline offset. VCD
noise is shown in the uppermost (dashed) trace.
Figure 6. UV-vis absorption (bottom) and CD (top) of (+)-(S)-nyasol
in MeCN (61 mg/mL), path length of 5 µm. Based on the assignment
derived from the VCD spectra, the CD spectrum represents (S)-nyasol.
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and once with brine (200 mL). The organic layer was dried
over Na2SO4, filtered, and concentrated in vacuo. The product
was purified by column chromatography using toluene-EtOAc
(20:1) as an eluent to give 6 (7.47 g, 75%) as pale yellow
crystals, mp 92-94 °C (MeOH): 1H NMR (CDCl3, 300 MHz)
δ 1.55-2.05 (12H, m, CH2 groups from THP); 3.26 (1H, dd, J
) 6.6, 16.8 Hz, H-8); 3.35 (1H, dd, J ) 7.8, 16.8 Hz, H-8); 3.56-
3.64 (2H, m, OCH2 groups from THP); 3.81-3.94 (2H, m, OCH2
groups from THP); 4.07 (1H, ddd, J ) 7.2 Hz, H-7′); 4.99 (1H,
d, J ) 17.4 Hz, H-9′); 5.03 (1H, d, J ) 10.2 Hz, H-9′); 5.37
(1H, ddd, J ) 3.0 Hz, O2CH group from THP); 5.51 (1H, ddd,
J ) 3.0 Hz, O2CH group from THP); 6.01 (1H, ddd, J ) 6.6,
10.8, 17.4 Hz, H-8′); 6.98 (2H, d, J ) 8.7 Hz, H-3′, H-5′); 7.06
(2H, d, J ) 8.7 Hz, H-3, H-5); 7.16 (2H, d, J ) 8.4 Hz, H-2′,
H-6′); 7.90 (2H, d, J ) 8.4 Hz, H-2, H-6).
(E)-1,3-Bis(4-[(tetrahydro-2H-pyran-2-yl)methyl]phe-
nyl)pent-4-en-1-ol (7). NaBH4 (3.24 g, 85.6 mmol) was added
to a solution of 6 (7.47 g, 17.1 mmol) in EtOH (150 mL), and
the solution was stirred overnight at room temperature. The
reaction mixture was quenched with an aqueous solution of
NaOH (5%, 300 mL), and the mixture was extracted twice with
Et2O (150 mL). The combined organic layers were dried over
Na2SO4, filtered, and concentrated in vacuo. The product was
purified by column chromatography using toluene-EtOAc (9:
1) as an eluent to give a mixture of the diastereomers as a
yellow syrup (7.20 g, 96%): 1H NMR (CDCl3, 300 MHz) δ 1.56-
2.34 (14H, m, H-8 + CH2 groups from THP); 3.32 (ddd, J )
7.5 Hz); 3.44 (ddd, J ) 8.1 Hz) (1H all together, H7′); 3.56-
3.60 (2H, m, OCH2 groups from THP); 3.84-3.93 (2H, m, OCH2
groups from THP); 4.43 (dd, J ) 6.0 Hz); 4.54 (dd, J ) 6.0 Hz)
(1H all together, H-7); 4.96-5.06 (2H, m, H-9′); 5.36-5.40 (2H,
m, O2CH groups from THP); 5.89 (ddd, J ) 7.5, 9.9, 17.4 Hz);
5.96 (ddd, J ) 7.5, 9.9, 17.4 Hz) (1H all together, H-8′); 6.95-
7.23 (8H, m, H-2, H-3, H-5, H-6, H-2′, H-3′, H-5′, H-6′).
Hinokiresinol (2) (racemic). To a solution of the alcohol
7 (7.19 g, 16.4 mmol) in MeOH (150 mL) was added a 7%
aqueous solution of HCl (85 mL), and the mixture was refluxed
for 1 h. After cooling it was poured into a saturated aqueous
NaHCO3 solution (500 mL). The mixture was extracted twice
with CH2Cl2 (200 mL). The combined organic layers were
washed with brine (200 mL), dried over Na2SO4, filtered, and
concentrated in vacuo. The product was purified by column
chromatography using toluene-EtOAc (9:1) to give racemic 2
as colorless crystals, which over time turned red (1.93 g, 47%),
mp 69-71 °C (CHCl3): 1H NMR (acetone-d6, 300 MHz) δ 4.12
(1H, t, J ) 6.9 Hz, H-7′); 5.09 (2H, m, H-9′); 6.09 (1H, ddd, J
) 6.9, 9.9, 17.7 Hz, H-8′); 6.26 (1H, dd, J ) 6.9, 15.9 Hz, H-8);
6.36 (1H, d, J ) 16.2 Hz, H-7); 6.78 (2H, d, J ) 8.7 Hz, H-3′,
H-5′); 6.80 (2H, d, J ) 9.0 Hz, H-3, H-5); 7.10 (2H, d, J ) 8.7
Hz, H-2′, H-6′); 7.27 (2H, d, J ) 9.0 Hz, H-2, H-6); 8.24 (1H, s,
br, OH); 8.41 (1H, s, br, OH)
Optical Resolution of Hinokiresinol (2). Racemic hi-
nokiresinol was resolved over a Daicel Chiralcel OD 0.46 ×
25 cm chiral column using petroleum ether-2-propanol (94:
6) with added HOAc (0.4%) as an eluent and a flow of 1 mL/
min. The two enantiomers eluted with retention times of 64.2
min ([R]D25 -1.7° (c 0.27, acetone)), lit.25 -3°) and 71 min ([R]D25
+4.4° (c 0.38, acetone)).
Antiplasmodial Assay. The antiplasmodial activity toward
the chloroquine-sensitive 3D7 Plasmodium falciparum strain
(IC50 24 nM) was determined as previously described.26 The
experiments were performed three times, each time in tripli-
cate.
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Abstract—Electrospray ionization mass spectrometry-guided isolation of extracts from Didiscus aceratus led to the discovery of sev-
eral new derivatives of the bioactive bisabolene-type sponge metabolite (S)-(+)-curcuphenol (1). The compounds obtained by this
method included a mixture of known (2) and new (3) dihydroxylated analogs as well as a novel family of dimeric derivatives, dic-
urcuphenols A–E (4–8), and dicurcuphenol ether F (9). Dimers 4–9 were also subsequently obtained through a hemisynthetic meth-
od in which 1 was incubated with the enzyme laccase. Atropisomeric dimers 5 and 6 were subjected to vibrational circular dichroism
analysis thereby establishing their absolute biaryl axial chirality as P andM, respectively. In contrast to 1, metabolites 2–9 exhibited
weak or no cytotoxic or lipoxygenase inhibitory eﬀects.
 2005 Elsevier Ltd. All rights reserved.
1. Introduction
Bisabolene-type sesquiterpenoids constitute a class of
broadly active natural products biosynthesized by a di-
verse range of organisms from both terrestrial and mar-
ine habitats. Within the marine environment alone,
numerous bisabolene sesquiterpenoids have been report-
ed from sponges (Acanthella,1 Arenochalina,2 Axinyssa,3
Ciocalypta,4 Didiscus,5,6 Epipolasis,7,8 Halichondria,9
Haliclona,10 Myrmekioderma,11 and Theonella12,13), a
nudibranch,14 gorgonians,15–18 a sea hare,19 and red
algae.20,21 Included among these discoveries are a num-
ber of uniquely functionalized bisabolene species such as
heterocyclic,10 nitrogenous,3,4,9,13 halogenated,19 poly-
hydroxylated quinone,15 and acetylated20 derivatives
that have signiﬁcantly broadened the biosynthetic scope
of this distinct chemical family. It is of particular interest
to note that two unique classes of bisabolene-type
metabolites are recognized based on their C-7 absolute
stereochemistry. As previously described,10 all known
sponge-derived bisabolenes possess a 7S conﬁguration
while the remaining marine and terrestrial metabolites
exhibit a 7R conﬁguration.
The lead compound of this family, (S)-(+)-curcuphenol
(1) (C15H22O), has attracted much attention due to its
distribution among marine sponges and biological activ-
ities. This compound has been encountered as a major
sesquiterpene metabolite (yield > 1 % dry weight) in four
sponge genera (Arenochalina,2 Didiscus,5,6 Epipolasis,7,8
and Myrmekioderma11) from the Caribbean,5,6,8,11 wes-
tern Australia,2 and Japan.11 In contrast, the marine
occurrences of the optical antipode of 1, (R)-()-curcu-
phenol, have been limited to several New World gorgo-
nians from the genus Pseudopterogorgia.15,16,18 These
compounds are reported to possess numerous biologi-
cal eﬀects including antimicrobial,5,6,18 H/K-ATPase
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inhibitory,7 antiplasmodial,5 and cytotoxic activities.22
In light of these promising ﬁndings, we believed that
the search for novel derivatives of 1 would be rewarding.
It could provide opportunities to explore new structural
themes and further probe the pharmacological activities
in this family of bioactive metabolites.
Herein, we report on the discovery of a unique branch in
this family of sponge-derived curcuphenol metabolites
based on ESIMS screening of extracts. The goal of the
project was to engage in the structure elucidation, abso-
lute conﬁguration analysis, cytotoxicity, lipoxygenase
inhibition, and active site modeling of the new com-
pounds encountered. Further insights addressing the
biogenic origin of the curcuphenol-derivatives are also
addressed. Additionally, we highlight the ﬁrst applica-
tion of vibrational circular dichroism (VCD)23 to the
stereochemical analysis of marine natural products. Tra-
ditional UV–circular dichroism (CD) studies, as exem-
pliﬁed by numerous scholarly studies performed by
Prof. Koji Nakanishi and colleagues,24,25 have greatly
enhanced the ﬁeld of stereochemical analysis in organic
chemistry. Our studies serve as an extension of these
insightful eﬀorts via the application of contemporary
VCD analysis methodologies that should serve to com-
pliment traditional UV–CD techniques.
2. Results and discussion
2.1. Summary of compounds studied
Sponges from the western Indo-Paciﬁc region have con-
tinued to serve as a source of unique and bioactive sec-
ondary metabolites. Many of the specimens in our
extensive collection have been subjected to preliminary
bioactivity screening with a simple brine shrimp assay.26
Partitioning of the total crude organic extract of Didis-
cus aceratus (Ridley and Dendy)27 yielded a CH2Cl2 sol-
uble fraction that exhibited potent toxicity against brine
shrimp (100% lethality in 20 min, 10 lg/mL). Bioas-
say-guided isolation of the active fraction provided
(S)-(+)-curcuphenol (1) (Fig. 1) identiﬁed by its HRE-
SIMS (m/z 219.1746 [MH]+, calcd for C15H23O,
219.1749), NMR data, and optical rotation value.6,7
Studies of the cancer cell cytotoxicity of compound 1
were performed as previously described.28 These data
revealed that 1 possessed moderate, but nonspeciﬁc tox-
icity against human bone marrow, leukemia, and colon
solid tumor cell lines as observed earlier for similar cur-
cuphenol analogs22 and therefore was not pursued for
subsequent in vivo evaluation.
Interestingly, further consideration of the planar struc-
ture of 1 revealed that it shared several key features with
other marine biomolecules previously isolated by our
laboratory that exhibited potent inhibition against
human lipoxygenases.29–32 These attributes included (i)
a polar phenolic head group, (ii) a lipophilic tail, (iii)
moderate c Log P value (4.9), and (iv) probable redox
activity. In view of these features, compound 1 was test-
ed and determined to be a potent, but nonselective
inhibitor of human lipoxygenases (human 12-lipoxyge-
nase (12-hLo): IC50 2.9 ± 0.4 lM and human 15-lipoxy-
genase (15-hLo): IC50 1.6 ± 0.3 lM).
The overwhelming presence of 1 in the D. aceratus
extracts (>8% of total crude extract) precluded the direct
bioassay-guided isolation of related analogs from the
remaining fractions due to the masking eﬀects of 1.
Another approach based on ESIMS analysis of the
sponge extracts was utilized to systematically screen
Figure 1. Structures of the bisabolene sesquiterpene (S)-(+)-curcuphe-
nol (1) and derivatives (2–9) obtained from Didicus aceratus in this
study.
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for the presence of analogs of compound 1. It was antic-
ipated that these compounds would help compliment
our growing library of marine-derived human lipoxyge-
nase inhibitors and shed further light on key structure–
activity relationships of these biomolecules. Conse-
quently, two fractions were identiﬁed that exhibited
m/z 253 [MH]+ (C15H25O3) and 435 [MH]
+ (C30H43O2)
representing dihydroxylated and dimeric curcuphenol
species, respectively. Subsequent ESIMS-guided isola-
tion led to the puriﬁcation of a mixture of the known
10b-hydroxycurcudiol5 (2) and new 10a-hydroxycurcu-
diol (3) as well as six curcuphenol dimers, dicurcuphe-
nols A–E (4–8) and dicurcuphenol ether F (9) (Fig. 1).
2.2. Structure determination of compounds 2–9
Compounds 2 and 3, obtained as a mixture, were not
further separated because their characterization as
10-hydroxycurcudiol (syn 10,11-dihydroxycurcuphenol)
diastereomers was straightforward. The HRESIMS
(obsd m/z 253.1800; calcd for C15H25O3, 253.1804) of
the single HPLC peak containing 2 and 3 indicated that
two OH groups have been added to the curcuphenol (1)
skeleton. Further attempts on separating 2 and 3 by
HPLCprovided inadequate resolution of themetabolites;
therefore, structure determination proceeded with the
mixture. Inspection of the 1H, 13C, and DEPT NMR
spectra of the mixture conﬁrmed the presence of 10b-
hydroxycurcudiol (2) that was previously reported as a
microbial biotransformation product of 1.5 A second set
of closely aligned peaks of equivalent intensity was also
noted in the NMR spectra. Careful examination of these
proton and carbon spins indicated that they were derived
from the C-10 epimer of 2, 10a-hydroxycurcudiol (3).
The remaining compounds, 4–9, were isomeric dimers
that each exhibited m/z 435 [MH]+ by low-resolution
MS. Their molecular formulas were subsequently estab-
lished as C30H42O2 by HRESIMS. Compared to curcu-
phenol (1), this represented nearly double the number of
carbon (2 · 15C), hydrogen (2 · 22H–2H), and oxygen
(2 · 2O) atoms expected for two units of monomeric 1.
The loss of 2H atoms was determined to arise from
the formation of a new covalent bond indicating that
4–9 were dimeric metabolites of 1. An initial assessment
of the 1H NMR spectra of 4–9 conﬁrmed that these
metabolites exhibited analogous spectral features to 1
thereby establishing their common curcuphenol-derived
skeleton. Most of the upﬁeld 1H NMR peaks appeared
doubled in 4–9 compared to 1; however, the downﬁeld
aromatic resonances of the dimers diﬀered signiﬁcantly
both in the absence of key proton spins and/or divergent
chemical shifts indicating that dimerization had oc-
curred through the aryl portion of 1. The structure elu-
cidation of 4–9 was greatly supported via utilization of
the comparative 1H NMR spectra as illustrated in Fig-
ure 2. Further conﬁrmation of these assignments was
achieved by 13C NMR and HMQC/HMBC experiments
focusing on the downﬁeld spectral region in order to dis-
cern the unique aryl linkages of these six dimers.
The benzenoid protons of dicurcuphenol A (4) appeared
as singlets (d 6.90, 6.87, 6.68, and 6.67) versus the dou-
blets observed in the aromatic region for 1 (H-4 to H-5
coupling). This indicated that the two possible dimeriza-
tion sites were either at the C-4 or C-5 positions of 1.
Thus, three possible dimers were envisioned with the
aryl linkages being between positions C-4 to C-4 0, C-5
to C-5 0, C-4 to C-5 0/C-4 0 to C-5. All of the nonaromatic
ring NMR signals of 4 could be correlated to resonances
of 1 including C-7 to C-15. Subsequent detailed analysis
of selected elements from 1D- and 2D-NMR data were
required to distinguish among the three alternatives for
the dimer skeleton.
The choice in favor of C-4 to C4 0 dimerization in 4 was
made as outlined below. The 13C resonances assigned
to C-4 and C-4 0 (d 134.8, two quaternary Cs) were
Figure 2. Comparative partial 1H NMR spectra of compounds 1
(panel a), 4 (panel b), 5 (panel c), 6 (panel d), 7 and 8 (panel e),
and 9 (panel f).
5602 R. H. Cichewicz et al. / Bioorg. Med. Chem. 13 (2005) 5600–5612
signiﬁcantly shifted downﬁeld (Dd  12) relative to C-4
of 1, and protons H-5 and H-5 0 (both singlets) in 4 were
shifted upﬁeld relative to that of the H-5 doublet in 1 as
illustrated in Figures 2a and b, respectively. The most
important 2,3JH–C data shown in Figure 3 consisted of
distinct three-bond HMBC correlations observed be-
tween H-7/C-5, H-15/C-4, H-7 0/C-5 0, and H-15 0/C-4 0.
Both of the alternate dimeric structures considered at
the outset were ruled out because several of these
HMBC correlations would span across four bonds.
Further HMBC correlations were ambiguous due to
the coincidental overlap of carbon resonances.
Once separated, it was clear that subtle structural fea-
tures were responsible for the diastereomeric diﬀerences
between dicurcuphenols B (5) and C (6). For example,
the downﬁeld resonances in the 1H NMR spectra for 5
and 6 exhibited identical multiplet patterns with very
similar chemical shifts as shown in Figures 2c and d,
respectively. However, this pair exhibited unique optical
rotatory properties with ½a25D +103.0 for 5 and ½a25D
+2.87 for 6. The downﬁeld 1H NMR data in Figure 2c
and d revealed that 5 and 6 possessed biaryl linkages
quite diﬀerent from that of 4. Two connectivity arrange-
ments were possible for 5 and 6 based on the multiplet
patterns observed for the aryl protons. For example in
5 this consisted of one set of ortho-coupled aromatic
protons (d 6.80 and 7.06, each 1H, d, J = 8.0 Hz, H-4 0
and H-5 0, respectively) and two singlets (d 6.76 and
6.94, each 1H, H-2 and H-5, respectively). Similar
NMR spectral data were observed for 6. Between the
two possibilities for dimerization, C-4 to C-2 0 and C-5
to C-2 0, only the former was consistent with three-bond
HMBC correlations observed in both 5 and 6 between
H-7/C-5 and H-2/C-4. The very subtle diﬀerences
between 5 and 6 could be attributed to the existence of
stable atropisomers arising from hindered rotation at
the biaryl bond due to the ortho substituents consisting
of one hydroxyl and two methyl groups.
An additional set of closely related diastereomers, dicu-
rcuphenols D (7) and E (8), were co-eluted from C18
HPLC as an inseparable mixture. As compared with
the downﬁeld 1H NMR spectra for 5 and 6 described
above, the aryl resonances for 7 and 8 in Figure 2e were
comprised of two sets of overlapping doublets. Further-
more, 7 and 8 were distinguished by the lack of singlet
aromatic resonances characteristic of H-2 in 1 (Fig.
1a). This unequivocally indicated the presence of a bia-
ryl bond connectivity from C-2 to C-2 0 in 7 and 8. In
analogy to the situation above, it was further concluded
that each compound could exist as atropisomers, as
there were now four ortho substituents present in the
vicinity of the biaryl bond. Finally, the resonances for
H-7and H-7 0 (Fig. 2e), as well as other upﬁeld signals,
provided insight as to the relative ratio of 7 to 8 in the
mixture (1:2.3, major isomer not deﬁned here).
It was immediately evident that the ﬁnal dimer isolated,
dicurcuphenol ether F (9) was diﬀerent than 4–8. Dimer
9 exhibited ﬁve aromatic protons (Fig. 2f), whereas all
the former ﬁve compounds had four such protons. The
aryl resonances in 9 consisted of two ortho-coupled pro-
tons, H-4 and H-5 (each d, J = 7.5 Hz) in addition to
three singlet resonances. These data indicated the pres-
ence of tri- and tetra-substituted aryl rings connected
in two possible ways: C-1 to C-4 0, or C-1 to C-5 0. The
singlet at d 6.32 (H-2) exhibited HMBC correlations to
C-4, which with the above information, was key in deﬁn-
ing the tri-substituted ring. Similarly, the tetra-substitut-
ed ring was delineated by the correlations between H-7 0/
C-5 0, H-7 0/C-1 0, and H-15 0/C-4 0. The other two nearly
overlapping singlets (d  6.67) were assigned by HMBC
as H-2 0 and H-5 0. The three sets of data supporting the
conclusion that 9 possessed the C-1 to C-4 0 linkage were
as follows. The similar shifts of 1 H-2 (d 6.62) versus 9
H-2 0 (d 6.67) were consistent with an additional oxygen
added to the meta and not ortho position in contrast to
the large ortho eﬀect diﬀerences in 1H-5 (d 7.05) versus 9
H-5 0 (d 6.67). Also, the nearly identical shifts of C-2 0
(d 118.0) and C-5 0 (d 118.8) meant that these carbons
were ortho and para relative to both oxygen substituents.
Finally, the three-bond HMBC correlations observed
between H-5 0/C-7 0, H-15 0/C-4 0, and H-7 0/C-1 0 ﬁxed
H-5 0 as being between C-6 0 and C-4 0.
2.3. Absolute conﬁguration analysis and laccase-mediated
formation of dicurcuphenols 4–9
With the planar structures of the dicurcuphenols estab-
lished, the next challenge was to elucidate their abso-
lute conﬁgurations. A key benchmark was the 7S
absolute stereochemistry of (S)-(+)-curcuphenol (1),
previously determined via total synthesis,33–35 and the
7R stereoisomer, (R)-()-curcuphenol, also established
by synthesis.34,36,37 From a biosynthetic perspective, it
seemed reasonable to assume that 4–9 also possessed
Figure 3. Signiﬁcant HMBC correlations (!) observed for dicurcu-
phenol A (4) and dicurcuphenol ether F (9).
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7S, 7 0S stereochemistry based on the co-occurrence of
1 with 4–9.
As a logical extension of this observation, it can be
hypothesized that the radical-mediated coupling of 1
would lead to the formation of dimers 4–9. The steps
in this process beginning with loss of H followed by
reassembly of the various possible radical species are
shown in Figure 4. Numerous organisms, particularly
fungi, are known to possess phenol oxidase-type en-
zymes that are capable of catalyzing the polymerization
of phenolic substrates under both natural and laborato-
ry conditions.38,39 The laccases, which are blue-copper
oxidases, constitute one prominent class of phenol oxi-
dases that have received widespread attention for their
industrial applications.40 Polyphenol oxidase (tyrosi-
nase)38 and horseradish peroxidase41 represent other
notable enzymes that carry out similar transformations.
To test the above hypothesis, an experiment was under-
taken with the goal of using 1 as a substrate for generat-
ing dimers. Accordingly, laccase, polyphenol oxidase,
and horseradish peroxidase were surveyed in a set of
preliminary experiments. The catalysis products were as-
sessed by ESIMS analysis with success achieved in 13
out of 78 diﬀerent experimental conditions employing
laccase while the other enzymes proved ineﬀective. Sum-
marized in Table 1 (and Table S1, Supplementary data)
are the conditions producing the desired [MH]+ peak at
m/z 435 (C30H43O2). Not shown here are data demon-
strating that similar results were obtained using a poly-
phenol oxidase-mimetic periodate oxidation system42
and Fenton peroxidation.43
Scale-up biocatalysis accompanied by isolation of the
targetm/z 435 products aﬀorded the series of compounds
illustrated in Figure 4. All six dimers, 4–9, were formed in
varying relative amounts. Also tabulated are the relative
percentages of these compounds isolated in this study
from the sponge source. Each enzyme reaction product
was identiﬁed by comparisons of their 1H NMR and
optical rotation data to that obtained for the sponge-de-
rived compounds. We were amazed to note that: (i) all of
the sponge-derived dicurcuphenols 4–9 were also pro-
duced by the laccase transformation of 1, (ii) no other di-
mers of 1 were detected, and (iii) the relative yield of the
dimers obtained from laccase incubation were, with
the exception of that for 4, parallel to that from the
sponge source (Fig. 4). These data intimate that 4–9
may also be produced in the sponge by a radical-medi-
ated coupling mechanism. Another important outcome
of the results of Table in Figure 4 is the implications
for bolstering the 7S stereochemical assignment pro-
posed herein for the dicurcuphenols. The biocatalysis re-
sults clearly show that the 7S stereochemistry of 1 is
maintained among dimeric products 4–9.
Figure 4. Yields and proposed mechanism for the formation of dicurcuphenols A–F (4–9) from the sponge Didicus aceratus and laccase-mediated
biocatalysis of (S)-(+)-curcuphenol (1).
Table 1. Summary of mediators, buﬀers, and co-solvents tested in the laccase-mediated biocatalysis of curcuphenol (1) to dimers (ESIMS m/z 435).
Mediators Buﬀers Co-solvents
Benzoic acid* Citrate (0.1 M, pH 5.0)* Acetone
Catechol Potassium phosphate (0.1 M, pH 7.0) Acetonitrile*
Hydroquinone* Butanol
4-Methoxybenzoic acid* Benzene
4-Methoxybenzoic acid polymer* Dimethylforamide*
Phloroglucinol Dioxane*
Tempo Ether
Ethanol*
Isopropanol*
Methanol*
Toluene
Triton X*
Items marked with an asterisk (*) were found to promote the transformation of compound 1. See Table S1 in Supplementary data for complete
experimental details of 78 combinations tested.
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Somewhat surprising is that despite numerous repeated
reisolations of compound 1 from sponges, it has not
been previously reported to be accompanied by dimer-
ized sesquiterpenes. Furthermore, a comprehensive
study5 on the microbial biotransformation products of
curcuphenol and curcudiol resulted in the formation of
a large number of functionalized analogs but no dimers
were observed. Surprisingly, these experiments em-
ployed several fungi that are likely to be competent for
the production of laccase or other phenol oxidases. By
ESIMS, we detected dimers of 1 in the sponge crude ex-
tracts and also observed the long-term bench-top stabil-
ity of compound 1 in a variety of solvents (MeOH,
CH2Cl2, CHCl3, and DMF) suggesting that 4–9 are
not artifacts of our isolation procedures.
It is interesting to note that a similar oxidative coupling
process has been proposed in the formation of the acyl-
phenol dimers, giganteones A and B from the fruits of
the Malaysian plant Myristica gigantea (Myristica-
ceae).44 Further biosynthetic parallels can also be drawn
to the formation of the biphenyl lichen metabolite, con-
tortin, from Psoroma contortum45 and cuparane-type
sesquiterpene dimers, mastigophorenes, from the liver-
wort Mastigophora diclados.46 The formation of com-
plex polymeric tyrosine metabolites such as bastadins
from Ianthella spp. sponges47–49 and pulcherosine from
sea urchin embryos50 represent pertinent parallels to
the metabolites observed in this study.
Up to this point, the absolute conﬁguration of the biaryl
axial chirality of atropisomers 5 and 6, as well as 7 and
8, still remained undeﬁned. The former two compounds,
and their acetyl and benzyl ester derivatives were oils
that precluded X-ray analysis, while the latter two resist-
ed all of our attempts at chromatographic separation.
The chiroptical data we obtained on the puriﬁed isomers
could not be further evaluated because of a lack of
appropriate reference compounds or applicable sets of
empirical rules. Therefore, a sensitive and reference-in-
dependent spectroscopic technique was sought that
could fulﬁll these required needs. Vibrational circular
dichroism (VCD)51 has developed in recent years as a
powerful, but underutilized method and it seemed rele-
vant to address the diﬃcult assignment of the axial chi-
rality for 5 and 6. In fact, important proof-of-concept
illustrations of the power of this technique to solve
our problem reside in the absolute conﬁguration deter-
mination by VCD of the cotton atropisomers (+)- and
()-gossypol as P and M, respectively,52 and in a
VCD study of an unexpected atropisomerically stable
1,1-biphenyl.53
The superimposed IR and VCD spectra of atropisomers
5 and 6 shown in Figure 5 provides the key data to be
applied in the stereochemical determination. As expect-
ed, the IR spectra for both atropisomers, are virtually
identical except for the negligible contributions of minor
impurities at 1700 and 1025 cm1. In contrast, their
VCD spectra contains important diagnostic bands be-
tween 1600 and 1425 cm1, which are of opposite inﬂec-
tion, arising from the axial chirality diﬀerences of this
pair. Some of the remaining VCD bands are nearly
superimposible due to the identical chiral alkyl side
chains present in both compounds. Consistent with this
trend are the appearance of the IR and VCD spectra for
1 shown in Figure 6. As expected, the IR spectra of 1, 5,
and 6 are similar while the VCD spectra of 1 is rather
featureless between 1600 and 1425 cm1. This latter
point strengthens observation that this region contained
peaks diagnostic of the P/M axial chirality. The region
between 1400 and 1000 cm1 includes features arising
from both the P/M and 7S chiralities. The strong posi-
tive VCD intensity near 1300 cm1 in 1, 5, and 6 is con-
sistent with 7S chirality for this trio of compounds.
The next step in completing the stereochemical analysis
involved generating theoretical VCD spectra expected
for the two conﬁgurational possibilities. However, the
ﬂexible nature of the biaryl alkyl side chains presented
a complication because a large set of nearly isoenergetic
solution phase conformations would need to be consid-
ered. As a simpliﬁcation, the truncated atropisomer (P)-
10 (Fig. 7) was selected for theoretical analysis since it
eliminates conformational ﬂexibility, thus permitting
the singular visualization of VCD eﬀects arising from
axial chirality. Calculations of VCD intensity at the
DFT level were needed for the (P)-atropisomer only
since the opposite (M)-10 structure must exhibit a
mirror image VCD spectrum of (P)-10.
Figure 5. IR (lower traces) and VCD (upper traces, with VCD noise
level shown above) spectra of 5 (red) and 6 (blue), in CDCl3 solution.
The IR spectra look quite similar with the exception of minor
discrepancies around 1000–1050 cm1 and 1700 cm1 arising from
impurities. Spectra are solvent subtracted.
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An additional step was needed in order to directly apply
the calculated VCD spectra of model compound (P)-10,
shown as the lower trace in Figure 8, to the stereochem-
ical determination under consideration. Reanalysis of
the VCD spectra for atropisomers 5 and 6 was carried
out to isolate the spectral eﬀects arising from axial chi-
rality. This consisted of subtraction of the VCD spec-
trum of 6 from that of 5 and dividing by 2, and the
resultant diﬀerence spectrum is shown in the upper trace
of Figure 8. Focusing on the VCD spectral region be-
tween 1600 and 1400 cm1 in Figure 8, a comparison
of the calculated spectrum for (P)-10 to the diﬀerence
spectrum [(VCD5  VCD6)/2 = VCDdiﬀerence] revealed
striking similarities among their prominent features.
The close correlation between these spectra is quite out-
standing in view of the simplicity of the model system
employed for this purpose. Therefore, it was unambigu-
ously determined that 5 and 6 exhibit P andM axial chi-
rality, respectively.
2.4. Biological activity and modeling studies of curcu-
phenol metabolites
Studies on the cytotoxic eﬀects of 1, using our standard
disk-diﬀusion assay,28 revealed that it possessed potent,
but nonspeciﬁc activity against several murine and hu-
man cell lines including colon and breast. This was in
accordance with previous bioactivity observations for
analogs of 1.22 Compounds 2–9 were subsequently
examined in this screen against the same cell lines, but
were found to be completely inactive. In addition, all
compounds were also examined in a bench-top brine
shrimp assay26 similar to that performed for 1. Only 1
displayed potent activity, killing all brine shrimp within
20 min (LC50 = 0.63 ± 0.04 lg/mL), while 2–9 exhibit-
ed no lethality even after 24 h at 100 lg/mL.
Curcuphenol (1) was examined for its lipoxygenase
inhibitory activity against both human 12-lipoxygenase
(12-hLO) and 15-lipoxygenase (15-hLO). These enzymes
represent important therapeutic targets for the develop-
ment of novel pharmaceuticals for the treatment of
cancer (12-hLO) and atherosclerosis (15-hLO).54
Compound 1 exhibited potent, but nonselective inhibi-
tory activity against both 12-hLO (IC50 2.9 ± 0.4 lM)
Figure 8. Observed (red, right axes) IR spectrum of 5 and diﬀerence
VCD [(5–6)/2] versus calculated (blue, left axes) spectra for the
truncated model compound (P)-10. The observed spectra have been
converted to molar absorptivities for direct comparison with the
calculated spectrum.
Figure 6. IR (lower trace) and VCD (upper trace, with the VCD noise
level shown above in red) spectra of monomer 1, in CDCl3 solution.
Both spectra are solvent subtracted.
Figure 7. Model phenol atropisomers (P)-10 and (M)-10 used for
theoretical VCD calculations.
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and 15-hLO (IC50 1.6 ± 0.3 lM). All of the other six
compounds isolated herein were tested against both lip-
oxygenases, but only dimer 4 tested positive in this assay
as it possessed modest and equipotent activity against
both 12-hLO (IC50 11.6 ± 1.8 lM) and 15-hLO (IC50
11.4 ± 2.5 lM). Not clear at this juncture are the struc-
tural features responsible for the inactivity of com-
pounds 2, 3, and 5–9 as compared to 1 and 4.
In further examining the lipoxygenase activity data and
structures for 1 and 4, we suspected that both functioned
as redox-type inhibitors. In our past experience, the
structural signature for such activity was the presence
of a phenolic head group.31 Using a ﬂuorescence-based
assay, it was determined that 4 did not reduce the active
site ferric iron species while 1 exhibited a more modest
reducing eﬀect over a relatively extended timeframe.
This suggested that 1 functioned through both compet-
itive- and redox-based inhibition mechanisms while 4
was not redox active.
These concepts were further explored by means of
molecular modeling analysis of the active site binding
of 1 and 4. A homology model of 15-hLO from rabbit
15-lipoxygenase (15-rLO) has recently been developed
by which the docking behavior of inhibitors can be
visualized.55 This model system has been eﬀectively
employed for the in silico selection and experimental
validation of potent (low mM) inhibitors of 15-hLO.
Shown in Figure 9 are docking results for 1 calculated
with GLIDE in the 15-hLO active site. As seen in the
upper panel (Fig. 9a), the hydroxyl moiety was predicted
to adopt a preferred orientation >4.0 A˚ away from the
active site iron atom and therefore would not be able
to reduce the iron atom. In this model, hydrogen bond-
ing was observed to occur between the OH group and
active site residues Glu355 and Gln546. Since the active
site iron can change the pKa of nearby ligands, deproto-
nated-1 was also docked in the same manner using
GLIDE (Fig. 9b). These conditions showed that the
hydroxide anion resided within 2.1 A˚ of the iron atom
and should be capable of redox inactivation. These
two supporting models help to explain the 15-hLO
inhibitory properties and weak redox activity observed
for 1. Further modeling studies (data not shown) per-
formed with the weak, nonreductive inhibitor 4 suggest-
ed that this compound is too sterically restrained within
the active site to function in a redox fashion.
3. Conclusions
Bisabolene-type sesquiterpenes constitute a diverse
assemblage of terrestrial- and marine-derived metabo-
lites. These compounds have demonstrated promising
biological eﬀects in a variety of assay systems, but none
appear to be under current consideration for preclinical
development. In an eﬀort to further probe the structural
and biological relationships of these metabolites,
ESIMS-guided isolation was used to obtain several
new dimeric curcuphenol (1) derivatives that were exam-
ined for their cell cytotoxicity and lipoxygenase inhibito-
ry activities. Dimerization of 1, both in the sponge and
through laccase biocatalysis, resulted in the general loss
of activity across all assay systems examined in this
study. Molecular modeling studies of 1 and 4 with
15-hLO provided intriguing evidence for the existence
of multiple active site conformations of this compound
resulting in a mixed inhibition proﬁle.
The biogenic origin of dimers 4–9 is likely due to the oxi-
dative coupling of 1 which can take place at more than
one site. Atropisomeric dimers 5 and 6 provided an
opportunity to explore the application of VCD spectros-
copy in the absolute conﬁguration determination of
marine-derived metabolites. This study oﬀered compel-
ling evidence that VCD is a powerful technique that
should ﬁnd broad application in modern structure deter-
mination studies. We are currently engaged in a wider
survey of bisabolene structural variants including higher
molecular weight congeners. This should lead to further
opportunities to discover novel structural themes and
biological activities within this chemical family. The
application of methodologies such as ESIMS in the
structure discovery process will be crucial in making this
assertion a reality.
4. Experimental
4.1. General methods
All 1D- and 2D-NMR spectra were recorded in CDCl3
(Cambridge Isotope Laboratories, Inc. Andover, MA)
Figure 9. Docking results for 1 (panel a) and deprotonated-1 (panel
b) in the active site of 15-hLO. Compound 1 is shown in blue with the
active site iron identiﬁed as a yellow sphere.
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on Varian UNITY INOVA 500 instruments. Multiplic-
ities of carbon resonances were conﬁrmed by DEPT
experiments. Low- and high-resolution ESIMS data
were obtained on an Applied Biosystems Mariner Bio-
spectrometry Workstation. Optical rotations were deter-
mined on a Jasco DIP 370 polarimeter using a 130 lL
microcuvett. VCD measurements were performed using
a Chiralir FT-VCD/IR spectrometer (BioTools, Wau-
conda, IL) with a liquid nitrogen-cooled MCT detector,
which has been modiﬁed with two photoelastic modula-
tors optimized at 1400 cm1.56
Chromatography materials and supplies were used as
previously described.31 Buﬀers and other chemicals for
biocatalysis studies were obtained from Sigma-Aldrich
and used without further puriﬁcation. Laccase was a gift
from L. T. Holst Jr. (Dexter Chemical L.L.C.) and used
without further puriﬁcation. Horseradish peroxidase
and polyphenol oxidase were purchased from Research
Organics and Worthington, respectively.
4.2. Animal material
The sponge (UCSC collection number 00372) was col-
lected by SCUBA from the region of New Britton, Pap-
ua New Guinea in 2000 and examined by R. W. N. Van
Soest (Zoological Museum, University of Amsterdam,
Amsterdam, The Netherlands) for taxonomic identiﬁca-
tion. The sponge (2.3 kg wet weight) exhibited a mas-
sive, lobate morphology with a light pink to tan exterior
and light yellow interior. The surface morphology of the
organism was characterized as composed of convoluted
grooves with a membraneous surface. The interior was
ﬁbrous featuring spicules in a chaotic composition.
These features support that UCSC 00372 is a relatively
rare specimen of Didiscus aceratus (Ridley and Dendy)
(Halichondrida, Desmoxyidae)27 (see Supplementary
data for underwater photo of the sponge). Immediately
following collection, the sponge was soaked in EtOH/sea
H2O (1:1) for 24 h after which the liquid was decanted
and the sponge transported to UCSC. Upon arrival,
the sponge was immediately immersed in MeOH and
placed in cold storage at 4 C until extracted. Voucher
specimens have been retained at UCSC and the Amster-
dam Zoological Museum (ZMAPOR 17712) for
reference.
4.3. Extraction and isolation
The sponge (UCSC 00372, 2.3 kg wet weight) was
extracted with MeOH (1 L, 3·) and MeOH/CH2Cl2
(1 L, 3·). These extracts were combined yielding 29.5 g
of brown oily residue. The total organic extract was dis-
solved in 800 mL MeOH/H2O (9:1) and partitioned
against hexane (800 mL, 3·). The aqueous MeOH ex-
tract was further diluted with H2O (ﬁnal 1:1, vol:vol)
and partitioned against CH2Cl2 (800 mL, 3·). The
CH2Cl2 extract (10.1 g) exhibited brine shrimp toxicity
(100% lethality at 10 lg/mL) and as a result was chro-
matographed over silica gel (gradient 100% hexane to
100% acetone) providing fractions S1 (31 mg), S2
(7.83 g) S3 (1.22 g), S4 (370 mg), and S5 (331 mg). Brine
shrimp toxic fraction S2 (100% lethality at 10 lg/mL)
was puriﬁed by C18 LPLC (50–100% acetonitrile) yield-
ing fractions B1 (1.73 g), B2 (5.02 g), B3 (105 mg), B4
(109 mg), and B5 (59 mg). All the biological activity
was associated with fraction B2 (100% lethality at
10 lg/mL) which was subsequently analyzed by MS
and HPLC and found to contain a single major
(50% by mass) component that upon further HPLC
puriﬁcation (semipreperative C18 HPLC, 80–100% ace-
tonitrile) was identiﬁed as (S)-(+)-curcuphenol (1)
ð½a25D +30.7, c 4.3, CHCl3) by comparison to literature
data.6,7 Compound 1 was responsible for all of the ob-
served brine shrimp toxicity (LC50 = 0.63 ± 0.04 lg/mL).
Based on a diﬀerent bioassay lead for compound 1 (hLO
inhibition, see Section 2), all other fractions were exam-
ined by MS analysis to determine the presence of poten-
tial related chemical species for further biological
evaluation. Fraction B1 exhibited an ion of m/z 253
[MH]+ suggesting the presence of a dihydroxylated
derivative. Further puriﬁcation of B1 by C18 preparative
HPLC (40–60% acetonitrile) and semipreparative HPLC
(isocratic 30% acetonitrile) yielded a 40 mg 1:1 mixture
of 10b-hydroxycurcudiol (2) and its C-10 epimer, 10a-
hydroxycurcudiol (3).
Further evaluation of fraction B2 provided evidence for
the presence of several putative dimeric derivatives (m/z
435 [MH]+) that were targeted for puriﬁcation. Accord-
ingly, fraction B2 was subjected to C18 preparative
HPLC aﬀording fractions P1 (86 mg), P2 (58 mg), P3
(2.89 g), P4 (18 mg), P5 (60 mg), P6 (31 mg), and P7
(18 mg). Fraction P3 was found to comprise mainly of
compound 1 (purity >95%). Fraction P5 was applied
to a PTLC plate and developed with toluene/ethyl ace-
tate (95:5). A band (27 mg) possessing a molecular
weight of m/z 435 was further puriﬁed by C18 semipre-
parative HPLC (isocratic 85% acetonitrile) yielding dic-
urcuphenol A (4). Similarly, fraction P6 was applied to
PTLC (100% toluene) providing fractions T1 (17 mg)
and T2 (15 mg) each possessing m/z 435. Both fractions
T1 and T2 were puriﬁed by C18 semipreparative HPLC
(isocratic 90% acetonitrile) aﬀording 13 mg each of dic-
urcuphenols B (5) and C (6), respectively.
Fraction P8 was chromatographed by C18 semiprepara-
tive HPLC (isocratic 90% acetonitrile) yielding H1
(6 mg) and H2 (11 mg). Fraction H1 was further puriﬁed
by C18 semipreparative HPLC (isocratic 90% acetoni-
trile) aﬀording 5 mg of a 1:2.3 mixture of dicurcuphenols
D (7) and E (8), respectively. Fraction H2 was also puri-
ﬁed by C18 semipreparative HPLC (isocratic 90% aceto-
nitrile) yielding 10 mg of dicurcuphenol ether F (9).
4.3.1. 10a-Hydroxycurcudiol (3). Clear oil; 1H NMR
(CDCl3, 500 MHz) d 7.04 (1H, d, J = 8.0 Hz, H-5),
6.73 (1H, d, J = 8.0 Hz, H-4), 6.67 (1H, s, H-2), 3.53
(1H, br d, J = 9.5 Hz, H-10), 3.23 (1H, sextet,
J = 7.0 Hz, H-7), 3.26 (3H, s, H-15), 1.70, (2H, m, H-8
and/or H-9), 1.46 (1H, m, H-8 and/or H-9), 1.24 (1H,
m, H-8 and/or H-9), 1.24 (3H, d, J = 6.5 Hz, H-14),
1.18 and 1.11 (each 3H, s, H-12 and H-13); 13C NMR
(CDCl3, 125 MHz) d 153.3 (C-1), 136.6 (C-3), 130.1
(C-6), 126.4 (C-5), 121.7 (C-4), 117.1 (C-2), 79.6 (C-
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10), 73.7 (C-11), 36.5 (C-8), 30.2 (C-7), 28.0 (C-9), 26.7
(C-12), 22.7 (C-13), 21.0 (C-14 and C-15); HRESIMS
m/z 253.1800 [MH]+ (calcd for C15H25O3, 253.1804).
4.3.2. Dicurcuphenol A (4). Clear oil; ½a25D +61.5 (c 4.7,
CHCl3);
1H NMR (CDCl3, 500 MHz) d 6.90 (1H, s, H-
5), 6.87 (1H, s, H-5 0), 6.68 and 6.67 (each 1H, s, H-2
and H-2 0), 5.13 (2H, t, J = 7.0 Hz, H-10 and H-10 0),
4.70 (2H, br s, OH), 3.03 (1H, sextet, J = 7.0 Hz, H-
7), 3.00 (1H, sextet, J = 7.0 Hz, H-7 0), 1.97 (6H, s, H-
15 and H-15 0), 1.94 (4H, m, H-9 and H-9 0), 1.68 and
1.67 (each 3H, s, H-12 and H-12 0), 1.67 (2H, m, H-8a
and H-80a), 1.59 (2H, m, H-8b and H-8
0
b), 1.56 and
1.51 (each 3H, s, H-13 and H-13 0), 1.23 (6H, d,
J = 7.0 Hz, H-14 and H-14 0); 13C NMR (CDCl3,
125 MHz) d 151.9 and 151.8 (C-1 and C-1 0), 134.8
(C-4 and C-4 0), 134.3 (C-3, C-3 0), 132.1 and 132.0 (C-
11 and C-11 0), 130.1 (C-6 0), 130.0 (C-6), 128.8 (C-5 0),
128.5 (C-5), 124.7 (C-10 and C-10 0), 116.6 (C-2 and
C-2 0), 37.4 and 37.3 (C-8 and C-8 0), 31.8 (C-7 0), 31.3
(C-7), 26.3 and 26.1 (C-9 0, C-15, and C-15 0), 25.8 (C-
9, C-12, and C-12 0), 21.4 (C-14 0), 21.1 (C-14), 17.8
(C-13 and C-13 0); HRESIMS m/z 435.3262 [MH]+
(calcd for C30H43O2, 435.3263).
4.3.3. Dicurcuphenol B (5). Clear oil; ½a25D +103.0 (c 1.0,
CHCl3);
1H NMR (CDCl3, 500 MHz) d 7.06 (1H, d,
J = 8.0 Hz, H-5 0), 6.94 (1H, s, H-5), 6.80 (1H, d,
J = 8.0 Hz, H-4 0), 6.76 (1H, s, H-2), 5.15 (1H, t,
J = 7.0 Hz, H-10 0), 5.11 (1H, t, J = 7.0 Hz, H-10), 4.80
and 4.67 (each 1H, br s, OH), 3.09 (1H, sextet,
J = 7.0 Hz, H-7 0), 3.03 (1H, sextet, J = 7.0 Hz, H-7),
1.96 (3H, s, H-15 0), 1.93 (3H, s, H-15), 1.93 (4H, m,
H-9 and H-9 0), 1.76 (2H, m, H-8a and H-80a), 1.67 (6H,
s, H-12 and H-12 0), 1.65–1.58 (2H, m, H-8b and H-80b),
1.56 and 1.52 (each 3H, s, H-13 and H-13 0), 1.24 (3H,
d, J = 7.0 Hz, H-14 0), 1.22 (3H, d, J = 7.0 Hz, H-14 0);
13C NMR (CDCl3, 125 MHz) d 153.2 (C-1), 150.5 (C-
1 0), 136.5 (C-3), 134.6 (C-3 0), 132.2 and 131.3 (C-11
and C-11 0), 131.6 (C-6), 130.5 (C-6 0), 129.5 (C-5),
127.1 (C-2 0), 126.9 (C-4), 126.0 (C-5 0), 125.0 (C-10 0),
124.5 (C-10), 121.3 (C-4 0), 117.7 (C-2), 37.2 (C-8), 36.9
(C-8 0), 32.7 (C-7 0), 31.3 (C-7), 26.5 (C-9 0), 26.0 (C-9),
25.8 (C-12 and C-12 0), 21.4 (C-14), 21.0 (C-14 0), 19.9
(C-15 0), 19.1 (C-15), 17.8 (C-13 and C-13 0); HRESIMS
m/z 435.3261 [MH]+ (calcd for C30H43O2, 435.3263).
4.3.4. Dicurcuphenol C (6). Clear oil; ½a25D +2.87 (c 1.6,
CHCl3);
1H NMR (CDCl3, 500 MHz) d 7.08 (1H, d,
J = 8.0 Hz, H-5 0), 6.96 (1H, s, H-5), 6.82 (1H, d,
J = 8.0 Hz, H-4 0), 6.77 (1H, s, H-2), 5.13 and 5.12 (each
1H, t, J = 7.0 Hz, H-10 and H-10 0), 4.85 and 4.65 (each
2H, br s, OH), 3.14 (1H, sextet, J = 7.0 Hz, H-7 0), 3.00
(1H, sextet, J = 7.0 Hz, H-7), 1.96 (3H, s, H-15), 1.94
(4H, m, H-9 and H-9 0), 1.93 (3H, s, H-15 0), 1.68 and
1.66 (each 3H, s, H-12 and H-12 0), 1.68 (2H, m, H-8a
and H-80a), 1.56 (2H, m, H-8b and H-8
0
b), 1.54 and 1.53
(each 3H, s, H-13 and H-13 0), 1.26 (3H, d, J = 7.0 Hz,
H-14 0), 1.24 (3H, d, J = 7.0 Hz, H-14); 13C NMR
(CDCl3, 125 MHz) d 153.2 (C-1), 150.5 (C-1 0), 136.6
(C-3), 134.6 (C-3 0), 132.2 and 131.3 (C-11 and C-11 0),
131.7 (C-6), 130.5 (C-6 0), 129.6 (C-5), 126.9 (C-4 and
C-2 0), 125.7 (C-5 0), 125.0 (C-10 0), 124.5 (C-10), 121.4
(C-4 0), 117.8 (C-2), 37.7 (C-8 0), 37.3 (C-8), 31.9 (C-7 0),
31.7 (C-7), 26.3 (C-9 0), 26.2 (C-9), 25.8 (C-12 and C-
12 0), 21.1 (C-14), 21.0 (C-14 0), 19.9 (C-15 0), 19.0 (C-
15), 17.8 and 17.7 (C-13 and C-13 0); HRESIMS m/z
435.3262 [MH]+ (calcd for C30H43O2, 435.3263).
4.3.5. Mixture of dicurcuphenols D and E (7 and 8). Clear
oil; ½a25D 10.0 (c 0.3, CHCl3); 1H NMR (CDCl3,
500 MHz) d 7.16 (d, J = 7.5 Hz, H-5E and H-50E), 7.15
(d, J = 7.5 Hz, H-5D and H-5
0
D), 6.89 (d, J = 7.5 Hz,
H-4E and H-4
0
E), 6.88 (d, J = 7.5 Hz, H-4D, H-4
0
D), 5.13
(m, H-10D, H-10
0
D, H-10E and H-10
0
E), 4.75 and 4.74
(br s, OH), 3.13 (t, J = 7.0 Hz, H-7E and H-7
0
E), 3.12
(t, J = 7.0 Hz, H-7D and H-7
0
D), 1.954 (s, H-15D and
H-150D), 1.946 (s, H-15E and H-15
0
E), 2.02–1.98 (m, H-
9D, H-9
0
D, H-9E and H-9
0
E), 1.76–1.53 (m, H-8D, H-8
0
D,
H-8E and H-8
0
E), 1.67 (s, H-12D, H-12
0
D, H-12E and H-
120E), 1.54 (s, H-13D and H-13
0
D), 1.53 (s, H-13E and
H-130E), 1.243 (d, J = 6.5 Hz, H-14E and H-14
0
E), 1.240
(d, J = 6.5 Hz, H-14D and H-14
0
D);
13C NMR (CDCl3,
125 MHz) d 151.4 (C-1D, C-10D, C-1E, and C-1
0
E), 135.7
(C-3D, C-3
0
D, C-3E, and C-3
0
E), 131.4 (C-6D, C-6
0
D, C-
6E, C-6
0
E, C-11D, C-11
0
D, C-11E, and C-11
0
E), 127.8
(C-5D and C-5
0
D), 127.6 (C-5E and C-5
0
E), 124.8 (C-10D,
C-100D, C-10E, and C-10
0
E), 122.3 (C-4D, C-4
0
D, C-4E,
and C-40E), 119.6 (C-2D, C-2
0
D, C-2E, and C-2
0
E), 37.6
(C-8E and C-8
0
E), 36.9 (C-8D and C-8
0
D), 32.6 (C-7D
and C-70D), 32.0 (C-7E and C-7
0
E), 26.4 (C-9D and C-
90D), 26.2 (C-9E and C-9
0
E), 25.8 (C-12D and C-12
0
D,
C-12E and C-12
0
E), 20.9 (C-14D, C-14
0
D, C-14E, and C-
140E), 19.4 (C-15D, C-15
0
D, C-15E, and C-15
0
E), 17.7 (C-
13D, C-13
0
D, C-13E, and C-13
0
E); HRESIMS m/z
435.3260 [MH]+ (calcd for C30H43O2, 435.3263).
4.3.6. Dicurcuphenol ether F (9). Clear oil; ½a25D +67.5 (c
0.7, CHCl3);
1H NMR (CDCl3, 500 MHz) d 7.13 (1H, d,
J = 7.5 Hz, H-5), 6.79 (1H, d, J = 7.5 Hz, H-4), 6.673
and 6.666 (each 1H, s, H-2 0 and H-5 0), 6.32 (1H, s, H-
2), 5.11 (2H, m, H-10 and H-10 0), 4.55 (1H, br s, OH),
3.24 (1H, sextet, J = 7.0 Hz, H-7), 2.94 (1H, sextet,
J = 7.0 Hz, H-7 0), 2.19 (3H, s, H-15), 2.12 (3H, s, H-
15 0), 1.89 (4H, m, H-9 and H-9 0), 1.74 (1H, m, H-8a),
1.67 and 1.66 (each 3H, s, H-12 and H-12 0), 1.59 (3H,
m, H-8b and H-8
0), 1.54 and 1.52 (each 3H, s, H-13
and H-13 0), 1.25 (3H, d, J = 7.0 Hz, H-14), 1.17 (3H,
d, J = 7.0 Hz, H-14 0); 13C NMR (CDCl3, 125 MHz) d
155.8 (C-1), 149.1 (C-1 0), 148.2 (C-4 0), 136.4 (C-3),
133.4 (C-6), 132.2 (C-6 0), 131.8 and 131.3 (C-11 and
C-11 0), 128.3 (C-3 0), 127.2 (C-5), 124.9 and 124.6 (C-10
and C-10 0), 122.7 (C-4), 118.8 (C-5 0), 118.0 (C-2 0),
115.6 (C-2), 37.3 (C-8), 37.2 (C-8 0), 32.0 (C-7), 31.7
(C-7 0), 26.5 (C-9), 26.0 (C-9 0), 25.8 (C-12 and C-12 0),
21.4 (C-14), 21.2 (C-15 and C-14 0), 17.8 (C-13 and C-
13 0), 16.0 (C-15 0); HRESIMS m/z 435.3262 [MH]+ (calcd
for C30H43O2, 435.3263).
4.4. Enzyme-mediated synthesis of dicurcuphenols
Three enzymes, horseradish peroxidase, polyphenol oxi-
dase, and laccase, were screened for their ability to cat-
alyze the production of the dimeric dicurcuphenols from
the monomeric 1. Very little transformation to the
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desired dimeric species was observed among the horse-
radish peroxidase and polyphenol oxidase preparations.
However, several laccase preparations (13 of 78 combi-
nations of buﬀers, co-solvents, and mediators) were
identiﬁed as capable of catalyzing this transformation
(see Supplementary data) and therefore this enzyme
was selected for further scale-up studies.
Three, 1 L Erlenmeyer ﬂasks were prepared each con-
taining 150 mL of 100 mM citrate buﬀer (pH 5) and
50 mL of MeOH. The crude enzyme preparation (4 g)
was gently stirred for 30 min in 50 mL of citrate buﬀer
and allowed to settle for 2 min before use. The cloudy
suspension was decanted to remove the insoluble solid
residue and the supernatant divided equally among the
three ﬂasks. Compound 1 (1.5 g) was dissolved in
3 mL DMF and 500 mg of 1 distributed to each of the
three ﬂasks. The ﬂasks were loosely capped with alumi-
num foil and placed on a rotary shaker at 150 rpm for
24 h.
The ﬂasks were removed and their contents pooled be-
fore extraction by partitioning with a mixture of ethyl
acetate/sec-butanol (95:5) (200 mL, 3·). The organic
layer was removed and dried over MgSO4 yielding
1.6 g of crude extract. Analysis by ESIMS of this extract
was performed giving evidence for the presence of di-
mers (m/z 435) of 1. The extract was subjected to repeat-
ed C18 HPLC and silica gel PTLC as outlined above
yielding 608 mg of untransformed 1 and dicurcuphenols
4 (46 mg), 5 (22 mg), 6 (18 mg), 1:2.3 mixture of 7 and 8
(11 mg), and 9 (11 mg).
4.5. Periodate oxidation of 1
A periodate oxidative catalytic resin was prepared as
described57 with minor modiﬁcations. Brieﬂy, 2.5 g of
Amberlite IRA-900 ion exchange resin was combined
with 2 g NaIO4 in 20 mL deionized H2O and stirred
overnight. The liquid was decanted and an additional
2 g NaIO4 in 20 mL deionized H2O was added. This
was stirred for 6 h at room temperature. The resin was
ﬁltered and washed with H2O, THF, and ethyl acetate
before being dried in a desiccator. Dimerization of 1
was performed as described.42,57,58
4.6. Fenton peroxidation of 1
Compound 1 was incubated with Fenton-type reagents
as described.43,59 Brieﬂy, 5 mM of metal (Fe2+, Cu2+,
and Mn2+) salts were combined with 5 mM EDTA,
5 mg of 1, and 1 mM H2O2 in a mixture of 0.1 M potas-
sium phosphate buﬀer (pH 7.0) with acetonitrile (1:1,
vol:vol). Reactions proceeded at 37 C for 60 min at
which time cold H2O was added and the mixture
extracted with diethyl ether.
4.7. Vibrational circular dichroism (VCD) studies
Compounds 5 (0.23 M) and 6 (0.11 M) were dissolved in
CDCl3 and placed in CaF2 cells (path length 98 lm) for
analysis. Spectra were acquired over 10 h at a resolution
of 4 cm1.
Calculations were performed on the model atropisomer
(P)-10 using Gaussian 0360 at the DTF level (B3LYP
functional and 6-31G(d) basis set). Vibrational frequen-
cies were scaled by 0.97 and converted to Lorentzian
bands with 6 cm1 half-widths for comparison to exper-
imental data. The truncated (P)-10 lacking the alkyl tails
was chosen for analysis due to its limited conformation-
al ﬂexibility and so as to eliminate the contribution of
the C-7 chiral center, thereby providing a spectrum
whose features were dependant solely on the C-2/C-4 0
axial chirality. The scaled VCD spectra for 5 and 6 were
subtracted from one another and the resultant diﬀerence
spectrum aligned and visually compared with that gen-
erated for (P)-10.
4.8. Lipoxygenase inhibition assay
Human reticulocyte 15-lipoxygenase (15-hLO) and hu-
man platelet 12-lipoxygenase (12-hLO) were expressed
and puriﬁed as previously described.29,61 The IC50 val-
ues for compounds 1–9 against these enzymes were
determined as previously described with minor modiﬁ-
cations.29,62 Brieﬂy, all inhibitors and enzyme substrates
were dissolved in MeOH (1 mg/mL) and added to 2 mL
buﬀer with 0.1% Triton-X under constant stirring. After
a brief equilibration, 15-hLO (25 mM HEPES, pH 7.5)
or 12-hLO (25 mM HEPES, pH 8) was added and the
enzyme activity monitored based on the rate of diene
product formation at 234 nm at room temperature.
Multiple data points inclusive of the 50% inhibitory
concentration were acquired and the data were ﬁt to a
simple saturation curve.
4.9. Redox inhibition studies
Characterization of a redox mode of inhibition of com-
pounds against lipoxygenase was performed as previous-
ly described.31 Brieﬂy, the iron atom in the model
lipoxygenase, soybean 15-lipoxygenase (15-sLO), was
activated to the ferric species with 13-hydroperoxy-
9(Z),11(E)-octadecadienoic acid (HPOD). The oxidation
status of the 15-sLOwasmonitored by ﬂuorescence (exci-
tation: 280 nm; emission: 328 nm) while test compounds
were added to the reaction cell containing 2 mL borate
buﬀer (pH 9.2) at room temperature with constant stir-
ring. A relative increase in the ﬂuorescence signal intensi-
ty indicated a reduction of the 15-sLO active site iron.
4.10. Molecular modeling studies
The 15-hLO homology model was created using the Pro-
tein local optimization program (PLOP, University of
California, San Francisco) whereby conserved residues
were aligned with the rabbit 15-lipoxygenase (15-rLO)
template. Docking of 1 and deprotonated-1 into the ac-
tive site was performed using GLIDE. Active site van
der Waals forces were reduced and the ligand inserted.
The protein was then relaxed about the ligand using
PLOP. The resultant Ramachandran maps generated
from the STRIDE database indicated that all residues
were within acceptable phi psi spaces. Compound 1
and its ion form were then redocked into the minimized
protein active site and found to adopt chemically
5610 R. H. Cichewicz et al. / Bioorg. Med. Chem. 13 (2005) 5600–5612
reasonable poses. Full details of these methods and cre-
ation of the 15-hLO homology model can be found in
Chorny and co-workers.55
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Abstract. Vibrational Circular Dichroism (VCD) and IR spectroscopy combined 
with DFT (B3LYP/6-31G(d)) calculations have successfully been applied to determine 
the absolute configuration of Ginkgolide B (GB) from Ginkgo Biloba. In addition, the 
calculated spectra indicate that it is possible to distinguish GB from stereoisomers with 
inversion at a single chiral center (C1 or C10) and from the other Ginkgolides A, C, J, 
and M (GA, GC, GJ and GM) by VCD and IR spectroscopy. The VCD and IR spectra 
of GB were recorded using two different solvents (DMSO-d6 and CD3CN) and a KBr 
pellet and two different VCD instruments. The elucidation of vibrational spectral bands 
of GB has been improved compared to previous assignments in the literature.1-3 
  
Introduction. The interest in the medical effects of the Ginkgo-tree has persisted since 
ancient time in Eastern Asia. Extracts from the Ginkgo-tree comprise GA, GB, GC, GJ 
and GM. The latter is only found the root bark and GJ only in the leaves while the 
others can be isolated from all parts of the tree.4 The ginkgo tree itself is very 
remarkable in being a specimen that has survived since the Jurassic era.2,4 In 1932 
Ginkgolides were discovered to be terpene trilactones, but the elucidation of their 
structure and their ability to interact with the platelet activating factor (PAF) receptor in 
1985 markedly increased the attention. Among the ginkgolides, GB is found to be the 
most potent PAF antagonist.4  
The overall IR spectral features of ginkgolides comprise characteristics of alcohols, 
ethers, esters and aliphatic hydrocarbons, which are all strongly entangled by sharing of 
many atoms among the rings.1 The fingerprint spectral region is therefore highly 
complex, and spectral bands should rather be assigned to the vibrational character of the 
whole molecular frame than to specific molecular bonds as for simpler organic 
compounds. Addition and removal of OH-groups as well as chiral inversion should 
therefore have a dramatic effect on both the IR and VCD spectra. There are 10-12 chiral 
centres in ginkgolides depending on the type as shown in table 1. However, 3 of these 
(C4, C5 and C9) cannot contribute to the number of possible diastereomers without 
rupture of the 6-ring structure, and 4 (C2, C3, C6 and C12) will severely alter the shape of 
molecular frame. Inversion of C8 and C14 implies change of the t-butyl and methyl 
group orientations, respectively. Thus, we have limited our investigations for GB to 
inversions at the positions 1 and 10 (denoted GB-C1i and GB-C10i, respectively). These 
isomers are also relevant for total synthesis of GB where stereospecific addition to 
double bonds at C1 and C10 occurs. The strength of VCD together with IR is not limited 
only to distinguish between enantiomers, but also enables vibrational assignment of 
diastereomers that occur on inversion of one or several chiral centres. In the case of 
ginkgolides, in particular, discrimination between stereoisomers with inversion at just 
one chiral center is essential, with reference to both synthesis and isolation.5 
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In this work we wish to demonstrate that VCD spectroscopy combined with DFT 
calculations is a powerful tool for absolute configuration determination of even 
relatively large organic molecules with many chiral centres such as GB and to test the 
reliability when distinguishing GB from selected diastereomers and other types of 
ginkgolides. Molecular mechanics force field calculations, two types of DFT 
calculations and three different sample preparations which implied use of two different 
VCD instruments have been examined and compared. The DFT calculations were done 
with GAUSSIAN 03 ™.6 GB (C20H24O10) has 224 electrons and no symmetry and is 
among the larger molecules studied by this combination of experimental and theoretical 
methods, albeit similar works on even larger molecular systems have been published.7-9 
Results and Discussion. The Boltzmann weighting of the conformers with relevance of 
GB, GC and GM shown in table 2 illustrates that the IR and VCD spectra at room 
temperature are dominated by main contributions from the lowest energy conformer by 
95.8%, 96.8% and 97.8%, respectively. Only minor changes in the calculated spectra 
could be seen when incorporating the weighted data from the second conformers that in 
the same order are 7.8, 8.5 and 9.4 kJ/mol higher in energy. The geometry optimized 
structure of GB at B3LYP/6-31G(d)-level is identical to that of earlier work.10 The 
overall agreement between the calculated and experimental VCD spectra of GB is 
striking, see Figure 2, and thus indicates that VCD spectroscopy can be applied in 
determination of absolute configuration of ginkgolides. The absolute configuration 
determined in this work agrees with the crystal structure of GB.10,11 However, it is also 
necessary to demonstrate that the calculated spectra of other stereoisomers of GB differ 
significantly from the recorded spectrum, in order to validate that the assignment is 
unambiguous, see below.  
The IR spectrum of GB in KBr and/or Nujol has previously been assigned.1,2,3 
As seen in figure 2, VCD improves the spectral assignment: In the 1000 to 1200 cm−1 
region, five broad and intense IR bands are observed at 1168, 1130, 1098, 1065 and 
1044 cm-1. The last two of these are obscured by solvent absorption in the DMSO-d6 
experiment. Overarchingly, these bands are accompanied by negative VCD at 1168, 
1134 and 1046 cm-1 and positive VCD at 1098 and 1068 cm−1. There is nonetheless a 
significant discrepancy for the band at 1168 cm−1 where the intensity calculation fails 
for both IR and VCD. For this mode, C-O-H bending is prominent and the discrepancy 
may be caused by changes in the hydrogen bonding pattern on exposure to solvent. Here 
the bands at 1065 and 1044 cm−1 are assigned to C-O-H bending. This is in excellent 
agreement with both the observed KBr spectrum in figure 2 and the scaled frequencies 
from the DFT calculations. By visualization of the Gaussian results, C10OH and C3OH 
bending could be assigned to the band at 1168 cm-1 while C1OH shows bending motion 
at 1134 cm−1. 
 The IR and VCD spectrum for GB differs markedly from those of GB-C1i and 
GB-C10i and the other Ginkgolides, figure 3. At 872, 926, 986, 1031, 1082, 1157 and 
1282 cm−1 the VCD spectra display distinct differences. However, at other spectral 
regions great care should be taken as several IR and VCD patterns appears quite alike. 
The highly distinguishable C=O stretching bands and the striking differences at 950, 
1030, 1120, 1140, 1170 and 1230 cm−1 should be remarked. 
The differences between the different ginkgolide spectra in figure 4 are puzzling, 
but at certain wavenumbers the deviations are clear. At  1425 cm−1 GC, GJ and GM has 
IR peaks that is also accompanied with a positive-negative VCD feature for GC and 
GM. Around 1340 cm−1 GA and GJ shows similar VCD patterns, but this appears to be 
inverted in case of GM. At 1300, 1320 and 1360 cm−1 GB have a characteristic pattern 
consisting of three positive VCD peaks that seems to occur also for GC. The negative 
VCD features for GB between 1300 and 1260 cm−1 looks like those for GC that also has 
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a negative VCD shoulder at 1250, whereas GA and GJ have positive VCD peaks at 
1270 cm−1. For GM this negative VCD pattern is limited to the range from 1280 to 1250 
cm−1. The strong negative VCD band at 1170 cm−1 is observed for all the ginkgolides 
but GM where the peak is shifted to 1160 cm−1. As the only one, GA lacks a negative 
VCD peak near 1140 cm−1. 
Thus IR and VCD can be used to discriminate between the various ginkgolides. 
Similarly, and perhaps most importantly, the calculated spectra for GB with inversion of 
chirality at the C1 or C10 positions are clearly different from the GB spectrum, indicating 
that IR and VCD spectroscopy may be applied to discriminate between stereoisomers 
where only one chiral center is inverted. That is, the technique may be applied to 
investigate the stereochemistry at individual chiral centers in molecules with many such 
centers. 
 
Experimental Section 
 Sample Preparation and VCD Spectroscopy. Ginkgolides are very soluble in 
highly polar and hydrogen bonding solvents as water/acetone mixtures, methanol or 
DMSO but they are insoluble in low dielectric constant solvents as CCl4 and CHCl3.2 
DMSO-d6, CD3CN and KBr were chosen as media for sample preparation. DMSO-d6 
dissolves GB most efficiently, evaporates slowly but suffers from a limited transparency 
range (1100 to 2100 cm−1). CD3CN has a much better transparency range (500 to 2500 
cm−1) but dissolves less GB and evaporates faster while KBr pellets might cause 
artifacts in VCD spectra due to mechanical stress that is difficult to reproduce. In all 
cases care should be taken to avoid water because of hygroscopicity, and the risk of 
lactone ring opening which occurs at pH over 6.12 
Both instruments used were of the FT-type with PEM modulation of the IR light. The 
first instrument at QuP, is a Thermo Nicolet Nexus 870 infrared spectrometer equipped 
with a single PEM and improved with a filter that only allowed light in the range 
between 1000 and 1750 cm−1 to pass.  
The second is a modified Chiral/IR FT-VCD instrument at Syracuse University, New 
York. Here, an extra PEM is added after the sample, which eliminates most of the LD 
artifacts that often occur. As a consequence this instrument produces a much flatter 
baseline but background spectra still have to be recorded.13 
3.9 mg GB (424 g/mol) was dissolved in 20 µl DMSO-d6 and placed in a 48 µm CaF2 
sandwich-cell in the Thermo Nicolet instrument with the PEM set to 1500 cm−1. 
Assuming volume-additivity of solvent and GB (ρ = 1.377 g cm−3,11) the concentration 
was c = 0.40 M. Sample and solvent were scanned for 57 h and the latter spectrum was 
subtracted. The cell was solvent-tight for several days. A calibration of the instrument 
was performed immediately after scanning of the sample. In the narrow spectral range 
1000-1750 cm−1 the effectivity of the PEM is approximately constant, and the raw VCD 
data were calibrated by multiplication with the constant 0.565.  
The next two measurements were made with the modified ChiralIR instrument in 
Syracuse. 1.8 mg GB was dissolved in 50 µl CD3CN and transferred to a 54 µm BaF2 
cell. The concentration was c = 85 mM. ~½ mg GB recovered from the CD3CN 
experiment was ground with 250 mg KBr (ρ = 2.75 g cm−3, CRC) and pressed to a 13 
mm diameter disk for 4 min at 13000 lbs. The GB concentration and disk path-length 
was calculated to be c = 13 mM and l = 0.69 mm, respectively. In both cases the PEMs 
were set to 1400 cm−1. Here the VCD spectra were corrected automatically by the 
software using previous calibration measurements. 
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Theoretical Calculations. Structures of all ginkgolides and two stereoisomers 
of GB were subjected to conformational analysis using MacroModel prior to DFT 
calculations. An energy window of 50 kJ/mol was applied and the input files were 
generated from published crystal structures of GA, GB and GC or modifications of 
these.11,14 The relative energies of the relevant conformer outcome are shown in table 2. 
The DFT calculations were run at Qup and at HPC, the University of Oslo. Sets of 
conformers with energies within a 20 kJ/mol from the lowest level for each ginkgolide 
type were geometry optimized with B3LYP/6-31G(d). In case of GA, GJ, GBC1i and 
GBC10i, there was at least 17 kJ/mol to the conformer with next lowest energy, leaving 
back one conformer of each for further calculations. In case of GB, GC and GM, at least 
two conformers of each were subjected to VCD calculations. To be able to perform a 
more precise Boltzmann weighting analysis for the actual sets of conformers, a single 
point energy calculation was undertaken for each geometry optimized conformer with a 
larger basis set (6-311+G(2d,2p)). The Gibbs free energies were calculated by addition 
of the electronic energies from the higher quality single point calculations to thermal 
correction to the corresponding 6-31G(d) frequency calculations. However, the thermal 
energy corrections should be used with care due to larger deviations from harmonic 
behavior of the vibrational modes with lowest frequencies that are heavily populated at 
room temperature. The VCD and IR spectra were extracted from the Gaussian output 
files, and a Lorentzian band profile of 5 cm−1 bandwidth was applied. A scaling factor 
of 0.982 were multiplied with the calculated frequencies and band intensities. This 
ensured the best fit to the data in the fingerprint region. 
 
Acknowledgement. We are grateful for financial support from The Lundbeck 
Foundation for the funding allocated to this project. We also wish to thank the 
University of Oslo, Norway, for providing the superdome calculation facility at HPC 
and for collaboration with IMBV and the Department of Chemistry. 
 
References 
 
(1) Broquet, C.; Braquet, P. In Ginkgolides – Chemistry, Biology, Pharmacology and 
Clinical Perspectives. P. Braquet (Ed.) J.R. Prous Science Publishers, S.A. (1988). 
 
(2) van Beek, T. A. Bioorganic & Medicinal Chemistry 13 (2005) 5001–5012. 
 
(3) Okabe, K.; Yamada, K.; Yamamura, S.; Takeda, S. J. chem. Soc. C (1967) 2201-
2206. 
 
(4) Strømgaard, K; Nakanishi, K. Angewandte Chemie - International Edition 43, 13 
(2004), 1640–1658. 
 
(5) Corey, E.J.; Gavai, A.V., Tetrahedron Lett. 1988, 29, 3201-?? 
 
(6) Frisch, M. J.;Trucks, G.W.; Schlegel, H.B.; Scuseria, G. E.;Robb,M.A.;Cheeseman, 
J.R.; Montgomery, J. A.; J., Vreven, T.;Kudin, K. N.;Burant, J. C.;Millam, J.M.; 
Iyengar, S. S.; Tomasi, J.; Barone, V.;Mennucci, B.;Cossi, M.; Scalmani, G.; Rega, N.; 
Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; 
Hasegawa, J.; Ishida, M.; Nakajima, T.;Honda, Y.; Kitao, O.;Nakai, H.; Klene, M.; Li, 
X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; 
Stratmann, R. E.; Yazyev, O.; Austin, A. J.;Cammi, R.; Pomelli, C.;Ochterski, J. 
 5
W.;Ayala, P. Y.; Morokuma, K.;Voth, G. A.; Salvador, P.; Dannenberg, J. J.; 
Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. 
K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. 
G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; 
Komaromi, I.;Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M.A.; Peng, C. 
Y.;Nanayakkara, A.; Challacombe, M.;Gill, P. M.W.; Johnson, B.; Chen, W.; Wong, M. 
W.; Gonzalez, C.; Pople, J. A. Gaussian 03, Revision B.04. Gaussian, Inc., Pittsburgh 
PA, 2003. 
 
(7) Freedman, T. B.; Cao, X.; Rajca, A.; Wang, H.; Nafie L. A. J. Phys. Chem. A  107 
(2003) 7692-7696. 
 
(8) Brotin, T; Cavagnat, D; Dutasta, J.-P.; Buffeteau, T. J. Am. Chem. Soc. 128 (2006) 
5533-5540. 
 
(9) Bürgi, T.; Urakawa, A.; Behzadi, B.; Ernst, K.H.; Baiker, A. New J. Chem. 
3 (2004) 332-334. 
 
(10) Zhu, W.-L.; Puah, C. M.; Tan, X.-J.; Jiang, H.-L.; Chen, K.-X.; Ji, R.-Y. Journal of 
Molecular Structure (Theochem) 528 (2000) 193-198. 
 
(11) Dupont, L.; Dideberg, O.; Germain, G.; Braquet, P. Acta Cryst. C42 (1986) 1759-
1762. 
 
(12) Zekri, O.; Boudeville P.; Genay, P.; Perly, B.; Braquet, P.; Jouenne, P.; Burgot, J.-
L., Anal. chem. 1996, 68, 2598-2604. 
 
(13) Nafie, L. A. Applied Spectroscopy 54 (2000) 1634-1645. 
 
(14) Sbit, M.; Dupont, L; Dideberg, O; Braquet, P. Acta Cryst. C43 (1987) 2377-2381 
 
 6
 
 
Figure 1 
Sketch of the Ginkgolide skeleton showing the relative orientation of the 6 five-rings. 
Rings A & B are aliphatic while rings C, E & F are γ-lactone rings and ring D an ether 
ring. The numbering of the Carbon atoms grossly follows the order of the letters for the 
rings. 
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Figure 2 
Calculated and measured IR- (lower panel), VCD-spectra (middle panel) and VCD-
noise (upper panel) of pure GB. From bottom to top: Calculated spectrum at B3LYP/6-
31G(d) level scaled by a factor 0.982, spectrum of GB in a pressed KBr pellet, GB 
dissolved in DMSO-d6 and in CD3CN.  
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Figure 3 
Calculated IR and VCD spectra (upper panel) of GB, GB-C1i and GB-C10i scaled with a 
factor 0.982. The IR bands between 1600 and 2000 cm−1 have been multiplied with 0.2.  
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Figure 4 
Calculated IR and VCD spectra for GB, GA, GC, GJ and GM scaled with a factor 
0.982. The IR spectra were multiplied with a factor 0.2 in the 1600 to 2000 cm cm−1 
region.  
 
 
 
Ginkgolide R1 on C3 ring A 
R2 on C1 
ring A 
R3 on C7 
ring B  
R4 on C10 
ring C 
N° of chiral 
centers 
A OH H H OH 10 
B OH OH H OH 11 
C OH OH OH OH 12 
J OH H OH OH 11 
M H OH OH OH 12 
Table 1 
 
 9
 
 Energies in kJ/mol 
 Macro-
Model 
Gaussian 03 
Ginkgolide 
type & 
Conformer 
number 
 B3LYP 
6-31G(d) 
B3LYP 
6-311+G(2d,2p) 
Sum of electronic 
and thermal Free 
Energies 
Thermal 
correction 
to Gibbs 
Free 
Energy 
      
GB  -1528.81188050 -1529.30880065 -1528.92409965 0.384701 
1 0.0 0.0 0.0 0.0 1010.0 
3 7.6 7.3 7.3 7.8 1010.5 
2 5.8 16.4    
4 11.7 18.7    
GA  -1453.59918521 -1454.06370226 -1453.68326226 0.38044 
1 0.0 0.0 0.0 0.0 998.8 
2 13.8 19.6    
GC  -1604.02098315 -1604.55046206 -1604.16204506 0.388417 
1 0.0 0.0 0.0 0.0 1019.8 
3 8.9 7.3 7.5 8.5 1020.8 
4 10.3 16.5    
2 3.0 17.2    
GJ  -1528.80830905 -1529.30545244 -1528.92116144 0.384291 
1 0.0 0.0 0.0 0.0 1009.0 
2 12.2 17.3    
3 17.0 19.1    
GM  -1528.80929453 -1529.30642498 -1528.92131598 0.385109 
1 0.0 0.0 0.0 0.0 1011.1 
3 9.5 8.2 7.9 9.4 1012.6 
2 5.2 17.5    
GB-C1i  -1528.80861698 -1529.30348050 -1528.91806450 0.385416 
1 0.0 0.0 0.0 0.0 1011.9 
2 16.3 22.7    
GB-C10i  -1528.80018326 -1529.29802106 -1528.91404606 0.383975 
1 0.0 0.0 0.0 0.0 1008.1 
2 13.2 18.2    
Table 2 
Relative energies of ginkgolide conformers from MacroModel and DFT calculations on 
GA, GB, GC, GJ, GM and GB with the atoms C1 and C10 inverted. The energies in the 
ginkgolide name containing rows are in atomic units, while relative energies referring to 
each column are given in kJ/mol.  
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2Abstract
The infrared (IR) and vibrational circular dichroism (VCD) spectra of six chiral oxorhenium(V) 
complexes, bearing a hydrotris(1-pyrazolyl)borate (Tp) ligand have been investigated. These 
complexes are promising candidates for observation of parity violation (PV) (symmetry breaking 
due to the weak nuclear force). New chiral oxorhenium complexes have been synthesized, namely 
[TpReO(K2-O(CH3)CH2CH2O-O,O)] 4a and 4b diastereomers, [TpReO(K2-N(CH3)CH2CH2O-
N,O)] 5 and [TpReO(K2-N(tBu)CH2CH2O-N,O)] 6 enantiomers. All compounds could be obtained 
in enantiomerically pure forms by using either column chromatography or HPLC over chiral 
columns. Vibrational circular dichroism (VCD) spectroscopy of these compounds and of 
[TpReO(K2-N(CH3)CH(CH3)CH(Ph)O-N,O)] 2 and [TpReO(K2-N(CH2)3CHCO2-N,O)] 3 (with
chiral bidentate ligands derived respectively from ephedrine and proline)  were studied. It allowed 
the absolute configuration determinations of all compounds together with their conformational 
analysis, by comparing calculated and experimental spectra.  This is the first VCD study of rhenium 
complexes which further demonstrates the applicability of VCD spectroscopy in determining 
chirality of inorganic complexes, both in solution and in KBr pellets. 
Introduction
Oxorhenium complexes have proven useful in catalysis
1
 and in radiopharmaceutical chemistry
2
.
Moreover, chiral oxorhenium complexes have revealed to be good candidates for the observation of 
parity violation (PV) effects in chiral molecules.
3
 Parity violation is a fundamental effect which 
breaks the space symmetry and which is due to weak interaction between elementary particles.
4
 It 
has been experimentally observed in atoms and in nuclear physics.
5
 At the molecular level, PV is 
known to induce a very tiny energy difference (PVED) between the two enantiomers of a chiral 
molecule.  However, observing such a tiny energy difference 'EPV ('EPV c.a. 10-17 kT) is still a 
scientific challenge and requires very accurate spectroscopy methods together with a good chiral 
model molecule.
6
 For example, parity violation (PV) may be observed by unpolarized IR 
spectroscopy, i.e., by measuring slightly different absorption frequencies for opposite enantiomers. 
PVED measurements have already been searched on simple chiral hetero-halogenomethanes such 
as CHFClBr, resulting in the determination of an experimental upper limit of 10 Hz for this effect.
7
Meanwhile, theoreticians have shown that transition metal complexes such as rhenium compounds, 
i.e. bearing a heavy metal
3,8
 nearby the chirality center, are very promising compounds. Indeed, 
they display much higher PV effects than organic compounds, thanks to the dependence of 'EPV  on
the number of electrons and neutrons in the nucleus; this difference ('EPV) scales approximately 
like Z
5
.
9
Finding the ideal chiral candidate molecule for the first observation of parity violation at the 
molecular level is a real challenge. The design of the best candidate is related to the ultra-high 
resolution spectroscopy technique involved for the measurement. The experimental and theoretical 
aspects
10,6
 of the PV measurement imposes several requirements such as: i) a very simple molecule 
with a total number of atoms as few as possible, ii) a heavy atom like rhenium nearby the chirality 
center, iii) a rigid molecule for good spectroscopic properties, and iv) an isolated absorption peak 
with a frequency lying in the domain 1000±100 cm
-1
 which is imposed by the use of ultrastable CO2
laser in the case of the ultrahigh resolution IR spectroscopy.
7
Oxorhenium complexes usually 
display a sharp Re=O stretching mode around 950 cm
-1
. We have found a number of chiral 
oxorhenium complexes in the literature
11
 and have focused our attention on enantiomerically pure 
Faller’s oxorhenium complexes containing a hydrotris(1-pyrazolyl)borate (Tp) ligand because they 
are readily available, robust and “chiral at the rhenium”.
11b
 In this context, we show in this paper 
that VCD spectroscopy is a valuable tool for finding the best candidate molecule which displays all 
the features discussed above.  The VCD spectrum of the bulk solution provides important 
3information on whether the Re=O stretching absorption band is active or not, on the absolute 
configuration of the sample, and on the conformations present in solution.  
Vibrational circular dichroism (VCD) spectroscopy is an advanced form of infrared (IR) 
absorption spectroscopy, in which information about the chirality of a sample is obtained by the 
differential absorption of left and right circularly polarized IR radiation.
12
 Compared to electronic 
circular dichroism, VCD spectra are more detailed because of the many bands contained in the mid-
IR “fingerprint” region. Since the discovery of VCD three decades ago,
13
 the technique has been 
applied mostly to small organic molecules. Commercial software for calculations of VCD spectra 
has been introduced in 1998, allowing direct comparison with experimental data. Recently, VCD 
has been calculated for several transition metal complexes and successfully compared to 
experiments.
14
 This paper presents the synthesis and the separation of enantiomerically pure new 
compounds (RRe*,RC*) and (RRe*,SC*)-[TpReO(K2-O(CH3)CH2CH2O-O,O)] 4a and 4b respectively 
(four stereoisomers), together with RRe and SRe-[TpReO(K2-N(CH3)CH2CH2O-N,O)] 5 and RRe and 
SRe-[TpReO(K2-N(tBu)CH2CH2O-N,O)] 6, where Tp = hydrotris(1-pyrazolyl)borate (See Schemes 
1 and 2). Analytical and semi-preparative HPLC over chiral columns of 5 and 6 enantiomers have 
been performed. A benchmark analysis of chiral oxorhenium complexes is presented in detail, 
which includes IR and VCD spectra of the compounds along with the density functional theory 
(DFT) calculated ones. In a first step, the calculation methods (choice of the basis sets and of the 
density functional) have been determined on already known complexes RRe,RO-C,SC-N-(+)-2 and 
RRe,RC-(-)-3. In a second step, the comparison of experimental and calculated VCD spectra allowed 
the determination of the RRe,RC-(+)-4a, RRe,SC-(-)-4b, RRe-(-)-5 and RRe-(-)-6 absolute
configurations.  X-ray crystallography enabled to confirm absolute configurations for 4a and 4b
(see Figure 1). In the case of compounds 3, 4b and 5, VCD studies showed the presence of several 
conformers in solution. These are important features for the choice of the best candidate for future 
PV measurements by IR spectroscopy. 
Results and discussion
Synthesis and separation of compounds 
The samples studied first were the two enantiomeric pairs SRe,SO-C,RC-N- and RRe,RO-C,SC-N-
[TpReO(K2-N(CH3)CH(CH3)CH(Ph)O-N,O)] 2, and SRe,SC- and RRe,RC-[TpReO(K2-
N(CH2)3CHCO2-N,O)] 3 because they were readily synthesized according to literature 
procedures
11b
from the precursor TpReOCl2. For both cases, only one diastereomer was obtained 
among the two possible ones, due to steric interactions. The absolute configurations of these two 
compounds have already been determined by Faller and Lavoie by X-ray crystallography
11b
 and 
they could be confirmed by our VCD spectroscopy studies (see below). Following the same 
synthetic strategy, diastereomeric compounds SRe,SC-4a and RRe,SC-4b were obtained from S-1,2-
propanediol as described in Scheme 1, together with their enantiomers RRe,RC-4a and SRe,RC-4b
when using R-1,2-propanediol. No diastereoselectivity was observed with these less hindered chiral 
diols: the two possible diastereomers corresponding to the both R and S configurations at the 
rhenium chiral center were obtained in equal proportions. These diastereomers could however be 
separated by regular column chromatography over silical gel and no epimerization was observed. 
SRe,SC-(-)-4a and RRe,SC-(-)-4b could therefore be obtained with ee’s  better than 99% from S-1,2-
propanediol. Their enantiomers RRe,RC-(+)-4a and SRe,RC-(+)-4b could also be prepared in the same 
way by using R-1,2-propanediol. The absolute configurations SRe,SC-(-) and RRe,RC-(+) for 4a and 
RRe,SC-(-) and SRe,RC-(+) for 4b were first determined by VCD spectroscopy as explained in detail 
below. Later on, they were confirmed by X-ray crystallography analysis of RRe,RC-(+)-4a and 
RRe,SC-(-)-4b samples which gave monocrystals and whose absolute structures are displayed in 
Figure 1. Their detailed crystallographic data are given in Table 1. 
4In order to simplify one step further the molecules for PV experiments, enantiomerically pure 
pairs RRe- and SRe-5 and RRe- and SRe-6 were prepared by using achiral aminoalcohols, namely N-
methylaminoethanol and N-tert-butylaminoethanol. These compounds were prepared in their 
racemic form by reacting TpReOCl2 with the achiral aminoalcohols with good yields (Scheme 2). 
Monocrystals of (±)-5 were obtained and their X-ray structure analysis revealed a centrosymmetric 
space group which means that the RRe and SRe enantiomers are found in the same asymmetric unit 
i.e. (±)-5 is a            racemic compound (see Figure 1 and Table 1). The separation, impossible by 
direct crystallization, was therefore investigated by HPLC over chiral stationnary phases. The 
screening of ChirBase
15
 revealed that a few chiral rhenium complexes have already been separated 
by this method.
16
 Eleven chiral stationary phases were tested in order to find the best separation 
conditions to resolve the two enantiomers at a semi-preparative scale (see supplementary). For both 
racemates, Chiralcel OD-H (250x4.6 mm, cellulose tris-3,5-dimethylphenyl-carbamate) gave 
excellent baseline separation, good enantioselectivity and resolution (see Figure 2). So, the semi-
preparative chiral separations were performed on Chiralcel OD (250x10 mm) to give 22 mg of each 
enantiomer of 5 and 9 mg of each enantiomer of 6, with enantiomeric excesses higher than 99.5% 
(see supplementary for details). The separated enantiomers were characterized by their optical 
rotation: > @25DD  = +935 (CHCl3, c 0.04) for the first eluted enantiomer of 5 and –930 (CHCl3, c 0.04) 
for the second eluted, > @25DD  = +1240 (CHCl3, c 0.03) for the first eluted enantiomer of 6 and –1235 
(CHCl3, c 0.03) for the second eluted. Those specific rotation values are the highest related for such 
chiral rhenium compounds. Interestingly, samples of resolved 5 were heated at 50°C in chloroform 
for 24 hours and no racemization could be observed. Furthermore, we have shown that compound 2
sublimates under mild conditions without alteration of its chemical composition and optical 
rotation. These features provide evidence for the robustness of these oxorhenium(V) compounds 
and let consider confidently the possibility to generate a molecular beam for high resolution 
spectroscopy.
 Oxorhenium complexes bearing a Cp* of the type LReO3 have been extensively studied by 
Herrmann et al..
17
 Replacement of the Tp ligand by a Cp* have been considered in order to simplify 
the structure of our complexes, and we have therefore synthesized [Cp*ReO(K2-
N(CH3)CH(CH3)CH(Ph)O-N,O)] from Cp*ReOCl2 and ephedrine but we observed that such a 
complex was not stable at all and that epimerization at the rhenium center occurred spontaneously. 
We therefore did not pursue this direction further. 
VCD spectroscopy studies
[TpReO(K2-N(CH3)CH(CH3)CH(Ph)O-N,O)] (2) 
 Conformational analysis revealed only one conformer of RRe,RO-C,SC-N-2 (2-I), shown in 
Figure 3, optimized at the DFT/B3LYP level with the basis sets 6-31G* [H, B, C, N, O] and 
Stuttgart RSC 1997 ECP [Re]
18
 (abbreviated as 6-31G*/Stuttgart). Very little variation is seen in 
the optimized structure when different basis sets are used. Geometry optimization of the SRe,RO-
C,SC-N-2 diastereomer gave an energy 3.01 kcal/mol higher, suggesting a population fraction of 
0.6%, consistent with the results from the synthesis.  
 IR and VCD spectra of 2 are shown in Figure 4, where the IR and raw VCD spectra of both 
enantiomers in CDCl3 are shown. The VCD intensities are very close to opposite in sign for the 
enantiomers.  To eliminate minor absorption artifacts and increase the signal-to-noise ratio, the 
average VCD spectrum of the enantiomers (corresponding to a racemic sample) was used as the 
VCD baseline in subsequent figures. 
 In Figure 5, the observed IR and VCD spectra are compared to the array of calculated ones 
with the B3LYP function and the basis set LanL2DZ for all elements
19,20,21
, or a combination of 6-
31G(d) for elements H through O and a larger basis set for Re (Hay-Wadt VDZ (n+1) ECP
22
 or 
Stuttgart RSC 1997 ECP.
18
Experimental spectra using both CHCl3 and CDCl3 solutions have been 
combined to cover a wider spectral range to 880 cm
-1
.  A progressively better fit to the experimental 
spectra can be seen when increasing the basis set size. The results for the SDD basis set for all 
5elements (not shown) are almost identical to the B3LYP/LanL2DZ calculation. In general, the 
comparison of observed and calculated VCD spectral patterns is quite good and allows for an 
unambiguous verification of absolute configuration. However, the relative intensities of VCD peaks 
differ somewhat between the observed and calculated spectra. We find the best agreement using the 
combination of the Stuttgart basis set for rhenium and 6-31G* for the other elements.  
 Most of the observed vibrational bands can be assigned based on the Gaussian 03 
calculations. The Re=O stretching band at ~930 cm
-1
 is the most interesting vibration in this study 
because of the ongoing search for PV effects. The two large basis sets for rhenium yield slightly 
different results in the Re=O stretching region. With the Hay-Wadt basis set for Re, the Re=O 
stretch couples more strongly with a phenyl ring deformation than with the Stuttgart basis set 
(which has an additional 15 basis functions).  In addition to large Re=O stretching motion, the 
normal mode generating positive VCD intensity for 2 at ~930 cm
-1
 has contributions from 
deformations of the entire ephedrine ligand, as well as Tp deformation. 
 Closer inspection of the observed Re=O stretching band reveals a non-Lorentzian shape due 
to shoulders at lower frequencies, which are not readily assigned by the calculations. Similarly, the 
B-H stretching band at 2500 cm
-1
 has shoulders at higher frequencies. Figure 6 displays higher 
resolution (0.25 cm
-1
) IR spectra in these regions, recorded for samples both in CHCl3 solution and 
as a KBr pellet. The shoulders cannot be readily assigned to other normal modes, since there is only 
one additional calculated normal mode near the Re=O stretch, and its calculated IR intensity is 2 
orders of magnitude smaller. The B-H stretching band is completely isolated between the 
fingerprint and C-H stretching regions. 
 Several explanations can be invoked in order to explain the observed shoulders. Both 
rhenium and boron have naturally occurring isotopes, i.e., 37% 
185
Re and 20% 
10
B, which would 
generate minor peaks at shifted frequencies. The size of these frequency shifts can be estimated 
from the reduced masses or calculated for the isotope with Gaussian 03 to be 0.37 cm
-1
 for Re=O 
and 11 cm
-1
 for B-H, making only the B-H shift observable experimentally. Additional shoulders in 
the BH stretching region may arise from Fermi resonance with overtones of B-H deformations, 
which indeed are found in the calculation at around half the stretching frequency.  The shoulders to 
the Re=O stretch may also arise due to Fermi resonance, since the calculated Re=O stretching at 
970 cm
-1
 (unscaled) matches combination bands for modes calculated at 146 and 823 cm
-1
(involving the N-Re=O angle deformation), as well as 301 and 669 cm
-1
 (involving ephedrine 
chelate ring deformation). 
 IR spectra at a roughly 13 times lower concentration were recorded, and they reveal 
practically no difference in band shape beyond the scaling factor (data not shown). This evidence 
supports the possibility of solvent interaction or intramolecular effects like Fermi resonance and 
precludes solute-solute interactions as sources for the additional weak features in the BH and Re=O 
stretching regions. 
[TpReO(K2-N(CH2)3CHCO2-N,O)] (3) 
Two conformers of the RRe,RC-[TpReO(K2-N(CH2)3CHCO2-N,O)] sample (3) have been 
identified, with different puckering of the five-membered proline ring, referred to as 3-I and 3-II,
shown in Figure 7. In the gas phase, the calculated energies for the two conformers differ by 0.11 
kcal/mol according to the B3LYP/LanL2DZ calculation, corresponding to Boltzmann populations 
of 55% 3-I vs. 45% 3-II. With the 6-31G(d)/Stuttgart basis set, the energy difference is smaller and 
opposite, with 3-I lying 0.013 kcal/mol higher in energy, suggesting almost equal populations.  
Interestingly, the presence of two conformers is also suggested by the published crystal structure,
11b
where the relevant 50% probability ellipsoids in the ORTEP representation appear prolate.  At the 
B3LYP/LanL2DZ level, the SRe,RC-3 diastereomer is calculated to lie 5.1 kcal/mol higher in energy 
than RRe,RC-3, consistent with the presence of only the RRe,RC-diastereomer in the experimental 
sample.  
 IR and VCD spectra were calculated for both conformers 3-I and 3-II, and the average 
spectra for the two conformers (B3LYP/6-31G(d)/Stuttgart) is compared to experiment in Figure 8. 
The overall agreement in VCD patterns between observed and calculated spectra again provides an 
unambiguous assignment of absolute configuration, but the agreement is not as good as for 2.
6Positive VCD intensity near 1200 cm
-1
 correlates with modes involving the proline ligand.  The 
carbonyl stretching mode is calculated to exhibit fairly intense, positive VCD intensity, but with a 
frequency 100 cm
-1
 too high with 6-31G(d)/Stuttgart and 100 cm
-1
 too low with LanL2DZ and SDD 
basis sets (not shown). The observed C=O stretching band also has two separate peaks observed at 
1691 and 1704 cm
-1
, but the calculated carbonyl stretching frequencies for the two conformers 
differ only by 2 cm
-1
.  The Re=O and B-H bands also reveal shoulders in the 0.25 cm
-1
 resolution IR 
spectra (data not shown), which can be explained in the same way as for 2.
[TpReO(K2-O(CH3)CH2CH2O-O,O)] (4a and 4b) 
 For the diastereomer RRe,RC,-4a, two diolate conformers were identified at the B3LYP/6-
31G(d)/Stuttgart level that differ by 2.2 Kcal/mol, suggesting only a 3% population of the minor 
conformer RRe,RC-4a-II (Figure 9).  The comparison between the composite calculated spectra and 
the observed spectrum for (+)-4a, shown in Figure 10, provides an unambiguous assignment of 
absolute configuration for this experimental diastereomer sample fraction as (RRe,RC)-(+)-4a,
consistent with the X-ray crystallography analysis presented above.   The Re=O stretch, calculated 
at 965 cm
-1
 (scaled by 0.97) correlates with positive VCD at 966 cm
-1
.
 Two optimized conformations that differ in conformation of the chelated diolate ring were 
identified for the diastereomer RRe,SC-4b at the B3LYP/6-31G(d)/Stuttgart level, shown in Figure 
11.  Conformer 4b-II is higher in energy by 1.1 Kcal/mol, yielding a population of 87% 4b-I and 
13% 4b-II at room temperature.  The calculated conformer spectra and their Boltzmann-population-
weighted composite are compared to experiment for (-)-4b in Figure 12, demonstrating very good 
agreement in VCD pattern and identifying the absolute configuration of this sample as RRe,SC(-)-4b.
In this case, the band with predominant Re=O stretch at 965 cm
-1 
(scaled frequency) has opposite 
sign for the two conformers, and correlates with the negative VCD at 968 cm
-1
, consistent with the 
larger population of 4b-I.  The comparison between observed and calculated spectra for the two 
conformations provides evidence for the presence of both conformations in solution, where, for 
example, the negative feature at 1050 cm
-1
 is characteristic of the minor conformer and the positive 
VCD feature at 1000 cm
-1
 is characteristic of the major conformer. 
[TpReO(K2-N(CH3)CH2CH2O-N,O)] (5)
The chelated bidentate ligand can assume two conformations, calculated to differ in energy by 
0.30 Kcal/mol, with populations 62% 5-I and 38% 5-II (Figure 13).  From the Boltzmann-
population-weighted sum of the calculated spectra, shown in Figure 14, sufficient agreement with 
experiment is found for assignment of the absolute configuration as RRe-(-)-[TpReO(K2-
N(CH3)CH2CH2O-N,O)].  In regions where the two conformations exhibit VCD bands opposite in 
sign, the agreement between the composite calculated spectra and experiment is not quite as good.  
The Re=O stretches for the two conformers are opposite in sign, with rather weak negative VCD 
intensity calculated for the dominant conformation at 945 cm
-1
 (scaled frequency).  An absorption 
band near this frequency appears at the cut-off for the CDCl3 solvent measurements, but no distinct 
VCD feature is observed for 5 in this region.
[TpReO(K2-N(tBu)CH2CH2O-N,O)] (6) 
The two optimized conformers for 6, shown in Figure 13, differ by 2.5 Kcal/mol, indicating a 
population of less than 2% for conformer  6-II.  The comparison of the experimental VCD spectrum 
for (-)-6 with the calculated spectrum for 6-I (Figure 14) identifies the absolute configuration as 
RRe-(-)- [TpReO(K2-N(tBu)CH2CH2O-N,O)].  The Re=O stretch generates the positive VCD band at 
~940 cm
-1
.
Summary
We have recorded good quality IR and VCD spectra of six enantiomeric pairs of rhenium 
complexes and successfully verified their absolute configuration by comparison to spectra 
calculated at the DFT level for one of each enantiomeric pair. Several basis sets have been 
investigated, and the best fit to experiments has been obtained using the B3LYP functional and a 
custom basis set for rhenium, Stuttgart RSC 1997 ECP, along with 6-31G(d) for the remaining 
elements. 
7 Only one conformation of 2 was found during the calculations, but the remaining samples 
exist in solution as two chelate ring conformers with different populations.  For 3, 4b, and 5, both 
conformers contribute to the observed spectra in solution at room temperature.  The Re=O stretch is 
identified by a distinct VCD band in the 930 to 965 cm
-1
 region in 2, 3, 4a, 4b, and 6.  For 5, the 
opposite signs for the VCD of the two populated conformers results in little or no VCD intensity for 
the Re=O stretch.
 All samples investigated reveal bands with several components, both in solution and in a 
solid-state matrix. This is apparent from the fine structure of the Re=O stretch and B-H stretching 
absorption bands, which consist of several peaks, and most prominently in the C=O vibration of 3,
which has two distinct peaks. Both inter- and intramolecular effects have been considered to 
explain these effects. In solution, we expect negligible solvent interaction. We attribute the splitting 
of the B-H and Re=O stretching bands to Fermi resonance and isotope shifts by 
10
B.  The key 
results for all the samples have been summarized in Table 2. 
Conclusion
New chiral oxorhenium(V) complexes have been synthesized from TpReOCl2 and suitable chiral 
diols or achiral aminoalcohols. Regular column chromatography could be used to prepare 
diastereomerically pure complexes [TpReO(K2-O(CH3)CH2CH2O-O,O)] [(SRe,SC)-(-)-4a and
(RRe,SC)-(-)-4b and their mirror-images]. On the other hand, semi-preparative HPLC over chiral 
stationary phases has proven very efficient to obtain enantiomerically pure complexes [TpReO(K2-
N(CH3)CH2CH2O-N,O)] [SRe-(+) and RRe-(-)-5] and [TpReO(K2-N(tBu)CH2CH2O-N,O)] [SRe-(+)
and RRe-(-)-6].  Absolute configurations were determined by VCD studies and some were confirmed 
by X-ray crystallography. The advantages vs. drawbacks towards using such chiral complexes for 
parity violation experiments have been considered. The main advantages are their ease of synthesis, 
their robustness and their enantiomeric stability, which is not straightforward in inorganic 
chemistry. These complexes all display a sharp Re=O stretching mode that may be carefully studied 
by using an ultrastable CO2 laser in the case of the ultrahigh resolution IR spectroscopy.
7
  The main 
drawbacks are the total number of atoms (especially because of the Tp ligand) and the presence of 
several conformational isomers in solution as evidenced by VCD. Indeed, in addition to 
identification of absolute configuration of the complexes without the need for X-ray studies, the 
VCD study has characterized the solution conformations of the complexes and identified complexes 
that may not be suitable for further study because of opposite VCD intensities (and presumably 
other chiral properties) for the Re=O stretch for two populated conformers (4b and 5).  The Re=O 
stretches are identified by distinct vibrational bands in the region 930 to 965 cm
-1
, with dominant 
Re=O stretching motion accompanied by motion of the ligand rings.  The sign and intensity of the 
Re=O stretching VCD is influenced by the chirality at the rhenium, the chirality of the ligand 
chelating TpReO and by the conformation of the chelating ligand.   
Aknowledgment. The Agence Nationale pour la Recherche (ANR) is warmly thanked for 
fundings (NCPMOL project). 
“Supporting Information Available”: listings of experimental procedures, HPLC separations, 
crystallographic data, VCD measurements and theoretical calculations. This material is free of 
charge via the Internet at http://pubs.acs.org. 
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Figure 1. ORTEP diagrams (50% probability) of molecules RRe,RC-(+)-4a and RRe,SC-(-)-4b (only 
one out of three molecules in the asymmetric unit shown) and (±)-5 (only one out of the two 
enantiomeric molecules in the asymmetric unit shown). 
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Figure 2. Analytical chiral HPLC chromatograms for the separations of compounds 5 and 6 on 
Chiralcel OD-H, with hexane/2-PrOH (7/3) as mobile phase at 1 ml/min for 5, and hexane/2-PrOH 
(9/1) for 6, and with UV (254 nm) and polarimetric detectors. 
Figure 3. Optimized structure of the single conformation of RRe,RO-C,SC-N-2, 2-I (B3LYP/6-
31G*/Stuttgart calculation). 
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Figure 4. Observed IR (lower frame) and VCD (upper frame) of the two enantiomers of 2 in 
CDCl3, 10 mg sample in 300 µL solvent (58 mM); 4 cm
-1
 resolution; instrument optimized at 1400 
cm
-1
;  collection time 12 h. IR spectra are solvent subtracted.  
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Figure 5. Observed IR (lower frame) and VCD (upper frame) spectra for RRe,RO-C,SC-N-2 (right 
axes) compared to DFT calculations for 2-I with the B3LYP functional and three basis sets (left 
axes, shown offset for clarity):  LanL2DZ for all elements and Stuttgart or Hay-Wadt for Re with 6-
31G(d) for elements H through O.  Observed IR spectra are solvent subtracted and VCD is baseline 
corrected using the average of the two enantiomers.  Experimental data presented for CHCl3 solvent 
(dashed line) and CDCl3 solvent (solid line).  Experimental conditions as in Figure 2.   
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Figure 6. Higher resolution IR spectra of 2 in CHCl3 solution and in a KBr pellet, showing the B-
H stretching (top) and Re=O stretching regions (bottom).  Resolution 0.25 cm
-1
; collection time 90 
min. KBr spectra are offset for clarity. 
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Figure 7. The two optimized conformers of RRe,RC-3, 3-I (left, 51%) and 3-II (center, 49%). 
Geometries optimized using B3LYP/6-31G*/Stuttgart.
Figure 8. Expeimental IR (bottom) and VCD (top) spectra for (-)-3, with VCD noise as the 
uppermost trace (right axes,  both chloroform and deuterated chloroform solutions; 5 mg/150 PL
solvent (63 mM); IR spectra solvent subtracted; VCD spectra enantiomer subtracted; 4 cm
-1
resolution; instrument optimized at 1400 cm
-1
; collection time 12 h) compared to calculated spectra 
for RRe,RC-3 (left axes, B3LYP/6-31G*/Stuttgart; frequencies scaled by 0.97; bandwidth to 5 cm
-1
)
averaged for the two conformers 3-I and 3-II.
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Figure 9. The two conformers of RC,RRe-4a, 4a-I (left, 97%) and 4a-II (center, 3%), optimized 
using B3LYP/6-31G*/Stuttgart. 
Figure 10. IR (bottom) and VCD (top) spectra for RC,RRe-4a. Calculated spectra (left axis) are 
weighted averages of the two conformers 87% 4a-I + 13% 4a-II determined using B3LYP/6-
31G*/Stuttgart. Frequencies are scaled by 0.97, and the bandwidth is set to 4 cm
-1
.  Observed 
spectra for (-)-4b (right axis, 4 mg/100 PL CDCl3 (81 mM)) are solvent subtracted,  resolution 4 
cm
-1
; instrument optimized at 1400 cm
-1
; collection time 9 h. 
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Figure 11. The two conformers of SC,RRe-4b, 4b-I (left, 87%) and 4b-II (center, 13%), optimized 
using B3LYP/6-31G*/Stuttgart. 
Figure 12. IR (bottom) and VCD (top) spectra for SC,RRe-4b. Calculated spectra (left axis) are 
weighted averages of the two conformers 4b-I and 4b-II determined using B3LYP/6-
31G*/Stuttgart. Frequencies scaled by 0.97, bandwidth 4 cm
-1
. Observed spectra for (-)-4b (right 
axes, 4 mg/100 PL CDCl3 (81 mM)) are solvent subtracted; resolution 4 cm-1; instrument optimized 
at 1400 cm
-1
; collection time 9 h. 
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Figure 13. The two conformers of RRe-5, 5-I (left, 62%) and 5-II (right, 38%), optimized using 
B3LYP/6-31G*/Stuttgart.
Figure 14. IR (bottom) and VCD (top) spectra for RRe-5.  Calculated spectra of the two 
conformers 5-I and 5-II and their Boltzmann-population weighted sum (left axes, B3LYP/6-
31G*/Stuttgart; frequencies scaled by 0.97; bandwidth 5 cm
-1
) compared to observed spectra for (-)-
5 (right axes, 3 mg/100 PL CDCl3 (61 mM); solvent subtracted; resolution 4 cm-1; instrument 
optimized at 1400 cm
-1
; collection time 12 h). 
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Figure 15. The two conformers of RRe-6, 6-I (left, 98%) and 6-II (center, 2%), optimized using 
B3LYP/6-31G*/Stuttgart.
Figure 16. IR (bottom) and VCD (top) spectra for RRe-6. Calculated spectra of the predominant 
conformer 6-I (left axis; B3LYP/6-31G*/Stuttgart; frequencies scaled by 0.97; bandwidth 4 cm
-1
)
compared to observed spectra for (-)-6 (right axis; 4.8 mg/100 PL CDCl3; solvent subtracted; 
resolution 4 cm
-1
; instrument optimized at 1400 cm
-1
; collection time is 12 h). 
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Table 1. Crystallographic data for compounds 4a, 4b and 5.
RRe,RC-(+)-4a RRe,SC-(-)-4b 5
Empirical formula 
Formula weight 
Crystal system 
Space group 
Unit cell dimensions  
Unit cell volume (Å
3
)
Z
Calculated density  
Absorption coef. (mm
-1
)
F000 
Crystal size (mm
3
)
Trange for data collection 
Limiting indices 
Reflections collected / 
unique 
Rint
Completeness to Tmax 
Transmission coef. max / 
min 
Data / restraints / parameters 
Goodness of fit on F
2
Final R indices [I>2sig(I)]: 
R1 / wR2 
Final R indices [all data]: R1 
/ wR2 
Absolute structure parameter 
Largest diff. peak and hole 
(e.Å
-3
)
C12 H16 B N6 O3 Re 
489.32 
monoclinic 
P 21
a =  8.3663(5) Å 
b =  8.3379(5) Å 
c =  11.3364(8) Å 
E= 101.869(3)° 
773.89(9) 
2
2.100 
7.874 
468
0.25 x 0.25 x 0.20 
2.77 – 27.62 
-10 d h d 10 
-10 d k d 9 
-14 d l d 14 
5310 / 3344 
0.034 
96.7% 
0.207 / 0.140 
3344 / 1 / 028 
1.105 
0.0352 / 0.0891 
0.0392 / 0.0905 
0.081(18) 
4.58 / -2.41 
C12 H16 B N6 O3 Re 
489.32 
orthorhombic 
P 21 21 21
a =  7.7937(4) Å 
b =  18.9861(10) Å 
c =  31.4245(17)Å 
4649.9(4) 
12 
2.097 
7.863 
2808 
0.30 x 0.02 x 0.02 
1.68 – 27.61
-10 d h d 9 
-24 d k d 24 
-40 d l d 40 
58695 / 10698 
0.045 
99.3% 
0.854 / 0.095 
10698 / 0 / 622 
0.995 
0.0207 / 0.0340 
0.0261 / 0.0349 
-0.014(4) 
0.68 / -0.59 
C12 H17 B N7 O2 Re 
488.34 
monoclinic 
P 21/n
a =  10.4580(2) Å 
b =  10.6516(3)   
c =  14.5438(4) Å 
E=  96.703(1) 
1609.02(7) 
4
2.016 
7.572 
936 
0.38 x 0.35 x 0.32 
2.74 – 27.58 
-13 d h d 13 
-13 d k d 13 
-18 d l d18
28509 / 3691 
0.040 
99.1% 
0.151 / 0.056 
3691 / 0 / 208 
1.058 
0.0276 / 0.0685 
0.0335 / 0.073 
1.46 / -1.90 
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Abstract
 A ten to 30-fold increase in vibrational circular dichroism (VCD) intensity is observed 
for several chiral Co(II) Schiff base complexes compared to corresponding Ni(II), Zn(II) or 
Mn(III) complexes.  The effect, termed resonance enhanced VCD (REVCD), is attributed to 
the occurrence of low-lying, magnetic-dipole-allowed, electronic d-d transitions, in the 
infrared region with energies comparable to the vibrational frequencies, that enhance the 
vibrational magnetic dipole transition moment.  Calculations at the DFT level with Ahlrich 
VTZ basis set for cobalt reproduce the magnitudes of the REVCD for the low-spin, 
approximately square-planar chiral Co(II) salen (CoSA, (R,R)-(+)-N,N’-Bis(3,5-di-tert-
butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)) and Co(II) saldiphenyl ((R,R)-[N,N’-
Bis(salicylidene)-1,2-diphenyl-1,2-ethanediaminenato]-Co(II)) Schiff-base complexes and 
some of the enhancement for the high-spin pseudotetrahedral Co(II) salbinaphthyl complex 
((R,R)-[[2,2'-[[1,1'-binaphthalene]-2,2'-diylbis(nitrilomethylidyne)]-bis(phenolato)](2-)-
N,N',O,O']-Co(II)).   DFT calculations with the smaller LanL2DZ basis set are sufficient to 
reproduce the non-enhanced VCD intensities for the Mn(III) salen-Cl and Ni(II) saldiphenyl 
complexes.  Formation of a P-peroxo bridged dimer through oxidative addition to Co(III) is 
demonstrated by loss of REVCD intensity as CoSAis titrated with 1-methylimidazole in the 
presence of oxygen.
Introduction.   Vibrational circular dichroism (VCD) intensities are typically associated with 
anisotropy ratios ('A/A) on the order of 10-4 to 10-5 and molar absorptivity differences ('H)
in the 10
-1
 to 10
-3 
range, and these intensities are reproduced with DFT calculations.
1,2
However, anisotropy ratios and VCD intensities ten to 100 times larger have been observed 
for stretches of ligands bound to certain metalloproteins and for vibrations of metal 
complexes when the metal has magnetic-dipole allowed electronic d-d transitions in the 
infrared region (below 4000 cm
-1
).  Such systems include tetrahedral high-spin Ni(II) and 
Co(II) complexes with (-)-sparteine,
3,4
 and azide and cyanide bound to low-spin Fe(III) in 
metmyoglobin.
5,6
  We examine here chiral Schiff-base complexes (Scheme 1) with both 
pseudoplanar and pseudotetrahedral coordination and high- and low-spin states for the metal 
ion, identifying a new class of metal center geometry and spin-state for which VCD intensity 
enhancement is generated, which we term resonance-enhanced VCD (REVCD).  The Schiff-
base complexes are important catalysts for asymmetric synthesis including enantioselective 
hydrogenation and epoxidation of alkenes and other reactions.
7-9
  Some of the complexes 
bind oxygen reversibly,
10-16
 and we also examine the effect of oxygen-binding on the 
REVCD spectra.  Whereas our previous attempts to calculate REVCD for high-spin 
pseudotetrahedral complexes of Co(II) and Ni(II) with (-)-sparteine, using commericial DFT 
implementations
17,18
  for VCD intensity calculations, were not successful,
3
 we demonstrate 
here calculations that reproduce the intensity enhancement for chiral low-spin pseudoplanar 
Co(II) complexes and verify the mechanism of enhancement.     
2Scheme 1   Schiff-base Metal Complexes 
Experimental:  (R,R)-(-)- and (S,S)-(+)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-
cyclohexanediaminocobalt(II) (1, abbreviated as (R,R)- and (S,S)-CoSA), and (R,R)-(-)-N,N’-
Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoM(III) chloride (2, M = Al(III), 
Cr(III), Mn(III); abbreviated as (R,R)-AlClSA, (R,R)-CrClSA) and (R,R)-MnClSA) were 
purchased from Aldrich and used without further purification.  (R,R)- and (S,S)-[N,N’-
Bis(salicylidene)-1,2-diphenyl-1,2-ethanediaminenato]-M(II) (3, abbreviated as (R,R)- and 
(S,S)-MSaldiphenyl; M = Co(II), Ni(II)) and (R,R)- and (S,S)-[[2,2'-[[1,1'-binaphthalene]-2,2'-
diylbis(nitrilomethylidyne)]bis[4,6-dichlorophenolato]](2-)-N,N',O,O']-M(II) (4, abbreviated 
as (R,R)- and (S,S)-MCl4Salbinapht; M = Co(II), Ni(II), Zn(II)) and (R,R)- and (S,S)-[[2,2'-
[[1,1'-binaphthalene]-2,2'-diylbis(nitrilomethylidyne)]-bis(phenolato)](2-)-N,N',O,O']-Co(II) 
(abbreviated as (R,R)- and (S,S)-CoH4Salbinapht) complexes were synthesized following 
literature procedures from the appropriate diamine and salicylaldehyde by refluxing in 
ethanol to produce the Schiff-base, followed by reluxing in methanol with the appropriate 
metal acetate and sodium methoxide to generate the metal complex.
9,19
 For VCD measurement, the metal complexes were dissolved in CDCl3 at an 
appropriate concentration and placed cell with BaF2 windows at a suitable pathlength to 
obtain IR intensity for bands of interest in the range 0.2 to 1 to obtain a good signal to noise 
ratio.  For the mid-IR region (800-2000 cm
-1
) the VCD spectra were measured for 1 hour 
with 4 or 8 cm
-1 
resolution on a modified ChiralIR VCD spectrometer (BioTools, Inc., 
Wauconda, IL) configured with two photoelastic modulators (PEMs).
1,20,21
  Some 
measurements on this instrument were also obtained for the larger 4000 -800 cm
-1
 region.  
For the C-H stretching region (2000-4000 cm
-1
) and near-IR region (4000-6000 cm
-1
) the 
VCD spectra were measured for 4 hours with 8 or 16 cm
-1
 resolution on modified ChiralIR
VCD spectrometers equipped for higher vibrational frequency coverage with two tungsten 
NN
HH
OO
Co
C(CH
3
)
3
C(CH
3
)
3
C(CH
3
)
3
C(CH
3
)
3
(R,R)-CoSA 1
NN
HH
OO
M
C(CH
3
)
3
C(CH
3
)
3
C(CH
3
)
3
C(CH
3
)
3
Cl
(R,R)-MClSA   (M = Al(III), Cr(III) and Mn(III))  2
N N
R
R
R
R
O O
M
             (R)-MR4Salbinapht 
(R = H or Cl, M = Co(II), Ni(II) and Zn(II))  4
3
5
3'
5'
N N
M
O O
(R,R)-MSaldiphenyl (M = Co(II) and Ni(II))  3
3halogen sources, two CaF2 PEMs and either a thermoelectrically-cooled MCT detector with 
coverage from 2000 to 4000 cm
-1
, or a room-temperature InGaAs detector with coverage 
from 4000 to 7000 cm
-1
.
22,23
  The VCD and IR baselines were corrected by subtracting the 
VCD or IR spectrum of the solvent from that of the sample. 
Calculation:  The VCD and IR spectra were calculated with Gaussian 03
18
 at the DFT level 
(B3LYP functional) with 6-31G(d) basis set for the ligand and Ahlrich VTZ basis set
24
 for 
Co(II) or Ni(II) for (R,R)-CoSA, (R,R)-CoSaldiphenyl, (R,R)-NiSaldiphenyl and (R)-
CoSalbinapht, and with the LanL2DZ basis set
25,26
 for a model for (R,R)-MnClSA without 
the t-butyl groups.  The magnetic field perturbation (MFP) method
17,27
 for VCD intensities is 
incorporated into Gaussian 03, utilizing gauge-invariant atomic orbitals.
2,28,29
Theoretical Background 
 VCD intensity is proportional to the rotational strength, the scalar product of electric and 
magnetic dipole transition moments for ground electronic state g and 0o1 transition of 
vibrational mode a, Eq. (1),
30
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Calculation of the rotational strength R requires the electronic contribution to the atomic axial 
tensor for atom A, I ADE , derived from the second derivative of the electronic energy (Eel) with 
respect to magnetic field (H) and nuclear velocity ( R ), a non-Born-Oppenheimer quantity.30
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The third equality in Eq. (3) is the magnetic field perturbation (MFP) expression
27
incorporated into Gaussian 03 for VCD calculations, which depends on derivatives of the 
ground-state electronic complex wavefunction 
g\ .  The implementation of the MFP 
formalism in Gaussian employs gauge-invariant atomic orbitals (GIAOs) for the magnetic-
field derivatives and hence achieves an origin-independent rotational strength.
2,28,29
  The last 
equality in Eq. (3) is the formally equivalent, vibronic coupling theory (VCT) sum-over-
states expression,
31
 where mˆ  is the magnetic-dipole moment operator and the sum is over all 
excited electronic states e.  The VCT expression shows how a low-lying electronic state 
(LLES) that is strongly magnetic-dipole allowed and vibrationally coupled to the ground state 
can lead to enhancement of the VCD intensity.  When the electronic transition energies are 
comparable to vibrational frequencies, the VCT expression must be modified as shown below 
(Eq. (6)), but direct dependence on the VCT expression in Eq. (3) remains.   One goal of the 
present study is to evaluate to what extent the current implementation of the MFP expression 
in Eq. (3) in Gaussian 03 can be applied to calculate REVCD in chiral Schiff-base complexes 
with LLES. 
4The neglect of vibronic detail in excited electronic states of the VCD formalism is an 
approximation that fails in the case of low-lying electronic states where the electronic state 
energy is comparable to that of the vibrational transition energy, and a theoretical correction 
to the standard formalism has recently been developed.
32
  The standard sum-over-states 
expression for the electronic contribution to the magnetic-dipole transition moment (Eq. 2) is 
given by
31,33
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If this expression is generalized to include vibronic detail for the excited electronic states, one 
has
32
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Removal of vibronic detail in Eq. (5) allows reduction to Eq. (4).  Under the assumption that 
the vibrational sublevels of the low-lying excited states are the same as those of the ground 
electronic state, the expression for Eq. (5) can be written as 
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The expression in brackets is written as the sum of a term representing the standard magnetic-
dipole transition moment in Eq. (4) plus a correction term that becomes significant only for 
electronic states with energy less than an order of magnitude above the vibrational energy 
levels.  One can see a significant new source of intensity enhancement in the limit that the 
excited state energy and the vibrational energy are the same.  The infinity in the resonance 
energy denominator can be avoided with appropriate damping terms representing the natural 
electronic and vibrational bandwidths.  For most systems of interest, the VCD enhancement 
is approximately 10-fold, and the non-enhanced VCD contributions can be ignored or 
subtracted.  REVCD could then be calculated by considering Eqs. (3) and (6) for only the 
low-lying electronic states e’:
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This is analogous to the approximations made for calculating resonance Raman intensities 
where only the resonant electronic state is needed in the formal sum over excited states.
34
The correction term is calculated individually for each LLES and for each normal mode of 
vibration, and imaginary damping terms can be incorporated to represent the finite spectral 
width of the LLES and the vibrational bandshape.  We are initiating implemention of this 
expression, but the calculations included in the current study ignore the correction terms. 
Results
Metal salen complexes (1 and 2).   The IR and VCD spectra of (R,R)- and (S,S)-
CoSA (1) measured on three VCD instruments, covering the spectral ranges in the fingerprint 
region (2000-930 cm
-1
), hydrogen stretching (4000-2500 cm
-1
) and CH-stretch/bend 
combination and CH-stretch overtone regions (6000-3900 cm
-1
) are compared in Fig. 1, 
demonstrating the mirror-image nature of the VCD spectra for the two enantiomers and the 
occurrence of broad electronic circular dichroism (ECD) features centered ~4200 cm
-1
 and 
5~2200 cm
-1
, both positive for (R,R)-CoSA.  A weak negative ECD feature for (R,R)-CoSA
occurs at 3700 cm
-1
, and an additional positive ECD feature is evident above 6000 cm
-1
.
Hydrogen-stretching REVCD features occur superimposed on the ECD near 3000 cm
-1
, and 
intense REVCD features are observed between 1650 and 1000 cm
-1
, beyond the region of 
ECD.  For (R,R)-CoSA, these latter REVCD features are primarily positive.  The largest 
VCD anisotropy ratios for (R,R)-CoSA are +4.3 x 10
-3
 at 1528 cm
-1 
in the mid-IR region and -
5.1 x 10
-3
 at 3020 cm
-1
 in the hydrogen-stretching region, an order of magnitude larger than 
for closed-shell metal complexes.
35
   Shown in Fig. 2 are the mid-IR region IR and VCD 
spectra for the pentacoordinate (R,R)-MnClSA, (R,R)-CrClSA and (R,R)-AlClSA complexes, 
all of which do not have low-lying electronic states and for which the VCD intensity is not 
enhanced.  The dramatic increase in intensity for REVCD is seen in the overlay of spectra for 
(R,R)-CoSA and (R,R)-MnClSA in Fig. 3, showing similar IR intensities, but a factor of 20-
30 increase in VCD intensity for (R,R)-CoSA.
 The optimized structures of (R,R)-CoSA and the model (R,R)-MnClSA' (without t-
butyl groups) are shown in Fig. 4.  (R,R)-CoSA has C2 symmetry with a distorted square-
planar coordination at the cobalt.  (R,R)-MnClSA' has distorted square-pyramidal 
coordination at manganese.  The intensity enhancement and most REVCD features are 
reproduced for (R,R)-CoSA at this level of DFT calculation with the Ahlrich VTZ basis set 
for low-spin Co(II)
24
 (Fig. 5).  Calculations were also carried out for (R,R)-CoSA with the 
LanL2DZ basis set
25,26
 for both the high and low-spin Co(II) cases, demonstrating some 
intensity enhancement in each case, but with a poorer fit to experiment (Fig. 6).  For the 
intense band observed near 1600 cm
-1
, for example, the VCD intensity ('H) is ~+2.5 for the 
observed and Ahlrich VTZ calculation (low spin), ~+1.0 for the LanL2DZ calculation (low-
spin) and ~+0.3 for LanL2DZ (high-spin).  Intensities (LanL2DZ basis set) calculated for the 
low-spin case approximately three times larger than for high-spin.  EPR data indicate that 
(R,R)-CoSA is low-spin.[Deeth, 1987 #56][Hitchman, 1977 #4]  In contrast, the LanL2DZ 
basis set calculation for the model (R,R)-MnClSA' shows very good agreement in both 
magnitude and sign pattern with the experimental spectra for high-spin (R,R)-MnClSA (Fig. 
7).
 A comparison IR and VCD spectra of (R,R)-CoSA in CDCl3 solution and in the solid 
as a mull in mineral oil is shown in Fig. 8, where the IR intensity of the mull has been scaled 
to that of the solution, with the same scale factor for the mull VCD, to estimate molar 
absorptivities for the mull for a better intensity comparison, since the concentration in the 
mull is not known.  The VCD intensity in the solid is decreased by a factor of ~5 compared to 
solution, and the features, while still enhanced 5-fold relative to MnClSA, exhibit some 
similarities in pattern to the VCD of the trivalent metal complexes (see Fig. 2).  The crystal 
structure of (R,R)-CoSA reveals that a dimer is formed in the solid
36
 (Fig. 9), which can alter 
the low-lying electronic states.[Hitchman, 1977 #4]  The coordination geometry at the cobalt 
center in the dimer resembles that of the trivalent metals in the MClSA complexes.   
Metal saldiphenyl complexes (3).  The IR and VCD spectra of (R,R)-CoSaldiphenyl 
and (R,R)-NiSaldiphenyl in CDCl3 solution are compared in Fig. 10.  The low-spin Co(II) 
complex exhibits a broad low-lying electronic CD feature centered at 2100 cm
-1
, with intense, 
primarily negative REVCD features extending to lower frequencies beyond the electronic 
band envelope.  The VCD anisotropy ratios are on the order of 10
-3
, with the highest value 
~6.7x10
-3
 at 1390 cm
-1
.  In contrast, low-spin (R,R)-NiSaldiphenyl, with no low-lying 
electronic states, generates VCD intensities an order of magnitude smaller than the (R,R)-
CoSaldiphenyl VCD intensities.  The calculated optimized geometries for the (R,R)-
CoSaldiphenyl conformer with axial phenyl groups, the (S,S)-CoSaldiphenyl conformer with 
equatorial phenyl groups and the (R,R)-NiSaldiphenyl conformer with axial phenyl groups 
are compared in Fig. 11, and the ring puckering for the Co(II) diamine rings for the 
6saldiphenyl complexes are shown in Fig. 12, compared to that calculated for (R,R)-CoSA.
In Fig. 13, the observed spectra for (R,R)-CoSaldiphenyl are compared with DFT calculations 
for the (R,R)-enantiomer conformer with axial phenyl groups and the (S,S)-enantiomer 
conformer with equatorial phenyl groups.  The calculated VCD intensites for the (S,S)-
equatorial and (R,R)-axial conformers are quite similar, and for the most intense bands, above 
1550 cm
-1
, show good agreement with experiment, allowing correlation of the VCD spectra 
in this region with the puckering of the Co(II) diamine ring (Fig. 12).  The calculated energies 
place the equatorial conformer 1.2 kcal/mol higher in energy (12% population).  Thus, the 
comparison of observed and calculated VCD spectra confirm the absolute configuration of 
the sample synthesized as (R,R), and identify a dominant axial phenyl group conformation in 
solution for CoSaldiphenyl.
 The electronic CD for (R,R)-CoSA and (R,R)-CoSaldiphenyl near 2200 cm
-1
 have 
opposite sign, and the REVCD features for (R,R)-CoSaldiphenyl are predominantly negative, 
whereas those for (R,R)-CoSA are predominantly positive. We note that the Co(II) diamine 
ring puckering is opposite for the two complexes (Fig. 12), and both the electronic CD and 
REVCD correlate with these opposite chiral environments at the Co(II), rather than with the 
(R,R) absolute configuration designation.
 The observed and calculated IR and VCD spectra for low-spin (R,R)-NiSaldiphenyl
are compared in Fig. 14.  The non-enhanced VCD intensity magnitudes and overall sign 
pattern are reproduced in the calculation.   The calculated geometry (Fig. 11) shows a slightly 
more planar metal-N2O2 coordination for the Ni(II) complex compared to the Co(II) complex, 
but a similar diamine ring puckering.   
Metal salbinaphthyl complexes (4).  The IR and VCD spectra for metal complexes 
with the binaphthyl Schiff-base ligand (R,R)-MCl4Salbinapht are compared for M = Co(II), 
Ni(II) and Zn(II) in Figure 15.  The low-lying electronic transition for (R)-CoCl4Salbinapht is 
observed at 2240 cm
-1
, with positive ECD intensity.  The mid-IR REVCD occurs on the low-
frequency tail of the ECD, with VCD anisotropy ratios for CoCl4Salbinapht on the order of 
10
-3
 with the highest value of ~5 x10-3 at 1380 cm-1.  The Ni(II) and Zn(II)-Cl4Salbinapht 
complexes do not have low-lying electronic transitions, and exhibit similar non-enhanced 
VCD intensities a factor of 10 lower than those of the Co(II) complex.   
 In Figure 16, the REVCD for four chiral Co(II) Schiff-base complexes are compared.  
Focusing on the two Salbinapht complexes, we can compare the effects of the H vs. Cl 
substituents at the 3-,  5-, 3’- and 5’-positions of the Schiff-base phenyl rings.  For (R)-
CoH4Salbinapht, positive ECD is observed centered at 2540 cm
-1
, 300 cm
-1
 higher than for 
CoCl4Salbinapht, and the maximum REVCD anisotropy ratio is ~5.7x10-3 at 1318 cm-1.
The differences in the IR and VCD patterns for the two Salbinapht complexes reflect the 
different vibrational contributions from the disubstituted and tetrasubstituted phenyl rings.    
 Geometry and VCD calculations were carried out for CoSalbinapht in both the low-
spin (doublet) and high-spin (quartet) states.  The calculated optimized geometries are quite 
different, with the CoN2O2 coordination distorted planar for low-spin, and distorted 
tetrahedral for high-spin (Figure 17).   Comparison of the observed and calculated spectra for 
the two spin states (Figure 18) shows better agreement with experiment for both IR and VCD 
for the high-spin state.  Although some of the VCD sign pattern agrees with experiment, the 
fit is not as good as for the low-spin, approximately square planar coordination in CoSA and 
CoSaldiphenyl complexes shown above in Figures 5 and 13.   
Effects of O2 Binding on the REVCD for (R,R)- CoSA. Cobalt(II) salen complexes have 
been shown to bind oxygen reversibly in the presence of a base such as 1-methylimidazole 
(1-MeIm) or pyridine.
13-16
  Two types of addition complexes have been considered, oxidative 
additions to form a monomeric species
13,16,37
 with O2
-
 and a dimeric species
11,12,38
 with O2
2-
(dimer shown schematically in Scheme 2).     
7 In Figure 18, we show spectra for several points in the titration of (R,R)-CoSA, 1,
with 1-methyl imidazole (0 to 2 molar equivalents) in the presence of oxygen.  A striking 
decrease in REVCD intensity is observed, concurrent with growth of IR features at 1629, 
1437 and 1100 cm
-1
 and decrease in IR intensity for bands near 1600 cm
-1
.   As seen from the 
comparisons with and without O2 in Figure 19, the VCD spectral changes occur only in the 
presence of oxygen, and with a 2-fold molar equivalent of base, the VCD intensity is reduced 
to a non-enhanced level.  We show plots of the IR intensity at 1629 cm
-1
 and VCD intensity 
at 1600 cm
-1 
as a function of 1-MeIm concentration in the presence of O2 in Figure 20.   The 
monomer and dimer equilibria with O2 in the presence of base and their associated 
equilibrium constants are  
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The concentration of CoSA in the solution at each point in the titration is proportional to the 
REVCD intensity at 1600 cm
-1
, because the VCD of the oxygen-bound complex is not 
enhanced and is thus very weak at that frequency.    The equilibrium constants can therefore 
be calculated at each point in the titration from the initial concentrations of CoSA and 1-
MeIm and the CoSA concentration deduced from the VCD spectrum.   For up to a 1-fold 
equivalent of 1-MeIm, a constant value is obtained for K2, but not for K1, confirming that the 
oxidative addition of O2 to CoSA in the presence of base generates a P-peroxide dimer 
(Scheme 2, Eq. 10) in CDCl3 solution at room temperature.  Above 1-fold molar equivalent 
base, competing equilibria, such as axial binding of two 1-MeIm molecules with the metal 
center, limit the formation of additional peroxide dimer.  Our data suggest that at room 
temperature and ambient oxygen pressure, the base only binds when oxygen is present, since 
the VCD spectrum with two-fold molar equivalent 1-MeIm without oxygen is identical to 
that in the absence of 1-MeIm.  The dramatic decrease in REVCD intensity during the 
titration is readily interpreted in terms of the oxidative addition producing a Co(III) center 
with no low-lying electronic states.    
Co
3+
OCo
3+
N
N
O N
N
Scheme 2 
8Fig. 1.  Observed VCD (upper frames) and IR (lower frames) spectra of (R,R)-CoSA (red) 
and (S,S)-CoSA (blue) in CDCl3 solution, in near-IR (left), C-H stretching (middle) and mid-
IR (right) regions.  Near-IR region: 31.1mg/700µL (R,R)- and 20.5mg/500µL (S,S)- in 
CDCl3,  1 mm pathlength BaF2 cell, 16 cm
-1 
resolution, 2 h collection, PEM optimized at 
4700 cm
-1
.  C-H stretching region: 8.5mg/200µL (R,R)- and 9.1mg/200µL (S,S)- in CDCl3,
92 µm pathlength BaF2 cell, 8 cm
-1
 resolution, 4 h collection, instrument optimized at 3000 
cm
-1
.  Mid-IR region: 5.4mg/154µL (R,R)- and 6.4mg/200µL (S,S)- in CDCl3, 92 µm 
pathlength BaF2 cell, 4 cm
-1
 resolution, 1 h collection, instrument optimized at 3000 cm
-1
.
Baselines corrected by subtraction of solvent spectra.  VCD artifact from intense CDCl3
absorbance indicated by *. 
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Fig. 2.  Observed VCD (upper frame) and 
IR (lower frame) spectra of (R,R)-AlClSA
(6.2mg/180µL, 57 mM), (R,R)-MnClSA
(5.4mg/150µL, 54 mM) and (R,R)-CrClSA 
(6.7mg/180µL, 57 mM) in CDCl3; 92 µm 
pathlength BaF2 cell, instrument optimized 
at 1400 cm
-1
, 4 cm
-1
 resolution and 1 h 
collection. Spectral baselines were 
corrected by subtraction of CDCl3 spectra 
from sample spectra.  Baselines corrected 
by subtraction of solvent spectra.  Spectra 
of CrClSA and AlClSA are offset on molar 
absorptivity axis for clarity. 
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Fig. 3.  Observed VCD (upper frames) and 
IR (lower frames) spectra of (R,R)-CoSA
(5.4mg/154µL, 58 mM in CDCl3) and 
(R,R)-MnClSA (5.4mg/150µL, 57 mM in 
CDCl3);  92 µm pathlength BaF2 cell, 
instrument optimized at 1400 cm
-1
, 4 cm
-1
resolution and 1 h collection. scanning.  
Baselines corrected by subtraction of 
solvent spectra.   
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Fig. 4.   Optimized structures of (R,R)-CoSA (left, B3LYP functional, Ahlrich VTZ (Co) and 
6-31G(d) (ligand) basis sets) and model for (R,R)-MnClSA without t-butyl groups (right, 
B3LYP functional, LanL2DZ basis set). 
Fig. 5.  Comparison of observed (right 
axes) and calculated (left axes) IR and 
VCD spectra of (R,R)-CoSA.  Sample 
measured with a concentration of 
5.4mg/154µL (58mM) in CDCl3, 92 µm 
pathlength BaF2 cell, 1 hour collection, 4 
cm
-1
 resolution, PEM optimized at 1400 
cm
-1
.  Calculation with Gaussian 03 at 
DFT level with B3LYP functional and 6-
31G(d) basis set for the ligand and Ahlrich 
VTZ
24
 basis set for low-spin Co(II), 5 cm
-1
half-width, frequency scaled by 0.97.
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Fig. 6.  Comparison of calculated IR 
(lower frame) and VCD (upper frame) for 
(R,R)-CoSA, DFT with B3LYP functional 
and LanL2DZ (high-spin and low-spin 
Co(II) and Ahlrich VTZ (Co)/6-31G(d) 
(ligand) basis sets, 5 cm
-1
 half-widths, 
frequencies scaled by 0.97.  
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Fig. 7. Comparison of observed (right 
axes) and calculated (left axes) IR and 
VCD spectra of (R,R)-MnClSA.   Sample 
measured with concentration 5.4mg/150µL 
(57 mM) in CDCl3, 92 µm pathlength 
BaF2 cell, instrument optimized at 1400 
cm
-1
, 4 cm
-1
 resolution and 1 h collection. 
Calculation with Gaussian 03 at DFT level 
with B3LYP functional and LanL2DZ 
basis set for complex without t-butyl 
groups.
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Fig. 8.  IR (lower frame) and VCD (upper 
frame) spectra of (R,R)-CoSA in CDCl3
solution (conditions as in Fig. 4, left axes) 
compared to mull in mineral oil (right 
axes, 1 h collection, 4 cm
-1
 resolution, 
instrument optimized at 1400 cm
-1
, IR 
intensity scaled to solution and same scale 
factor used for mull VCD).  Baselines 
corrected by subtraction of corresponding 
spectra of CDCl3 or mineral oil.  
Fig. 9.  Dimer of (R,R)-CoSA, from crystal 
structure.  Hydrogens and t-butyl groups 
omitted for clarity. 
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Fig.  10.  Comparison of observed VCD (upper frames) and IR (lower frames) spectra of 
(R,R)-MSaldiphenyl (M = Co(II) and Ni(II), sample concentrations are ~ 0.12 M in CDCl3).
Spectra collected with 6 1-h blocks at 8 cm
-1
 resolution using a 54 µm pathlength cell with 
BaF2 windows, and the PEM optimized at 2000 cm
-1
.  Baselines corrected by subtraction of 
solvent spectra.  Spectra of Ni(II) complex are offset in molar absorptivity for clarity.  
Artifacts from intense CDCl3 absorbance are indicated by *. 
Fig. 11.  Optimized geometries of (a) (S,S)-CoSaldiphenyl with equatorial phenyl 
substituents, viewed along inertial axis perpendicular to C2-axis, and (b) (R,R)-CoSaldiphenyl
and (c) (R,R)-NiSaldiphenyl with axial phenyl substituents, viewed along C2-axis.
(a)  (S,S)-CoSaldiphenyl       (b)  (R,R)-CoSaldiphenyl       (c)  (R,R)-NiSaldiphenyl
 equatorial   axial    axial 
13
 Fig. 12.  Comparison of ring puckering in (R,R)-CoSA with that in either (S,S)-
CoSaldiphenyl (equatorial phenyl conformer) or (R,R)-CoSaldiphenyl (axial phenyl 
conformer); structures taken from optimized DFT geometries.      
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Fig. 13.  Observed VCD (upper frame) and 
IR (lower frame) spectra of (R,R)-
CoSaldiphenyl compared with calculated 
spectra of the axial conformer of (R,R)-
CoSaldiphenyl and the equatorial 
conformer of (S,S)-CoSaldiphenyl.  The 
observed spectra were obtained under the 
same conditions as in Figure 10.  
Calculations of the VCD and IR spectra 
carried out with Gaussian 03 at DFT level 
with B3LYP functional and 6-31G(d) basis 
set for C, N, O, H and Ahlrich VTZ basis 
set for low-spin Co(II). 
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Fig. 14. Observed VCD (upper frame) and 
IR (lower frame) spectra of (R,R)-
NiSaldiphenyl compared with calculated 
spectra of the axial conformer.  The 
observed spectra were obtained under the 
same conditions as in Figure 10.  
Calculations of the VCD and IR spectra 
carried out with Gaussian 03 at DFT level 
with B3LYP functional and 6-31G(d) basis 
set for C, N, O, H and Ahlrich VTZ basis 
set for low-spin Ni(II). 
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Fig. 15.  Comparison of observed VCD 
(upper frame) and IR (lower frame) spectra 
of (R,R)-MCl4Salbinapht (M = Co(II), 
Ni(II) and Zn(II), sample concentrations 
~75mM in CDCl3).  Spectra were collected 
with six 1-h blocks at 8 cm
-1
 resolution 
using a 54 µm pathlength cell with BaF2
windows, PEM optimized at 2000 cm
-1
.
Baselines corrected by subtraction of 
solvent spectra.  Molar absorptivities of 
Zn(II) and Ni(II) complexes offset for 
clarity.
'H
0
2
4
6
8
3500 3000 2500 2000 1500 1000
Wavenumber (cm-1)
0
500
1000
1500
2000
2500
3000
M
o
la
r 
A
b
s
o
rp
ti
v
it
y
, 
H (R,R)-CoSA
(R,R)-CoSA
(R,R)-CoCl4Salbinapht
(R,R)-CoSalbinapht
(R,R)-CoCl4Salbinapht
(R,R)-CoSalbinapht
(R,R)-CoSaldiphenyl
(R,R)-CoSaldiphenyl
Fig. 16.  Comparison of observed VCD 
(upper frames) and IR (lower frames) 
spectra of (R,R)-CoSaldiphenyl (0.12M), 
(R)-CoSalbinapht (95 mM), (R)-
CoCl4Salbinapht (77 mM) and (R,R)-
CoSA (58mM) in CDCl3.  Spectra were 
collected with six 1-h blocks scanning at 8 
cm
-1
 resolution using a 54 µm pathlength 
cell with BaF2 windows, and the PEM 
optimized at 2000 cm
-1
.  Baselines 
corrected by subtraction of solvent spectra.  
Molar absorptivities offset for clarity.  IR 
absorbance near 2250 cm
-1
 due to intense 
CDCl3 solvent band. 
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Figure 17.  Optimized structures of CoSalbinapht, in high- and low-spin states (Gaussian 03, 
DFT with B3LYP functional, 6-31G(d) basis for ligand, Ahlrichs VTZ basis for Co(II)). 
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Fig. 18.  Comparison of VCD (upper 
frame) and IR (lower frame) spectra 
observed for (R)-CoSalbinapht (right axes) 
with calculated spectra for the high- and 
low-spin Co(II) complexes (left axes).  
Observed spectra were obtained under 
conditions in Figure 16.  Calculations of 
the VCD and IR spectra carried out with 
Gaussian 03 at DFT level with B3LYP 
functional and 6-31G(d) basis set for C, N, 
O, H and Ahlrich VTZ basis set for Co(II). 
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Fig. 19.  Observed VCD (upper frame) and 
IR (lower frame) spectra of (R,R)-CoSA 
(30 mM) equilibrated with 0 to 2 molar 
equivalents of 1-methylimidazole as 
indicated, in the presence of O2; 0.10 mm 
pathlength BaF2 cell, 1 hour collection, 4 
cm
-1
 resolution, PEM optimized at 1400 
cm
-1
.  Spectral baselines  corrected by 
subtracting solvent spectra. 
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Fig. 20.  Observed VCD (upper frame) and 
IR (lower frame) spectra of (R,R)-CoSA
(30 mM) with 0, 1 and 2 fold of 1-
methylimidazole with (red curves) and 
without (black curves) the presence of O2.
The spectra (optimized at 1400 cm
-1
) were 
collected at 4 cm
-1
 resolution, 0.1 mm 
pathlength cell with BaF2 windows, 1-h 
collection for solvent and sample.  Spectral 
baselines corrected by subtracting solvent 
spectra.  Spectra are offset in molar 
absorptivity for clarity. 
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Fig. 21.  Observed VCD intensity at 1600 
cm
-1
 (upper frame) and IR intensity at 
1629 cm
-1
 (lower frame) of (R,R)-CoSA in 
CDCl3(30mM) equilibrated with various 
concentrations of 1-methylimidazole in the 
presence of O2.
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